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Abstract 
Increasing epidemiological evidence for the beneficial health effects of 
(poly)phenol-rich products has led to a growing interest in the role of (poly)phenols 
in reducing the incidence of chronic diseases. Coffee is a major contributor to 
dietary chlorogenic acids. However, the majority of these, unlike free phenolic acids, 
first need to be cleaved in order to be absorbed and about 70 % of them reach the 
colon intact where they are processed by the microbiota population. 
First, the analysis of major free phenolic acids in five commercially available 
soluble coffees is described. The influence of roasting and decaffeination and the 
contribution of free phenolic acids to the appearance of derived metabolites in 
plasma resulting from a pre-colonic absorption are then assessed. The hypothesis 
was that, as reported for chlorogenic acids, both roasting and decaffeination would 
have a negative impact on the quantified compounds. The contribution of free 
phenolic acids to the appearance of derived pre-colonic metabolites in plasma was 
hypothesized to be significant, as these are easily absorbed in the gastrointestinal 
tract. Results indicated that roasting and decaffeination reduce the amount of 
hydroxycinnamic acids, which in the amounts consumed with a regular coffee 
beverage do not significantly contribute to the early appearance of derived 
metabolites. The hydrolysis of 5-O-caffeoylquinic acid and 3-O-caffeoylquinic acid 
is a likely major contributing mechanism to the early appearance of derived 
metabolites in plasma. 
In a second stage, the impact of habitual consumption of popular (poly)phenol-rich 
products on human health and the impact of habitual consumption of coffee on the 
absorption and metabolism of chlorogenic acids were assessed in an observational 
human study with 62 healthy adult participants. The health status of the study 
population was assessed by the quantification of selected biomarkers of health using 
optimized methods, which were based on published protocols. The major hypotheses 
in this second section were that the metabolism of the biomarkers was stable over 
the study period (i.e. max 16 weeks); that subjects with a higher regular 
consumption of (poly)phenol-rich products have a healthier profile of biomarkers 
and that subjects with a higher absorption of coffee (poly)phenols have a healthier 
- vi - 
profile of biomarkers. A healthy and overall stable metabolism of the quantified 
inflammation and cardiovascular biomarkers (i.e. total aminothiols, glucose, insulin 
and uric acid) over a period of at least 8 - 16 weeks was confirmed. Subjects with a 
higher consumption were more likely to also be higher consumers of other 
(poly)phenol-rich products. A higher consumption of (poly)phenol-rich products 
was not associated with a better inflammatory and cardiovascular health profile, but 
the a higher presence of two colonic metabolites (i.e. vanilloylglycine and 
feruloylglycine) was associated with higher levels of glutathione. Overall, the results 
suggested a reduced bioavailability of chlorogenic acids with a higher habitual 
consumption of coffee including associated (poly)phenols, and encourage future 
investigations targeting the colonic microbiota populations. 
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Chapter 1 
Literature review and objectives 
 In the human diet, (poly)phenols represent the most abundant antioxidants 
and have therefore attracted increasing interest. These plant secondary metabolites 
are present in all plant-derived foods and beverages (Pandey and Rizvi, 2009). 
Unlike primary metabolites, (poly)phenols are not essential for photosynthesis, 
respiration, growth or development of the plant, but they play an important role in its 
survival, as they are involved in processes such as protection against ultraviolet 
radiation, infection by pathogens or bacteria, through anti-mutagenic properties, and 
lignin biosynthesis (Pandey and Rizvi, 2009, Frohnmeyer and Staiger, 2003, 
Lattanzio et al., 2006). (Poly)phenols are present at a higher concentration in the 
outer layers and therefore also contribute to the organoleptic properties of the plant 
(i.e. pigmentation and bitter or astringent taste) (Crozier et al., 2006a). Of particular 
interest is the study of popular (poly)phenol-rich products such as coffee, tea and 
cocoa preparations, as well as fruits, vegetables, (poly)phenol-based supplements 
and some alcohol-containing beverages in terms of their effects on health. The 
present dissertation will focus on the influence of habitual consumption of 
(poly)phenol-rich non-alcoholic products, with emphasis on coffee, on human 
general health. Carefully selected biomarkers are a useful tool to assess a particular 
health status of a subjects as these are the result from the metabolism and will be 
used in this context to understand the impact on health of a habitual consumption of 
(poly)phenol-rich products, with emphasis on coffee. 
 
1.1 Coffee 
 Formerly consumed as its fruit or cherry for its energizing properties, coffee 
was later also sold for its believed medicinal qualities, such as clearing out the bowel 
(Brown et al., 1990). Coffee is now the second most traded commodity in the world 
after oil and is included amongst the most popular beverages worldwide 
(http://www.investorguide.com/article/11836/what-are-the-most-commonly-traded-
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commodities-igu/), along with water and tea, due to its stimulant properties on the 
body and mind and increasing public awareness of the bioactive contents of coffee 
and interest in the health benefits related to its constituent (poly)phenols. 
 
1.1.1 From bean to beverage 
 Ideal growing conditions for coffee are found between the Tropics of Cancer 
and Capricorn, where the average annual temperature is about 21°C, the rainfall is 
abundant and the soils are well drained and nutrient-rich. Although many Coffea 
species have been described, two major species of coffee plant, representing over 
60% of the world production, are grown for commercial purposes, namely Robusta 
(Coffea canephora) and Typica (Coffea arabica), and to a lesser extent Liberica 
(Coffea liberica) and Excelsa (Coffea dewevrei) (www.ico.org).  
 Coffee beans are contained in a red berry fruit. The first step in coffee 
processing, after picking, is the isolation of the beans from their involving layers. 
This can be achieved either using the “wet” or “dry” method. In the “wet” 
processing method, the coffee beans are sorted in a water-floatation system and sent 
to a puling machine to remove the outermost epicarp. During fermentation in water, 
the next layer (mesocarp) is enzymatically dissolved. The beans are then washed and 
dried in the sun or using mechanical dryers. Endocarp and spermoderm are removed 
in the final hulling step before storage and shipping. The “dry” processing method is 
a more economical option, as beans are usually stripped all at once, collected from 
the ground and sundried before the removal of the hull and most of the silverskin or 
testa by a coffee huller. 
 The different stages of coffee processing will influence the chemical 
composition of the beans, and consequently, the final flavour. Decaffeination, the 
removal of caffeine, however never absolute (≤ 0.1 % residual caffeine), is one of 
the processing steps of coffee performed on the unroasted green beans 
(www.ico.org). Four major commercial decaffeination methods exist and briefly 
consist of water, ethyl-acetate, methylene chloride and carbon dioxide decaffeination 
methods. In a water decaffeination, the coffee beans are immersed in a hot water 
saturated with water-soluble aromatic coffee components to minimize the loss of the 
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aroma. The saturated water is then passed through a filter of activated carbon that 
retains the extracted caffeine. The ethyl-acetate (also referred to as "natural 
decaffeination") and methylene chloride decaffeination methods are comparable, as 
in both methods, the coffee beans are first softened in hot water or steam. In this 
process, caffeine and a fraction of the oils and flavour are extracted. The 
recirculation of ethyl-acetate or methylene chloride in the extracting water removes 
the caffeine and allows the coffee beans to re-equilibrate and take up the lost 
aromatics and oils. Finally, in the decaffeination by carbon dioxide, carbon dioxide 
is added to the extracting water in its supercritical state (pressure of up to 250 atm). 
Subsequently, caffeine is selectively eliminated with the removal of carbon dioxide. 
This method does not affect the other coffee constituents, but it is also costly and 




1.1.2 Composition and biologically active components 
 There are variations in the amounts of chemical contents between C. arabica 
and C. robusta, but both have the same complex mixture of compounds. As the 
green beans undergo processing (e.g. storage and roasting), the original chemical 
profile of coffee changes as a result of transformation or even progressive 
destruction of certain components (Ludwig et al., 2014). Roasting particularly 
affects the constituent profile of coffee, with the production of compounds resulting 
from the Maillard reaction (Ludwig et al., 2014). Coffee has been reported to contain 
more than a thousand chemicals, including carbohydrates, vitamins, lipids, amino 
acids, non-protein nitrogenous compounds, minerals, the diterpenes kahweol and 
cafestol, alkaloids (e.g. caffeine) and phenolic compounds which are part of the 
bioactive compounds of coffee and possess various effects on health (Spiller, 1998, 
Ludwig et al., 2014). The compounds described below constitute only a small 
fraction of the chemical composition of coffee. 
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1.1.2.1 Caffeine 
 The major naturally occurring bioactive constituent of coffee beans, and 
probably the most well known, is caffeine or 1,3,7-trymethylxanthine. This purine is 
distributed in the coffee pulp and found free in the cytoplasm of the seed or bound to 
the cell wall. On a dry basis, there is about twice as much caffeine in C. robusta (1.7 
- 4.0%) as in C. arabica (0.8 - 1.4%). At the concentrations reached in plasma after 
coffee consumption (i.e. 20 - 40 μM), the principal pharmacological actions of 
caffeine are, due to structural similarities (Figure 1.1), the antagonism of A1 and A2a 
subtypes of the adenosine receptor (Fisone et al., 2004) with the main metabolic 
activities being the stimulation of the central nervous system and increase of the 
blood pressure, metabolic rate and diuresis (Carrillo and Benitez, 2000). Relatively 
recent findings also suggested a beneficial effect of this alkaloid on type 2 diabetes 
mellitus (T2DM) and obesity (Westerterp-Plantenga et al., 2006, Heckman et al., 
2010). Caffeine is rapidly and almost fully absorbed in the stomach and small 
intestine to then be distributed to all tissues. When ingested at higher doses, the 
clearance of caffeine is however decreased and the usual 3 - 6 hour half-life is 
extended (Heckman et al., 2010). Only about 1% of the caffeine is directly excreted 
in urine without being metabolized (Clifford, 1985), the rest of the caffeine is 
metabolized in the liver to form three major metabolites, namely 1,7-, 3,7-, and 1,3-
dimethylxanthine, or paraxanthine (84%), theobromine (12%) and theophylline 
(4%), respectively. These will in turn be further metabolized. 
 
 
Figure 1.1: Structural similarity between caffeine (a) and adenosine (b). Caffeine 
binds to the adenosine receptors A1 and A2a and acts as an inhibitor of these. 
A B 
- 5 - 
 
1.1.2.2 Diterpernes 
 Cafestol and kahweol are two diterpenes that can be isolated from coffee oil 
and identified as the cause of reported elevation of total and LDL cholesterol in 
serum (Urgert and Katan, 1997). This increase is, however, attenuated when the 
consumed coffee is filtered, as most of the cafestol and kahweol are retained (Jee et 
al., 2001). Aiming at understanding the molecular mechanisms behind the 
cholesterol-raising effect of cafestol consumption, APOE3 Leiden mice, a well-
recognized model used for patients with diet-induced hyperlipidemia, were used in a 
study carried out by Post et al. (2000). In this study, cafestol was shown to act by 
suppressing the synthesis of bile acids, which are essential for the regulation of 
dietary lipids and lipophilic vitamins. Besides their cholesterol-raising effect, 
cafestol and kahweol have the property of decreasing mutagenesis and tumorigenesis 
in animal models (Arab, 2010). 
 
1.1.2.3 Trace elements 
 Although micronutrients play key roles in the physiology of plant and animal 
organisms, these are not secondary metabolites and are therefore not categorised as 
bioactive compounds. Trace elements, such as minerals, are important in plant 
nutrition, and sometimes in the defence against disease (Clifford, 1985). In animal 
organisms, whether they are part of a catalytic centre and facilitating the conversion 
of substrates to end products (e.g. copper), whether they donate or accept electrons 
in redox reactions, whether they bind, transport and release oxygen in the body (e.g. 
iron) or whether they are of structural significance in the stabilization of the tertiary 
structure of biological molecules (e.g. zinc), micronutrients play an important role in 
maintaining a healthy and equilibrated metabolism (Shenkin, 2006). Micronutrients 
consumed through coffee could therefore also contribute to these health aspects in 
humans. 
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1.1.2.4 (Poly)phenols 
 (Poly)phenols are characterized by several hydroxyl groups on aromatic 
ring(s), but their chemical structure is variable and can reach high levels of 
complexity (D'Archivio et al., 2007). Their classification is based upon the number 
of phenol rings and the structural elements holding these together. Five main classes, 
namely phenolic acids, flavonoids, stilbenes, lignans and phenolic alcohols are 
recognized and each of them can be subdivided into sub-classes. Of particular 
interest in the present project are hydroxycinnamic acids, a sub-class of phenolic 
acids that is abundantly, but not exclusively, present in coffee (Clifford, 1999). The 
most common hydroxycinnamic acids are caffeic, ferulic, p-coumaric, 
dihydrocaffeic, isoferulic, dihydroferulic and 3, 4-dimethoxycinnamic acid (Figure 
1.2, A). In nature and unprocessed foods, hydroxycinnamic acids most often appear 
as their esters with quinic acid, referred to as chlorogenic acids. An increasing 
number of chlorogenic acids has been reported (Clifford, 1985, Clifford et al., 2006), 
but the ones of major interest for the present project chiefly consist of caffeoylquinic 
acids (i.e. 3-, 4- and 5-O-caffeoylquinic acid) (Figure 1.2, B), which can represent > 
70 % of the total chlorogenic acids in coffee (Stalmach et al., 2010). The remaining 
(poly)phenolic fraction is mainly represented by feruloyquinic acids (i.e. 3-, 4- and 
5-O-feruloylquinic acid), caffeoylquinic acid lactones (i.e. 3- and 4-O-caffeoylquinic 
acid lactone), dicaffeoylquinic acids (i.e. 3, 4-, 3, 5- and 4, 5-dicaffeoylquinic acid) 
and p-coumaroylquinic acids (i.e. 4- and 5-O-p-coumaroylquinic acid) (Stalmach et 
al., 2010). The chlorogenic acid composition of coffee is influenced by the species 
and cultivars (Clifford, 1985), as well as by processing (Crozier et al., 2006b). On a 
dry matter basis, green coffee beans contain about 5-10% chlorogenic acids (Ky et 
al., 1997), but a progressive destruction and modification of the chlorogenic acid 
profile is observed upon roasting (Ludwig et al., 2014). Despite this loss, the 
amounts of chlorogenic acids present in a regular cup of coffee are significant, and 
for regular coffee consumers, the daily chlorogenic acid intake can reach 1 g 
(Stalmach et al., 2009). Stalmach et al. quantified, in a 200 mL coffee beverage 
prepared from the solubilization of 3.4 g coffee pellets, a chlorogenic acid content of 
146 mg, of which 65 % were caffeoylquinic acids (Stalmach et al., 2009). Upon 
analysis of several espresso preparations, Crozier et al. reported a content of total 
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caffeoylquinic acids ranging from 24 to 422 mg for an espresso beverage of 23 to 70 

























Figure 1.2: Major free hydroxycinnamic acids (A) and chlorogenic acids (B) present 
in coffee. Hydroxycinnamic acids share a common C6-C3 skeleton structure 
(structure shown in A). Free hydroxycinnamic acids are mostly present as their ester 
with quinic acid (structure shown in A), referred to as chlorogenic acids. 
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1.1.3 Metabolism of chlorogenic acids 
 Once ingested, chlorogenic acids are exposed to different environments in 
the digestive system. In the mouth, the combined action of mastication, enzymes 
present in the saliva and bacteria contributes to the release of (poly)phenols from the 
food matrix and to their bioaccessibility (Bohn, 2014, Alminger et al., 2014). In the 
stomach, the low pH of 2 - 4, the gastric enzymes, such as pepsin, and the peristaltic 
movements further reduce the size of the digest and increase the bioaccessibility of 
(poly)phenols. In an in vitro model of gastric epithelium, upon incubation of coffee 
solutions (9, 18 or 27 mg/mL) under conditions mimicking the human gastric 
compartment, an increase in isoferulic, ferulic and dimethoxycinnamic acids, 
resulting from the hydrolysis of chlorogenic acids, as well as passive and facilitated 
absorptions of intact chlorogenic acids were observed (Farrell et al., 2011) (Figure 1. 
3), suggesting a possible absorption of these compounds in the stomach in vivo. In 
the small intestine the peristaltic movements remain present, however, the pH 
increases to approximately pH 7, which provides a favourable environment for the 
enzymes present in pancreatic and bile secretions. By comparing the excreted 
chlorogenic acid-derived urinary metabolites in ileostomy participants and in 
subjects with an intact colon, it was possible to assess that about 30 % of the 
ingested chlorogenic acids are absorbed before reaching the colon, while the 
remaining 70 % passes to the colon and are exposed to the microbiota activity 
(Stalmach et al., 2009, Stalmach et al., 2010). Microbiota are important constituents 
of the gastrointestinal tract and are essential for a balanced metabolic and immune 
system (Marín et al., 2014, Zoetendal and de Vos, 2014). As the gastrointestinal tract 
progresses, the microbiota population increases and reaches 10 
12
 cells per gram of 
content in the colon (Sekirov et al., 2010), where these will hydrolyze the glycosides 
into aglycones, allowing absorption. 
 Chlorogenic acids and other (poly)phenols are perceived as xenobiotics and 
are metabolised as such by the human organism. Once absorbed, the compounds are 
subject to a phase I and II metabolism. Phase I renders the compounds more 
hydrophilic, by reduction, oxidation, hydrolysis or hydration, thus facilitating the 
urinary and biliary excretion of the compound (Manach et al., 2004, Bohn, 2014). 
Phase II metabolism consists mainly of sulfation (by sulfurotransferase, SULT), 
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methylation (catechol-O-methyl transferase, COMT) and glucuronidation 
(glucuronosyltransferase, UGT) conjugation reactions and further facilitates the 
excretion. Although the liver is the major organ for phase II metabolism, conjugation 
by glucuronosyltransferases and sulfurotransferases also occurs in the small intestine 
where these enzymes have been detected (Manach et al., 2004). A schematic 
representation of the metabolism and absorption of major coffee chlorogenic acids 
as suggested by Farrell et al., Stalmach et al. and da Encarnação et al. is shown in 
Figure 1. 3. 
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Absorbed compounds undergo phase I (e.g. reduction, oxidation, hydrolysis, hydration) and 
phase II (sulfation, methylation, glucuronidation) metabolism for facilitating the excretion in urine

























































































































































































































































































































Figure 1. 3: Metabolism and absorption of chlorogenic acids, as suggested by Farrell et 
al. (2011) and metabolism and absorption of 3- and 5-caffeoylquinic acid in the small and 
large intestine, as suggested by Stalmach et al. (2010) and da Encarnação et al. (2014). 
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 In order to have any physiological effect (bioefficacy), a bioactive compound 
first needs to be absorbed and enter the circulation (bioavailable), which, however, 
does not imply that a compound with high bioavailability will necessarily have a 
high bioefficacy and vice versa. As previously seen, although chlorogenic acids are 
abundant in coffee, these have difficulty when passing the epithelial barrier of the 
gastrointestinal tract in their native form. Free hydroxycinnamic acids pass the 
epithelial barrier much more easily, and therefore, these aglycones of chlorogenic 
acids, as well as chlorogenic acid derivatives are more likely to be the compounds 
which have a higher impact on the metabolism. Although in vitro studies are 
important to understand the molecular aspects of the metabolism of (poly)phenols, 
they cannot replace human studies and in order to understand the impact of habitual 
consumption of (poly)phenol-rich products on human health, bioavailability studies 
are important as these include the analysis of plasma, urine and faecal samples upon 
consumption of a studied product. The analysis of metabolites in these biological 
samples improves the understanding of the metabolism. Specifically, in 
pharmacokinetic studies, the metabolites resulting from a pre-colonic or colonic 
absorption can be identified. Typically, compounds that are absorbed before the 
colon (e.g. caffeic, ferulic, isoferulic and 3,4-dimethoxycinnamic acid) appear in 
plasma approximately up to 3 hours (Tmax = 0.5 to 2.0 hours) upon consumption of a 
product, while compounds absorbed in the colon (e.g. dihydrocaffeic, dihydroferulic 
and free hydroxycinnamic acids resulting from the catabolism of chlorogenic acids) 
appear in plasma approximately 4 hours (Tmax = 4.8 to > 12 hours) after 
consumption of a product (Renouf et al., 2010b, Williamson et al., 2011). 
 
1.2 Coffee and other (poly)phenol-rich products and health 
 (Poly)phenols have been associated with a decreased risk of some diseases 
such as cancer, cardiovascular diseases and other chronic diseases (Scalbert and 
Williamson, 2000). Many earlier conclusions were, however, based on animal or in 
vitro studies, and although this initial research is important to understand the 
underlying molecular mechanisms of action, the outcomes are difficult to extrapolate 
to human metabolism. Weichselbaum et al. (2010) reviewed that in vitro studies 
have either shown or suggested several processes that could contribute to the 
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antioxidant properties of (poly)phenols. (Poly)phenols, such as flavonoids (Garcia-
Lafuente et al., 2009) or phenolic acids (i.e. caffeic acid) (Li et al., 2005) have also 
been shown to improve endothelial function and several epidemiological studies 
have demonstrated that diets enriched with tea, a flavonoid-rich product, were 
associated with a lower risk of myocardial infarction, whether in case-control or 
cohort studies (Peters et al., 2001). 
 As effective inhibitors of LDL oxidation, certain (poly)phenol-rich products 
have the potential to reduce the risk of developing certain chronic conditions such as 
atherosclerosis, and later cardiovascular disease. Aviram et al. (2000) reported upon 
conduction of an in vitro and ex vivo study, that pomegranade juice, rich in 
flavonoids, inhibited peroxidation in plasma and isolated LDL and HDL, in vitro and 
in vivo. Inactivation of free radicals, reduction of the oxidative potential of metal 
ions, inhibition of pro-oxidant enzymes, induction of antioxidant enzymes and 
possibly the protection of other antioxidants such as ascorbic acid are other potential 
mechanisms of indirect action that could further contribute to the antioxidant status 
of (poly)phenols in vivo. Iwai et al. (2004) investigated the in vitro antioxidative 
effects of seven hydroxycinnamoyl derivatives extracted from green coffee beans, 
namely, 3-, 4- and 5-cafeoylquinic acid, 5-feruloyquinic acid and 3, 4-, 3, 5-, and 4, 
5-dicafeoylquinic acid and their ability of inhibiting tyrosinase (Iwai et al., 2004). 
The free radical and superoxide anion radical scavenging activity was the highest for 
the dicaffeoylquinic acids, followed by the caffeoylquinic acids and 5-feruloylquinic 
acid. Similarly, the tyrosinase inhibitory activitiy was the highest for the 
dicaffeoylquinic acids, but 5-feruloylquinic acid had a stronger inhibition that the 
caffeoylquinic acids tested. In vitro studies frequently test native compounds and as 
earlier mentioned, the most abundant native forms might not be the most biological 
active ones and it is more likely that their metabolites are the compounds with the 
highest impact on the metabolism (Manach et al., 2004, Kroon et al., 2004). 
 A few mechanisms of action of chlorogenic acids and phenolic acids have 
been suggested and some of them are described below. In 2000, Hsu et al. (2000) 
tested caffeic acid for its antihyperglycemic effect, in male Wistar rats. Upon 
intravenous injection of caffeic acid (0.5 - 3 mg/kg) into two models of diabetic rats 
(i.e. streptozotocin-induced and insulin-resistant), the glycaemia decreased in a dose-
dependent manner, suggesting an insulin-independent action of caffeic acid. This 
- 13 - 
was not observed in normal non-diabetic rats. When the diabetic rats were pre-
treated with caffeic acid (1 mg/kg) and thereafter subject to a glucose challenge test 
(i.e. intravenous injection of glucose, 60 mg/kg), the elevation of plasma glucose 
was attenuated. Further investigation indicated that the uptake of glucose by isolated 
adipocytes was increased in a concentration-dependent manner, suggesting that this 
would be a plausible mechanism responsible for the lowering of plasma glucose by 
caffeic acid. 5-Caffeoylquinic acid was reported to have a similar mechanism of 
action. In an in vitro experiment conducted by Alonso-Castro et al. (2008), 5-
caffeoylquinic acid stimulated, without affecting adipogenesis, the uptake of 2-[N-
(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino]-2-deoxy-D-glucose in insulin-sensitive 
and insulin-resistant murine adepocytes. The uptake of glucose was stimulated by 
404 % in insulin-sensitive adipocytes in presence of insulin, by 176 % in insulin-
sensitive adipocytes in the absence of insulin, and by 141 % in insulin-resistant 
adipocytes in the absence of insulin. In the same year, Tousch et al. (2008) reported 
in an in vitro experiment a stimulation of glucose intake by 3-caffeoylquinic acid 
and chicoric acid in the rat skeletal muscle L6 cells, in presence of insulin. In the 
same research, 3-caffeoylquinic acid and chicoric acid stimulated the secretion of 
insulin from the pure β-cells (INS-1E cell line) and from isolated Langerhans islets. 
 Rodriguez de Sotillo et al. (2006) investigated in the obese Zucker (fa/fa) rat 
model (hepatic insulin-resistant), the in vivo effect of a 3-week treatment with 3-
caffeoylquinic acid (3-CQA) infused daily intravenously (5 mg/kg), on plasma 
insulin concentrations, liver protein and DNA concentrations, the activity of hepatic 
glucose-6-phosphatase and the expression of hepatic insulin receptor mRNA. In 
Zucker (fa/fa) rats, the plasma glucose levels after a glucose challenge or meal 
progressively increase with age and the fasting levels increase at fast, after the fourth 
week of age. In the experiments of Rodriguez de Sotillo et al., the plasma glucose 
level, 1 h after a glucose challenge, was attenuated in 3-CQA-treated 22 week-old 
rats, when compared to the same group of rats at 19 weeks of age, prior to the 3-
CQA treatment, suggesting an insulin-sensitivity enhancement by 3-CQA. The 
fasting levels of glucose were, however, similar between 3-CQA-treated 22 week-
old rats and the untreated rats of 12, 19 or 22 weeks of age. After 30 min of a 
glucose tolerance test, the 3-CQA 22 week-old Zucker (fa/fa) rats had lower plasma 
insulin levels, when compared to the same group at 19 weeks of age. At fast, in 22 
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year-old Zucker (fa/fa) rats treated with 3-CQA the fasting insulin levels were lower, 
when compared to the same group at 19 weeks of age and to the untreated rats of 22 
weeks of age. In 22-week old fasted Zucker (fa/fa) 3-caffeoylquinic acid-treated rats, 
the concentration of total protein and DNA increased, when compared to the 
untreated control group of the same age. The hepatic synthesis of protein is 
stimulated by insulin. In obese T2DM insulin-resistant animal models, the hepatic 
protein synthesis is lower. The increase of protein reported in the study by 
Rodriguez de Sotillo et al. could therefore be due to an increased liver sensitivity to 
insulin. The DNA increase could be due to the higher zinc and magnesium 
concentrations, which are important for the synthesis of DNA. The activity of 
glucose-6-phosphatase was unchanged between the 3-CQA-treated 22-week old rats 
and the untreated control group of the same age. Although the administered amounts 
of 3-CQA are plausible in a human diet, the compound was administered 
intravenously. Once ingested, the majority of chlorogenic acids are hydrolysed from 
their quinic acid moiety in order to be absorbed and enter the circulation, therefore, 
the circulating compounds are in majority derived metabolites.  The observed effects 
of 3-CQA may therefore not be significant with a regular diet. A further action of 3-
CQA was the inhibition of glucose-6-phosphatase reported by Hemmerle et al. 
(1997). 
 In an in vitro model, Li et al. (2005) tested the effect of caffeic acid on the 
angiotensin II-induced proliferation of aortic vascular smooth muscle cells  from 
spontaneously hypertensive rats and from healthy Wistar-Kyoto rats. When 
compared to the angiotensin II (100 nM) only treatment, an inhibition of 
intracellular superoxide anion production was observed when the muscle cells of the 
hypertensive rats were simultaneously exposed to angiotensin II (100 nM) and 
caffeic acid (100 μM). Also, the tyrosine phosphorylation of Janus kinase 2 (JAK2) 
stimulated by angiotensin II was inhibited by the simultaneous treatment with 
caffeic acid, with an optimal inhibition when caffeic acid was used at > 50 μM. 
Similarly, the tyrosine phosphorylation of STAT1 (α/β) stimulated by angiotensin II 
was significantly repressed when caffeic acid was added to the treatment. A further 
effect of caffeic acid was observed on the extracellular signal regulated kinase 
(ERK) cascade. The phosphorylation of ERK (1/2) observed upon angiotensin II 
treatment was significantly inhibited when the cells were exposed to caffeic acid. 
- 15 - 
Finally, the expression of heat shock protein 90, which responds to oxidative stress 
and is involved in cell proliferation, was stimulated by angiotensin II, which effect 
was antagonised by the addition of caffeic acid. Of note, the results were less 
marked in cells of normotensive rats and the caffeic acid concentration used in this 
study, i.e. 100 μM, were much higher than that observed in the circulation, i.e. 0.16 
μM, after the consumption of an instant coffee prepared from 8 g of coffee pellets 
(Renouf et al., 2013). 
 In spontaneous hypertensive rats, a reduction of the systolic blood pressure 
was observed after a single-dose and continuous 8-week administration of 
approximately 300 mg/kg weight 5-caffeoylquinic acid (Suzuki et al., 2006). This 
concentration is much higher than that achievable with a normal healthy diet. When 
administered as a single-dose, 30 mg/kg did not significantly decrease the systolic 
blood pressure. Associated with the decrease in systolic blood pressure upon the 8-
week treatment with 300 mg/kg 5-caffeoylquinic acid, was a decreased production 
of NADPH-dependent superoxide in the aorta and the inhibition of p22
phox
 gene 
expression. A major limitation in this study is the administrated dose representing 
approximately 20 times that of what is estimated to be consumed by humans for the 
combined chlorogenic acids and therefore, although those benefitial effects were 
observed, a decreased dose may not result in significant effects. 
 In a recently published research, Sompong et al. (2015) reported the effect of 
ferulic acid on protein glycation, lipid peroxidation, membrane ion pump activity 
and phosphatidylserine exposure in young healthy human erythrocytes, which are 
important for the transport of oxygen and the elimination of carbon dioxide, exposed 
to high glucose levels. Glycated haemoglobin was used as an indicator of protein 
glycation. When compared to the glucose (45 mM) only treatment, the addition of 
ferulic acid (10 and 100 μM) significantly decreased the measured amounts of 
glycated haemoglobin by approximately 15 %. At the same concentrations, ferulic 
acid increased the utilization of glucose by erythrocytes, when compared to 
erythrocytes subject to the glucose treatment only and it partly reversed the 




-ATPase activity. When the lipid 
peroxidation was investigated, a concentration as low as 0.1 μM ferulic acid had 
significant effects on lowering the lipid peroxidation. The strongest decrease was, 
however, observed with a concentration of 100 μM ferulic acid. At the same 
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concentrations (i.e. 0.1, 1, 10 and 100 μM), ferulic acid decreased 
phosphatidylserine exposure into the outer layer of the erythrocyte membrane, when 
compared to the glucose (45 mM) only treatment. These data suggest mechanisms 
on how ferulic acid may lower the circulating glucose levels and prevent cellular 
dysfunction and vascular complications associated to diabetes. 
 
1.2.1 Fruits and vegetables and health 
 In 2007, He et al. (2007) carried out a meta-analysis of 13 prospective cohort 
studies on the effect of fruit and vegetable consumption on the risk of developing 
coronary heart disease. The median follow up was 11 years and analyses included 
data from 278,459 adult subjects. Overall, upon adjustment for possible confounding 
factors (i.e. some anthropometric and physiological variables, lifestyle habits and 
post-menopausal status), although some studies did not show the same trend, the 
combined relative risk of the 13 studies indicated a decreased risk of coronary heart 
disease with a higher consumption of fruit and vegetables. He et al. reported a 17 % 
decrease in risk for an increase in consumption from < 3 to > 5 servings per day. The 
outcome was similar in four studies, in which the risk of non-fatal myocardial 
infarction was also investigated. As for all the meta-analyses, even if the 
measurements were adjusted for potential confounders, the studies did not adjust for 
the same counfounders, which could influence the outcome of the individual 
researches. 
 Three years later, Carter et al. (2010) carried out a meta-analysis of six 
prospective cohort studies to investigate the effect of fruit and vegetable 
consumption on the incidence of T2DM, a strong independent risk factor for 
cardiovascular disease. All the included studies adjusted for potential confounding 
factors (e.g. age, BMI and family history of T2DM), although not all for the same. 
The analysis revealed no significant decrease in the incidence of T2DM with 
increased consumption of either fruit or vegetables, or a combined consumption of 
fruit and vegetables, but a 14 % lower incidence of T2DM was observed with higher 
consumption from 0.2 to 1.35 servings per day of green leafy vegetables. Of note, 
only two of the analysed studies included male subjects and both indicated a 
beneficial effect of fruit and vegetable consumption on the incidence of T2DM, 
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therefore the outcome may have been different if more men had been part of the 
investigation. 
 In both He et al. and Carter et al.'s analyses, the consumption of fruit and 
vegetables was positively associated with physical activity. The latter was not taken 
into account in the adjusted analyses and therefore a different outcome cannot be 
excluded if this factor was corrected for. 
 More recently, Wang et al. (2014) carried out a meta-analysis of 16 
prospective cohort studies to investigate the link between the consumption of fruit 
and vegetables and death from all causes, from cardiovascular diseases or from 
cancer. In this review, the combined number of subjects was 833,234, of which 
56,423 had passed away from either a cardiovascular disease (n = 11,512) or from 
cancer (n = 16,817). The adjusted analyses indicated a curvilinear relationship 
between the combined consumption of fruit and vegetables and the risk of death 
from all causes, with estimated hazard ratios decreasing from 0.92 for 1 serving per 
day, to 0.74 for 5 servings per day, when compared to no consumption of fruit and 
vegetables. No further improvement was reported for > 5 servings per day. Similarly 
for their separate consumption, a higher consumption of fruit or vegetables was 
associated with a decreased risk in death from all causes, up to 2 and 3 servings per 
day, respectively. Specifically, there was a 4 to 5 % risk reduction of death from 
cardiovascular disease for each additional fruit and/or vegetables serving per day. As 
for the risk of death from cancer, the influence of a higher consumption of fruit and 
vegetable was not significant. 
 In regards to other health conditions, such as cancer, the intake of fruit and 
vegetables has been consistently inversely associated with renal cell cancer (Arab, 
2010). 
 
1.2.2 Tea and health 
 In a prospective cohort study, van Dieren et al. (2009) examined the effect of 
tea (mainly black) and coffee (section 1.2.3.1) consumption on the incidence of 
T2DM. The study included 38,176 female and male participants and had a mean 
follow-up of 10 years. Van Dieren et al. reported a negative relationship between the 
consumption of tea and the incidence of T2DM in a multivariate model which was 
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also adjusted for the consumption of coffee. The lowest hazard ratio was obtained 
for a consumption of > 5 cups per day, which is relatively high. When the 
relationship between the consumption of tea and biomarkers of T2DM was 
investigated in a smaller random study subgroup (n = 2,604), no significant 
association was detected. A major limitation of the study was that no distinction was 
made between the consumption of black tea or green tea and that the consumption of 
the latter was assumed to be 4.6 % based on the country statistics. 
 In a later prospective cohort study, De Koning Gans et al. (2010) investigated 
the association between the consumption of tea (mainly black) and coffee (section 
1.2.3.4), and cardiovascular diseases, with data from 37,514 healthy adult 
participants obtained during a mean follow-up of 13 years. Upon adjustment for the 
age, the gender and other potential confounders (e.g. physical activity, waist 
circumference, smoking status and alcohol intake), De Koning Gans et al. reported a 
negative linear association between the consumption of tea and the incidence of 
coronary heart disease, and a U-shaped relationship with the death from coronary 
heart disease, with the lowest hazard ratios obtained for 1 to 6 cups consumed per 
day. No association was detected between the consumption of tea and the incidence 
of stroke or associated death. As for the study of van Dieren et al., the consumption 
of black tea was assumed to be similar to that of the general population. A further 
important limitation of this study is the low number of subjects that died from 
coronary heart disease (n = 123) or stroke (n = 70), reducing the power of the 
analyses. These analyses, however, are suggestive of a beneficial effect of a long-
term consumption of tea in the incidence of coronary heart disease and associated 
death. 
 A meta-analysis by Yang et al. (2014) regarding the effect of different 
Camellia sinensis tea preparations on the incidence of T2DM, was recently 
published. Twelve cohort studies with a combined total of 761,949 subjects were 
included in the analysis. When compared to subjects consuming no tea or < 0 to 1 
cup per day, those consuming ≥ 4 cups per day had a 16 % lower relative risk. When 
the effect of the consumption of ≥ 3 cups per day on the incidence of T2DM was 
investigated, the combined result of nine eligible studies indicated a significant 
beneficial effect, with a 16 % reduction of relative risk. 
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1.2.3 Coffee and health 
 In 1985, very little research had been performed on the impact of coffee 
(poly)phenols or chlorogenic acids on health. The investigations mainly targeted 
caffeine due to its known pharmacological activities (Clifford, 1985). Although the 
outcomes of in vitro and in vivo studies are variable and some studies indicate a 
detrimental effect on human health (e.g. increase in plasma lipids and/or blood 
pressure), there is increasing epidemiological evidence for the beneficial effects of 
regular coffee consumption on the incidence of certain life-threatening chronic and 
degenerative diseases. Coffee consumption may thus reduce the risk of developing 
T2DM (Oba et al., 2010), cardiovascular diseases (Mineharu et al., 2011) and certain 
cancers (Arab, 2010). 
 
1.2.3.1 Type 2 diabetes mellitus 
 In a cross-sectional epidemiological study with 7,949 initially healthy 
subjects of both genders, Agardh et al. (2004) investigated the association between 
the consumption of coffee, the incidence of T2DM and impaired glucose tolerance. 
Upon adjustment for potential confounders, Agardh et al. reported a decreased 
relative risk of T2DM and impaired glucose tolerance in healthy subjects with a 
higher consumption of coffee. In diabetic subjects consuming ≥ 5 cups per day, the 
relative risk of insulin resistance and of a low β-cell function were decreased, when 
compared to subjects consuming ≤ 2 cups per day. In subjects with an impaired 
glucose tolerance, a higher consumption of coffee was associated with a decreased 
risk of insulin resistance. Additionally, in women with impaired glucose tolerance, 
but not in men, a decreased risk of low β-cell function was also reported. Due to the 
cross-sectional design of the study, it is difficult to establish the direction of the 
causality of associations. 
 In a later small-scale study of 11 healthy male subjects, an oral glucose 
tolerance test (OGTT) was performed 1 hour upon consumption of either a caffeine 
capsule, caffeinated coffee, decaffeinated coffee or a placebo dextrose capsule. The 
results revealed the highest insulin sensitivity index (indicative of a better response 
of glucose to insulin) when the same male subjects consumed decaffeinated coffee, 
when compared to caffeinated coffee and caffeine capsules, suggesting that coffee 
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compounds, other than caffeine, must account for this observation (Battram et al., 
2006). This study, however, only reflect the acute effect of these compounds and the 
long-term effect may not have a significant effect on the insulin sensitivity. In a later 
cross-over study with T2DM patients, the insulin sensitivity index upon an OGTT 
was similar after consumption of caffeinated coffee and decaffeinated coffee (Krebs 
et al., 2012). In the latter study, the number of participants was very low (n = 18), no 
adjustment for potential confounders was done and these observations would only 
apply for T2DM patients. A further OGTT study showed lower fasting glucose 
levels in subjects consuming ≥ 5 cups per day, when compared to irregular coffee 
consumers. An inverse association between the habitual consumption of coffee and 
glucose intolerance was also identified, suggesting that a habitual consumption of 
coffee may improve the fasting and postprandial glycaemia levels (Yamaji et al., 
2004). Limitations of the study include the fact that only male subjects from one 
ethnicity were recruited and, as previously mentioned, that the cross-sectional nature 
of the study does not allow the determination of causality of the detected 
associations. Finally, the Insulin Resistance Atherosclerosis Study, an 
epidemiological cross-sectional study with 954 healthy adults showed that regular 
consumption of caffeinated coffee was positively associated with insulin sensitivity 
and inversely to 2 hour post-load glucose (Loopstra-Masters et al., 2011). 
 In the previously mentioned prospective cohort carried out by van Dieren et 
al. (2009), a U-shaped relationship between the consumption of coffee (adjusted for 
the consumption of tea) and the hazard ratios of T2DM was observed. The lowest 
hazard ratio was obtained for a consumption of 4.1 to 6.0 cups per day. When the 
effect of the consumption of decaffeinated coffee was investigated, no association 
was found. When the relationship between the consumption of coffee and 
biomarkers of T2DM was investigated, no significant association was detected. The 
inclusion of blood pressure, the intake of magnesium, potassium and caffeine in the 
adjusted model did not significantly change the outcome, suggesting that other 
components in the coffee may explain the negative relationship observed. 
 Recently, Bhupathiraju et al. (2014) investigated the influence of a change in 
coffee consumption, over a period of 4 years, on the risk of T2DM in the subsequent 
4 years. The data used were obtained from three cohort studies which included both 
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female and male participants (n = 123,733). An increase in coffee consumption by > 
1 cup per day over a 4-year period was associated with a 11 % decrease in the 
incidence of T2DM in the subsequent 4 years (BMI- and weight-adjusted), when 
compared to an unchanged consumption of coffee. This decreased risk persisted in 
the subsequent 12 and 16 years. Inversely, an equivalent decrease in coffee 
consumption was associated with a 17 % rise in the incidence of T2DM in the 
subsequent 4 years, but not on a longer term. A similar trend was observed when the 
consumption of caffeinated coffee was taken into account. A change in the 
consumption of decaffeinated coffee was not associated with a higher or lower 
incidence of T2DM, however, the authors claim that the number of subjects that 
modified their consumption of decaffeinated coffee was very little and therefore the 
possibility of not detecting a true association may have been present. Also, the 
adjustment for the waist-to-hip ratio, which was not measured, would have been a 
better adjustment for the body fat, than the BMI. A further limitation of the study 
was that the information of the dietary habits was assessed once every fourth year, 
thus not taking into account any dietary change during the gap. 
 Overall, while some studies have shown no association between the 
consumption of coffee and the incidence of T2DM (Reunanen et al., 2003), there is 
increasing evidence supporting a beneficial effect of a long-term consumption of 
coffee and the incidence of T2DM (Salazar-Martinez et al., 2004, van Dam and Hu, 
2005). Whether caffeine is the cause for the beneficial effect on the glucose-insulin 
homeostatic system has been a matter of discussion. While it has been recognised 
that caffeine can improve insulin sensitivity (Yoshioka et al., 2003) and enhance its 
secretion (Shi, 1997), in a study where decaffeinated and caffeinated coffee 
consumers were followed, the reduction of the risk was not as significant for 
decaffeinated coffee consumers, but was still present, suggesting that compounds 
other than caffeine may also contribute to the protective effects on developing 
T2DM (Salazar-Martinez et al., 2004). Mechanisms responsible for a reduced risk of 
developing T2DM could include a reduction of glucose production during 
gluconeogenesis and glycogenolysis by the inhibitory competition of chlorogenic 
acid on G-6-phosphate translocase protein (Arion et al., 1997), a reduction of 
glucose absorption in the small intestine by chlorogenic acid and other coffee 
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phenolic compounds (Welsch et al., 1989), an increase in the energy expenditure as 
well as weight loss caused by caffeine. 
 
1.2.3.2 Inflammation 
 In a normal physiological situation, inflammation is a favourable response of 
the body to external stress or tissue damage for self-protection and will lead to 
restoration of a tissue's integrity and function and defence against the infection. A 
persisting status, however, can have pathological consequences and result in the 
development of several conditions such as type 1 and type 2 diabetes, atherosclerosis 
or several neurodegenerative diseases (Nathan, 2002). During inflammation, an 
increase in superoxide (O2
-
) is observed as a result of the NADPH oxidase 
activation, in the mitochondrial electron transport chain. In parallel, the induction of 
the nitric oxide synthases produces the nitric oxide radical (•NO) and subsequent 
reactive nitrogen species. O2
-
 and •NO can lead to further reactive oxygen and 
nitrogen species respectively. Inflammation is therefore closely related to oxidative 
stress. Coffee is known to have antioxidants compounds, which include 
(poly)phenols (Gonthier et al., 2003), caffeine (Nawrot et al., 2003), heterocyclic 
compounds (Illy, 2002, Yanagimoto et al., 2002) and aromatic compounds (Illy, 
2002) and following acute consumption of coffee by humans, a significant 5.5% 
increase in plasma antioxidant capacity has been reported (Natella et al., 2002). 
 In a human study with healthy participants investigating the effect of coffee 
consumption on the circulating levels of homocysteine, a biomarker of inflammation 
and cardiovascular disease, the results indicated that higher concentrations of the 
biomarker were positively associated with increased coffee consumption (Grubben 
et al., 2000). In this study, however, non-filtered coffee was given to the 
participants, and therefore, the cholesterol-rising diterpenes were still fully present. 
Also, the results would only apply to heavy drinkers, since the administered dose 
corresponded to 6 large mugs of strong coffee, equivalent to a daily consumption of 
1L of coffee. 
 In 2004, Zampelas et al. (2004) investigated the effect of coffee consumption 
on biomarkers of inflammation in a health population of 3042 healthy adults. In 
analyses adjusted for potential confounders, women and men that had a habitual 
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coffee consumption of > 200 mL per day had higher levels of C-reactive protein, 
interleukine-6, serum amyloid A and tumor necrosis factor-α, when compared to 
subjects consuming no coffee. These results would suggest a detrimental effect of a 
regular consumption of coffee, when compared to no consumption, however, in this 
study, no distinction was made between filtered and non-filtered and a different 
outcome cannot be excluded if the effect of filtered and non-filtered coffee was 
analysed separately. 
 In a cross-sectional study by Lopez-Garcia et al. (2006), the effect of a long-
term consumption of filtered coffee on various biomarkers of inflammation and 
endothelial health were assessed in two different female subcohort groups. The 
control group consisted of 730 women, with no diagnosed cardiovascular disease, 
cancer or T2DM, and the T2DM group consisted of 663 women, diagnosed with 
T2DM but no cardiovascular disease or cancer. The age ranged from 43 to 70 years 
old. Upon multivariate analyses (age-, BMI-, physical activity-, smoking status-, 
alcohol-, aspirin use-, postmenopausal hormone therapy-adjusted) an inverse 
association between the consumption of decaffeinated filtered coffee and the 
concentration of C-reactive protein (CRP) in the control group, and an inverse 
association with E-selectin and C-reactive protein (CRP) in the T2DM group. These 
results suggest that filtered coffee does not have a detrimental effect on 
inflammation or endothelial health, however, the study only included female 
participants and female hormones may influence the outcome. Another limitation of 
the study is the cross-sectional deisgn. 
 In the cohort Iowa Women's Health Study, 27,312 post-menopausal women 
were followed for 15 years to investigate coffee consumption and the total and 
cause-specific mortality. Data, adjusted for confounders, showed an inverse 
association between coffee consumption and death attributed to an inflammatory 
disease other than CVD and cancer (Andersen et al., 2006). This cohort targeting 
post-menopausal women, the results cannot be extrapolated to the general 
population. 
 In a recent intervention study carried out by Kempf et al. (2010), the 
association between the consumption of coffee at different doses on selected 
biomarkers of inflammation was investigated. Forty-seven participants, healthy but 
at a higher risk of developing T2DM, were recruited. When compared to a 1-month 
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period of coffee abstention, a 1-month period with a coffee consumption of 8 cups 
per day was associated with an increase in some markers of inflammation (i.e. IL-18, 
adiponectin), a decrease in 8-isoprostane, a marker of oxidative stress, and the 
increase of total cholesterol and apolipoproteins A-I, but did not influence the 
variables of glucose metabolism. In this study, the design was not randomized and 
the administered coffee dose of 8 cups coffee per day is very high and only 
achievable by a small population fraction. 
 In 2012, Yamashita et al. (2012) reported the data from a cross-sectional 
study with 3317 female and male participants on the effect of habitual consumption 
of coffee on inflammation and metabolic biomarkers. Upon analyses adjusted for 
potential confounders, a higher consumption of coffee was positively associated 
with adiponectin levels and negatively associated with leptin and liver enzymes, but 
no association with the biomarker of inflammation C-reactive protein, interleukin-6 
or tumor necrosis factor-α was osberved. Having a cross-sectional design, the 
causality of the association cannot be determined. 
 In a later randomized control study, Corrêa et al. (2013) investigated the 
effect of consuming filtered coffee with a different roast level over 4 weeks on 
biomarkers of inflammation and cardiovascular risk. In the 20 healthy adult subjects 
recruited, independently of which coffee type had been consumed, the levels of total 
homocysteine remained unchanged when compared to baseline values. Also relevant 
for the present dissertation, the serum glycaemic biomarkers, glucose and insulin, 
remained unchanged. From the other biomarkers of inflammation and cardiovascular 
risk analysed, Corrêa et al. suggested an inflammatory effect related to the 
consumption of coffee. The fact that only 20 subjects were subject to analysis, the 
power is reduced and unlikely to be representative of a healthy adult population. 
 
1.2.3.3 Cardiovascular health 
 The effects of coffee on cardiovascular health remain controversial. How 
coffee affects the cardiovascular parameters of health, such as endothelial function, 
partly depends on how the beverage is prepared. While a filtered coffee retains most 
of the cholesterol-raising diterpenes, the frequent and long-term consumption of 
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unfiltered coffee increases the chances of raising the blood cholesterol levels. 
Consuming caffeinated or non-caffeinated coffee also has an impact on the outcome. 
 In a double-blinded crossover study with healthy subjects, an acute ingestion 
of caffeinated, but not decaffeinated, coffee led to a significant decrease in flow-
mediated dilation and both systolic and diastolic blood pressures (Buscemi et al., 
2010), suggesting a negative effect of caffeine on cardiovascular health. In another 
study in which caffeinated and decaffeinated coffee was administered randomly to 
healthy subjects, arterial stiffness was assessed by measuring the carotid femoral 
pulse wave and the arterial wave reflection at the aorta. Results indicated an increase 
of these parameters after intake of caffeinated coffee (Mahmud and Feely, 2001). In 
these two latter studies, the statistical power is reduced by the limited number of 
study participants (n = 20 and 7, respectively). Also, the parallel analysis of caffeine 
as a pure compound would have been of interest, as in the study by Battram et al. 
(2006), to assess the contribution of coffee compounds other than caffeine to the 
counteraction of the negative effects observed. Although increases in several 
cardiovascular disease risk factors, such as blood pressure and plasma homocysteine, 
were detected, and a high coffee consumption (5 to 10 cups/day) has been associated 
with a significantly increased risk of coronary heart disease and myocardial 
infarction, the majority of prospective cohort studies and a more moderate 
consumption of 3-4 cups/day do not show this positive association (Sesso et al., 
1999). 
 In the previously mentioned prospective cohort study carried out by De 
Koning Gans et al. (2010), a higher consumption of coffee was associated with the 
incidence of coronary heart disease in a U-shaped relationship, with the lowest 
hazard ratio for subjects consuming 2.1 to 3.0 cups per day. De Koning Gans et al. 
did not find any association between the consumption of coffee, the incidence of 
stroke, and death from coronary heart disease, stroke or from all causes, in a model 
adjusted for age, gender and other potential confounders (e.g. physical activity, waist 
circumference, smoking status and alcohol intake). As previously mentioned, the 
small number of subjects that died from coronary heart disease or stroke reduces the 
power of the analyses for these associations. These findings, however, are suggestive 
of a beneficial effect of a moderate long-term consumption of coffee on the 
incidence of coronary heart disease and associated death. 
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 Recently, Lopez Garcia et al. (2011) published the data from a 24-year 
follow-up cohort study with female subjects who had suffered a non-fatal 
cardiovascular event. The association between the consumption of filtered 
caffeinated coffee and death from all causes or from cardiovascular disease was 
investigated in 11,697 women, of which 1,159 passed away during the follow-up 
period. In this follow-up, no association between the consumption of coffee and 
death from all causes or cardiovascular disease was detected, suggesting that the 
long-term consumption of filtered coffee does not have a detrimental effect on the 
incidence of death from cardiovascular disease or from all causes. The fact that the 
participants had suffered a non-fatal cardiovascular event and that all were healtcare 
professionals may have influenced the choice of lifestyle for some of them, which 
may have had an impact on the results observed. 
 In the same year, Larsson and Orsini (2011) carried out a meta-analysis of 11 
prospective studies, aiming at assessing the association between the consumption of 
coffee and the incidence of stroke. Combined, a total of 479,689 subjects were 
included, 10,003 of which had a stroke. The analyses indicated a maximal 17 % 
reduction of the relative risk from no coffee consumption to up to 3 - 4 cups daily, 
whether the subjects were healthy from the start or whether the analysis included 
data from diabetic patients or from subjects that had recently had an acute 
myocardial infarction. These data suggest that a moderate long-term consumption of 
coffee may reduce the incidence of stroke.  
 
 Overall, a higher consumption of fruit and vegetables has mostly been 
associated with beneficial effects on the incidence of cardiovascular diseases. 
Characterised by a non-linear relationship, the highest decreased risk was assessed 
with the consumption of 5 servings per day. In general, when compared to no or 
very rare consumption, a tea consumption of ≤ 3 cups per day is associated with a 
lower incidence of T2DM. The results from studies with coffee are somewhat more 
controversial and the effect of coffee on health remains uncertain. Factors 
contributing to the variable outcomes observed include the variety of coffee 
constituents able to influence parameters that in turn influence inflammation, 
cardiovascular health or other health conditions; the preparation mode of the 
beverage that has an impact on the quality of the brew and therefore, on the 
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composition of the coffee; the frequency of consumption; as well as the genetics of a 
person (Cano-Marquina et al., 2013). The underlying mechanisms of the observed 
beneficial effects of a higher consumption of coffee and other (poly)phenol-rich 
products are still unclear, but good candidates are the constituent (poly)phenols. 
However, in order to have any physiological effects, these first need to be absorbed. 
To assess whether a better health status is significantly related to a higher 
consumption of (poly)phenol-rich foods, the links between the habitual consumption 
of (poly)phenol-rich products, the absorption of (poly)phenols and the health of 
subjects require investigation. 
 
1.2.4 Biomarkers and their importance 
 The health status of a subject can be assessed by the measurement of 
biological markers (biomarkers). These can be measured in different tissues or body 
fluids, but are frequently measured in blood or urine. An accurate definition of 
biomarkers was given by the Biomarkers Definitions Working Group, in 2001 as "A 
characteristic that is objectively measured and evaluated as an indicator of normal 
biological processes, pathogenic processes, or pharmacologic responses to a 
therapeutic intervention" (BDWG, 2001). 
 When studying the impact of an external factor on biomarkers of health in a 
healthy population, unless the healthy range is very broad, one may miss true 
associations, as extreme values, which are easily obtained in subjects suffering from 
a particular condition, may be difficult to obtain in healthy subjects. Several 
epidemiological studies and human studies on the postprandial changes of health 
biomarkers upon consumption of (poly)phenol-rich products (e.g. coffee, tea, fruits 
and vegetables) have been conducted, however there is still a lack of information 
concerning the link between the bioavailability of (poly)phenols and the general 
health status of subjects. When studying the general health status, it is important to 
measure the biomarkers of health at fast, in order to avoid any postprandial 
influence. Glucose and insulin are two good examples of biomarkers that easily 
fluctuate upon consumption of food. Also, the choice of biomarkers needs to be 
done carefully, as these should be reliable markers for conditions of interest (e.g. 
glucose, insulin for diabetes; aminothiols, cholesterol for cardiovascular health; 
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aminothiols, CRP, cystokines such as IL-10, TNF-α for inflammation). In the 
present study, the total aminothiols cysteine, homocysteine, cysteinylglycine and 
glutathione, glucose, insulin and uric acid were subject to analysis. Although these 
only represent a small fraction of indicators of cardiovascular and inflammation 
health status, they have been reported to be reliable. 
 Aminothiols are metabolically related via the transsulfuration pathway, 
which links the methionine to the biosynthesis of glutathione. Small increases in 
homocysteine are an independant risk factor for premature cardiovascular conditions 
(Moat et al., 2001) and a possible explanation is a the lower bioavailability of nitric 
oxide (NO) and subsequent endothelial dysfunction caused by an increased 
production of superoxide radicals. The latter may originate from the autoxidation of 
homocysteine, from uncoupled endothelial nitric oxide synthase (eNOS), or from 
higher levels of asymmetrical dimethylarginine (Antoniades et al., 2009). As a 
consequence of higher levels of homocysteine, some mediators of inflammation are 
activated, including the nuclear factor-kappa B (NFκ-B).  
 Cysteine, the most abundant aminothiol in plasma,  has been suggested to be 
an antioxidant although contradictory data were reported (Moat et al., 2001). 
Cysteine is a substrate for the production of NO, an important vasodilator. Lower 
levels of cysteine may thus decrease the availability of NO, which in turn may lead 
to endothelial dysfunction, a risk factor for cardiovascular disease (Moat et al., 2001; 
Hermann M et al., 2006). 
 Glutathione, a tripeptide of glutamate, cysteine and glycine, plays several key 
functions in the metabolism. Through its ability to detoxify reactive oxigen species, 
glutathione plays an important role as a regulator of the redox status and may thus 
prevent cellular damage from oxidative stress, which may lead to inflammation 
(Shimizu et al., 2004).  
Analysing the aminothiols simultaneously is important, as  not only the individual 
concentration in plasma is important, but the relative amounts to each other is 
determinant for the health as they may give indication of the enzymatic activities in 
the transsulfuration pathway. 
 Glucose and insulin are two determining biomarkers in cardiovascular heatlh. 
An unbalance in their metabolism may lead to the development of diabetes, which 
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puts the subjects are higher risk for developing other conditions, such as 
cardiovascular diseases. In healthy subjects, an increase of glucose (> 3.3 mM) leads 
to the secretion of insulin by the pancreatic β-cells. When a subject develops insulin 
resistance, although the glycaemic levels can be normal, the secretion of insulin is 
increased. Insulin secretion can however decrease with the age, thus raising the 
glycaemia in these subjects. Subject developing diabetes have a mortality rate of 2 to 
4 times higher than that of healthy subjects (Poretsky, 2010). A few mechanisms by 
which hyperglycaemia may lead to cardiovascular health issues have been described 
and all of them have in common and increase formation of superoxide (Gleissner et 
al., 2007). As an example, in case of normal glycaemic levels, toxic aldehydes are 
reduced to inactive alcohols by the aldose reductase with little effect on glucose (and 
little production of sorbitol), due to their low affinity for each other. In presence of 
higher glucose levels, however, the production of sorbitol and subsequently fructose 
is increased. In this situation the intracellular accumulation of sorbitol and 
consumption of NADPH required for the production of glutathione leads to an 
oxidative stress. On the other side, the higher levels of fructose increase the 
formation of advanced glycation end products, which contribute to increase the 
oxidative stress and inflammation (Uribarri et al., 2010). 
 Uric acid, a product of the metabolism of purines, is the cause of gout, an 
inflammatory condition caused by the deposition of monosodium urate crystal in 
several anatomical locations (Ghaemi-Oskouie and Shi, 2011). The accumulation of 
monosodium urate crystals leads to the production of IL-1β and IL-18, two pro-
inflammatory cytokines.  
 The measurement of the biomarkers described above is relevant as changes 
can be observed at early stages and in healthy stubjects and therefore be targets for 
the prevention of inflammation and cardiovascular diseases. For this reason, these 
biomarkers of health were selected to be analysed in the healthy population of the 
present research. Other biomarkers not investigated due to monetary, equipment 
and/or time limitation are good reflectors of inflammation and cardiovascular health. 
Examples are the c-reactive protein, a biomarker of chronic low-grade inflammation, 
TNF-α, interleukins-1, -6, or -10 (Zakynthinos and Pappa, 2008). 
 In health, numerous factors can lead to the development towards diseases and 
information about each factor can be collected in different ways in order to assess 
- 30 - 
the status of a subject. Figure 1. 4 shows examples of risk factors that may lead to 
cardiovascular diseases. Only the factors that were of interest in the present study 
(gray boxes) and how information about each of them was collected (dashed boxes) 
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Figure 1. 4: Risk factors contributing to the development of cardiovascular disease 
(full boxes) analysed in the present study, and  possible ways of assessing a status of 
a subject in regards to a particular factor (dashed arrows and boxes). Other 
biomarkers and assessment methods, not presented in this diagram, exist. 
1.3 Objectives 
 The questions raised and aimed at to be answered with the present PhD thesis 
were the following: 
1. Does roasting or decaffeination have an impact on the free phenolic acid content 
(i.e. caffeic, dihydrocaffeic, ferulic, isoferulic, dihydroferulic and 3,4-
dimethoxycinnamic acid) of soluble coffee? 
2.  Chlorogenic acids are present in significant amounts in coffee, however, 
although some absorption of native esters was reported (Farrell et al., 2011, 
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Renouf et al., 2013), these first need to be cleaved into their derivative 
aglycones. As observed in previous pharmacokinetic studies (Renouf et al., 
2013), the chlorogenic acid-derived metabolites, caffeic, ferulic, isoferulic and 
3,4-dimethoxycinnamic acid, appear in plasma mainly between 1 and 3 hours 
upon consumption of coffee indicating that these mainly result from a pre-
colonic absorption. A further aim was thus to investigate whether native 
aglycones that are present in a regular cup of coffee can significantly contribute 
to the appearance of respective metabolites observed in plasma between 1 and 3 
hours, and resulting from a pre-colonic absorption, following the consumption of 
the beverage. 
3. Are subjects with a higher consumption of particular (poly)phenol-rich products, 
targeting non-alcoholic beverages (i.e. coffee, tea, cocoa) and common solid 
products (i.e. fruits, vegetables, herbs and spices and supplements), more likely 
to also have a higher intake of other (poly)phenol-rich products? 
4. Based on methods available in the literature, a selection of methods was 
improved, mainly for time efficiency, and validated. Using these, it was assessed 
whether selected inflammation and cardiovascular health biomarkers in plasma 
are stable over a period of at least 8 weeks, in healthy human adults. 
5. Do healthy human adults with higher habitual consumption of (poly)phenol-rich 
products have a better profile of selected inflammation and cardiovascular health 
biomarkers in plasma? 
6. Does the absorption and metabolism of coffee chlorogenic acids have an impact 
on selected inflammation and cardiovascular health biomarkers in the plasma of 
healthy human adults? 
7. Does the habitual consumption of coffee and some non-dietary daily habits have 
an impact on the absorption of coffee chlorogenic acids in healthy human adults? 
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Chapter 2 
Free phenolics in soluble coffee and their contribution to the pool of 
metabolites derived from a pre-colonic absorption 
 
2.1 Abstract 
 Coffee is a rich source of chlorogenic acids, but also contains free phenolics. 
Upon ingestion of coffee, phenolic acids have been identified in plasma 
approximately up to 3 hours (early appearance) or approximately 4 hours (late 
appearance) after the consumption of the beverage (Renouf et al., 2010b). These 
values are typical for compounds resulting from a pre-colonic and colonic 
absorption, respectively. No publication was found on the possible contribution of 
free phenolic acids present in a consumed coffee beverage to the early appearance of 
derived metabolites in plasma. The present chapter thus reports the analysis of major 
free phenolics in various commercially available soluble coffees and the subsequent 
assessment of their possible contribution to the early appearance of derived 
metabolites in plasma, using pharmacokinetic modelling based on previously 
published data. In all the coffees analysed, caffeic acid was present in higher 
amounts, but overall, the phenolic acids were present at low levels, when compared 
to the chlorogenic acids. The results suggest that roasting and decaffeination 
significantly reduce the content of free phenolic acids. When present in amounts 
found in a regular cup of coffee, the contribution of the analysed free phenolic acids 
to the early appearance of derived metabolites was assessed to be non-significant. 
Other colleagues (Mr. Nicolai U. Kraut, Dr. Tracy Farrell and Ms. Alexandra Ryder) 
conducted experiments to indicate possible alternative mechanisms of contribution. 
These are the hydrolysis by small intestine and pancreatic esterases of certain 
chlorogenic acids, particularly of 3- and 5-O-caffeoylquinic acids, respectively, as 
assessed by in vitro enzymatic experimentation. 
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2.2 Introduction 
 Coffee is a rich source of chlorogenic acids, a diverse family of esters formed 
between quinic acid and certain phenolic acids, mainly hydroxycinnamic acids, such 
as caffeic, ferulic and p-coumaric acids (structure presented in Figure 1.2 of chapter 
1) (Clifford, 1999). Variations of chlorogenic acid levels amongst coffee types have 
been reported as a consequence of different bean quality and climates (Vaast et al., 
2006). Further contributing to the variation is processing, such as decaffeination and 
roasting, which has also shown to extensively modify the chemical composition and 
final chlorogenic acid content (Clifford, 1999, Perrone et al., 2010, Ludwig et al., 
2014). A limited number of studies have identified small amounts of free phenolic 
acids in green coffee beans and commercially available instant coffee (Alonso-
Salces et al., 2009, Farrell et al., 2011) and very little is known about the impact of 
processing of coffee on these.  
 Phenolic acids were identified in plasma approximately up to 3 hours or after 
4 hours following the consumption of coffee (Renouf et al., 2010b, Williamson et 
al., 2011). These values are typical for compounds derived from a pre-colonic and 
colonic absorption, respectively. Although intact chlorogenic acids have been 
identified in plasma at nM levels, these do not easily pass the gastrointestinal 
epithelium barrier without prior cleavage of the native form and about 70 % passes 
through to the colon, where they are subject to the hydrolytic action of the abundant 
microbiota population (Plumb et al., 1999, Stalmach et al., 2009). The occurrence of 
free phenolic acids in coffee may thus explain the early appearance of metabolites in 
human plasma, but to date, no study has elucidated the contribution of these to the 
pool of metabolites identified after coffee consumption. Supporting this hypothesis 
are previous investigations using cell models of the intestinal epithelium (Caco-2 
cells) indicating that phenolic acids are rapidly transported into the blood. Also, 
human intervention studies investigating the appearance of phenolic acids in human 
plasma have indicated that free phenolic acids, especially dimethoxycinnamic acid, 
are highly bioavailable after coffee consumption (Renouf et al., 2010b). 
 A significant amount of the phenolic acids appear at earlier time points in the 
blood (1-3 hours), especially for metabolites such as ferulic acid sulphate and 
dimethoxycinnamic acid (Renouf et al., 2010b), but it is not known if these are 
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derived from free phenolic acids already present in the coffee, or from the hydrolysis 
of chlorogenic acids by enzymes present in the small intestine. The latter could 
include pancreatic secretions and brush border enzymes. A previous study on human 
tissues indicated no hydrolysis upon incubation of chlorogenic acid (mainly 5-O-
caffeoylquinic acid) with extracts of human intestinal tissue, liver or plasma. On the 
other hand, chlorogenic acid was efficiently converted into caffeic acid when 
incubated with faecal extracts (Plumb et al., 1999). There is also some evidence for a 
small amount of gastric absorption of intact chlorogenic acids in animal and cell 
models (Lafay et al., 2006, Farrell et al., 2011). 
 Phenolic acids may be the principal bioactive compounds responsible for the 
observed beneficial health effects associated with regular coffee consumption 
(Huxley et al., 2009). There is growing evidence that chlorogenic acid metabolites 
may contribute to improved intestinal health by increasing mucosal membrane 
integrity (Bergmann et al., 2009). Additionally, studies with animal models of type 2 
diabetes mellitus indicated favourable antiglycemic effects and modulation of 
oxidative enzymes following consumption of caffeic acid (Jung et al., 2006) and 
ferulic acid (Balasubashini et al., 2004). It is now widely appreciated that chronic 
low grade inflammation plays a key role in development of degenerative diseases 
(Baker et al., 2011), and the reported bioactivity of phenolic acids may in part 
contribute to their control or prevention. 
 The aim of the analyses reported in the present chapter was to first verify the 
presence of major free phenolic acids, namely caffeic (CA), ferulic (FA), isoferulic 
(iFA), dihydrocaffeic (DHCA), dihydroferulic (DHFA) and 3,4-dimethoxycinnamic 
acid (3,4-DMCIN), in a variety of commercially available instant coffees and 
estimate the impact of roasting and decaffeination on the phenolic acid content. 
Pharmacokinetic modelling was then used to assess whether the amounts of free 
phenolic acids, present in a regular coffee preparation, could account for the levels 
of derived metabolites observed in human plasma after coffee consumption. In vitro 
experiments using pancreatic secretions (carried out by Mr. Nicolai U. Kraut) and 
preparations of Caco-2 cells monolayers (carried out by Dr. Tracy Farrell and Ms. 
Alexandra Ryder) were used to investigate the hydrolysis of individual 
caffeoylquinic acids and chlorogenic acids, as present in coffee, to assess the 
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potential alternative contributing mechanisms. The work reported in the present 
chapter has been recently published (da Encarnação et al., 2014). 
 
2.3 Materials and Methods 
2.3.1 Chemicals and materials 
 All chemicals were purchased from Sigma-Aldrich (Berkshire, UK) unless 
otherwise stated. Acetonitrile (HPLC-MS grade) was purchased from Fisher 
Scientific Ltd (Leicestershire, UK). Ferulic acid (≥ 99 %) and sinapic acid (≥ 99 %, 
HPLC) were purchased from Fluka Analytical; dihydroferulic acid (97 %) and 
dihydrocaffeic acid (> 98 %) were obtained from Alfa Aesar (Lancashire, UK); 
isoferulic acid was from Extrasynthèse (Genay France) and DMSO from Riedel-de 
Haën. 
 The instant coffees used were purchased from a local supermarket: A coffee 
made from 35 % unroasted and 65 % roasted green coffee beans (GrC), a golden 
roast with caffeine (GoC), a decaffeinated golden roast (GoD), a medium-dark roast 
with caffeine (MC), and a decaffeinated medium-dark roast (MD). 
 
2.3.2 Sample preparation 
 Standards: For the analysis of free phenolic acids in coffee solutions, 
calibration curves with concentrations ranging from 0.05 to 100 μM for caffeic acid, 
dihydrocaffeic acid, ferulic acid, dihydroferulic acid, isoferulic acid and 3,4-
dimethoxycinnamic acid were prepared in premixed 5 % acetonitrile and 94.9 % 
water acidified with 0.1 % formic acid (solvent A). Sinapic acid was used as internal 
standard at a final concentration of 100 μM. 
 Preparation of coffee solutions: Triplicates of spiked and non-spiked coffee 
samples were prepared from two different batches of commercially available instant 
coffees. Phenolic extraction was done by adding boiling deionized water to the 
coffee granules to a final 50 mg/mL concentration. This first extracted stock was 
then diluted to 5 mg/mL in solvent A. Spiked samples were supplemented with free 
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phenolic acids to a final concentration of 100 µM and sinapic acid was used as 
internal standard at a final concentration of 100 µM. 
 
2.3.3 Sample analysis 
 The analysis of the coffee solutions was performed on an HPLC-DAD-ESI-
QQQ. Dihydrocaffeic and dihydroferulic acids were analysed at 280 nm, and caffeic, 
ferulic, isoferulic and 3,4-dimethoxycinnamic acids at 325 nm. Upon optimization of 
the standards, the mass spectrometric variables shown in Table 2.1 were used. 
 
Table 2.1: Optimization variables for phenolic acids of interest used for the analysis 
on HPLC-DAD-ESI-QQQ. CA, caffeic acid; DHCA, dihydrocaffeic acid; FA, 
ferulic acid; DHFA, dihydroferulic acid; iFA, isoferulic acid; 3,4-DMCIN, 3,4-
dimethoxycinnamic acid; Rt, retention time (min); λ, wavelength of maximal 
absorbance (nm); [M-H
-
], mass-to-charge ratio (m/z) of negatively charged 
molecular ion; Fragm., fragmentor voltage (eV); MS
2
, mass-to-charge ratio of 
product ion produced by fragmentation of [M-H
-
]; CE1 and CE2, collision energy 




















DHCA 12.45 280 181 90 137, 59 8 15 
CA 15.77 325 179 90 135, 89 12 28 
DHFA 33.60 280 196 90 136, 121 12 25 
FA 36.31 325 193 90 178, 134 8 12 
SA 38.33 325 223 100 208, 164 5 10 
iFA 38.60 325 193 80 178, 134 5 12 
3,4-DMCIN 45.95 325 207 80 103, 163 8 10 
 
 Five μL of coffee solution was injected. Chromatographic separation was 
achieved on an Eclipse plus C18 column (30 °C, 2.1 mm x 100 mm, 1.8 µm pore 
size; Agilent Technologies) using a 61-min gradient of solvent A (premixed 94.9 % 
water in 5 % acetonitrile modified with 0.1 % formic acid) and B (premixed 5 % 
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water in 94.9 % acetonitrile modified with 0.1 % formic acid), based on a previously 
established gradient (Farrell et al., 2011). 
 
2.3.4 Recoveries 
 Recovery rates of phenolic acids extracted from coffee were estimated from 
the comparison of triplicate samples of non-spiked 5 mg/mL coffee solutions with 
100 μM-spiked 5 mg/mL coffee solutions. The increase of the peak area in spiked 
samples (AUCsp) was corrected for the peak area in non-spiked samples (AUCnon-sp). 
Recovery was calculated by comparing the concentration detected to the spiking 
concentration expected (AUCstd) for a particular compound, using the relevant 
calibration curve and the following formulas: 
 








2.3.5 Pharmacokinetic calculations 
 To estimate the possible contribution of unmodified free phenolic acids to the 
early plasma pool, pharmacokinetic curves of 4 g of GrC were computed assuming 
the following variables: 100 % bioavailability (F), a volume of distribution measured 
for another (poly)phenol, (-)-epigallocatechin gallate, equivalent to that of 200 mg in 
healthy human (Vβ/F 2009 +/- 1514 L), an administration dose of free phenolic acid 
as quantified in 4 g GrC (FA: 310.2 µg, iFA: 7.2 µg, DHFA: 17.2 µg, CA: 1116 µg, 
DHCA: 173 µg, 3,4-DMCIN: 149 µg), a maximal concentration (Cmax) and half-life 
(t1/2) taken from existing pharmacokinetic curves (Renouf et al., 2013), an 
elimination constant (ke) calculated from t1/2 (ke = ln(2)/ t1/2) and a ka calculated 
using the following formula: ka * tmax – ln(ka) – ke * tmax + ln(ke) = 0. 
 
2.3.6 Statistical analyses 
 The statistical software R was used for analyses of data. Each free phenolic 
acid was compared between coffees, using the Welch two-sample t-test. Only values 
of p < 0.05 were considered statistically significant. 
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2.4 Results 
2.4.1 Free phenolic acid content of coffee 
 By using a chromatographic detection with simple diode array detection, the 
identity of the peak could hardly be attributed and was based on the comparison with 
the chromatographs of spiked samples. With the simultaneous use of mass 
spectrometry, each phenolic acid of interest was attributed the corresponding peak 
with certitude. The conditions established for the analysis of free phenolic acids by 
HPLC-DAD-ESI-QQQ are shown in Table 2.1 and Figure 2.1 and a typical diode 
array detector chromatographic profile is shown in Figure 2.2. The limit of 
quantification per injection was 7.5, 45, 5.6 and 4.8 pg for CA, DHCA, FA and 
DHFA respectively. Using this method, the content of 6 free phenolic acids was 
determined in 5 different instant coffees (Table 2.2). All compounds were above the 
limit of detection. Amongst the 5 coffees analysed, the coffee originating from a 
mixture of roasted and unroasted beans (GrC) had the highest content of CA and FA 
(p < 0.001 and p < 0.05 respectively). On the other hand, the medium dark roast 
caffeinated coffee (MC) contained the highest content of DHCA, DHFA and iFA, 
and the golden roast caffeinated coffee (GoC) contained the highest level of 3,4-
DMCIN. Finally, the two decaffeinated coffees tested had, when compared to their 
corresponding roast caffeinated coffee, lower levels of all free phenolic acids. These 
observations suggest that not only roasting, but also decaffeination, may affect the 
content of free phenolic acids. The levels of free phenolic acids are > 2 orders of 
magnitude lower than that of chlorogenic acids typically present in the GrC coffee, 
as reported by Hoelzl et al. (2010) (. In the latter report, the content of chlorogenic 
acids was: 3-CQA: 42,000 μg/g coffee; 4-CQA, 49,600; 5-CQA, 162,400; 4,5-
diCQA, 23,200; 3,5-diCQA,16,000; 3,4-diCQA, 22,800; 4-FQA, 8,800; 5-FQA, 
31,600. 
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Figure 2.1: Typical diode array detector and total ion count chromatograms of the 
coffee sample containing 35 % of green coffee beans. Absorbance profile at 280 nm 
(A), Total ion counts from mass spectrometry (B, C), Individual transitions for 
indicated mass-to-charge ratio (m/z). 
 





























Figure 2.2: Typical diode array detector chromatographic profile of a coffee sample, 
at 280 nm. Profile of a 5 μL injection of the coffee originating from a mixture of 
roasted and unroasted beans (GrC). 
 
Table 2.2: Free phenolic acid content in 5 instant coffees. Values are given in μg 
phenolic acid per gram of dry weight of instant coffee. Standard deviations are for 
the two batches of coffee analysed, with three biological replicates, each with two 
technical replicates.: GrC, 35 % unroasted and 65 % roasted coffee caffeinated; 
GoC, golden roast caffeinated; GoD, golden roast decaffeinated; MC, medium roast 




DHCA CA DHFA FA iFA 3,4-DMCIN 
GrC 43 ± 1 279 ± 16 4.3 ± 0.2 77 ± 5 1.8 ± 0.1 37 ± 0 
GoC 56 ± 1 107 ± 3 4.1 ± 0.2 23 ± 1 2.7 ± 0.4 48 ± 1 
GoD 44 ± 2 72 ± 4 3.6 ± 0.2 22 ± 2 1.7 ± 0.6 19 ± 0 
MC 71 ± 1 87 ± 2 6.7 ± 0.2 29 ± 4 3.2 ± 0.3 32 ± 2 
MD 46 ± 1 75 ± 4 4.6 ± 0.2 22 ± 1 1.7 ± 0.0 15 ± 0 
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2.4.2 Estimation of the contribution of free phenolic acids to the early 
appearing phenolic acid metabolites in blood 
 Phenolic acid metabolites were reported in plasma in a previous human study 
where subjects consumed a cup of GrC coffee beverage at different concentrations 
(Renouf et al., 2013). To ascertain the contribution of phenolic acids present in 
coffee to the early appearance of phenolic acids metabolites in plasma, the contents 
in the GrC coffee from the current investigation were compared to computed 
pharmacokinetic curves (Figure 2.3) and to the maximum plasma values previously 
reported obtained after consumption of a cup of 4 g GrC coffee (Renouf et al., 
2013). Assumptions made are shown in section 2.3.5. However, these values are the 
maximum estimates and real values are likely to be less. Even in the unlikely event 
that these assumptions are underestimated by 10-fold, the amount of free phenolic 
acids in coffee is still not enough to account for the early appearing blood peaks by 
at least an order of magnitude, and more for some compounds. As an example, the 
free ferulic acid fraction in coffee would give rise to a peak of 0.5 nM in blood 
assuming 100 % absorption, compared to an obtained value of 200 nM after drinking 
a cup of coffee, i.e. approximately 400-fold higher. From this calculation, most of 
the early appearing phenolic acids is estimated to be due to hydrolysis of the 
constituent chlorogenic acids, which must occur either in the stomach or in the small 
intestine. 
 































































Figure 2.3: Theoretical pharmacokinetic curves for phenolic acids in plasma based 
on free phenolic acid content in 4 g of GrC and assuming a 100 % bioavailability. 
From published data, the small intestinal Cmax values (i.e. < 3 hours) after 
consumption of this amount of coffee were approximately: DHCA, 50 nM; DHFA, 
60 nM; 3,4-DMCIN, 500 nM; FA, 210 nM; CA, 180 nM; iFA, 80 nM. 
 
 Some possible sources of esterase in the small intestine were thus tested by 
former colleagues for the ability to hydrolyse the various chlorogenic acids present 
in coffee. As intestinal and liver tissue extracts did not hydrolyse 5-O-caffeoylquinic 
acid by Plumb et al. (1999), the pancreatic secretion, which is secreted into the small 
intestine, was tested (by Mr. Nicolai U. Kraut). Incubation of the coffee solution 
with porcine pancreatin led to the formation of free caffeic acid, but not ferulic acid. 
Further investigations with pure chlorogenic acids as the substrates for pancreatin 
indicated linear rates over 60 min, at increasing rates for 3-, 4- and 5-caffeoylquinic 
acid. When 3-, 4- or 5-feruloylquinic acids were incubated with the pancreatin 
solution, no significant increase in ferulic acid was observed. These data suggest that 
caffeoylquinic acids and more specifically 5-O-caffeoylquinic acid is a better 
substrate for pancreatin. In vitro experiments with Caco-2 cells (carried out by Dr. 
Tracy L. Farrell and Ms. Alexandra Ryder) confirmed to possess an esterase activity, 
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showed a distinctly lower hydrolysis of the caffeoylquinic acid isomers when 
compared to that of the methyl ester analogue used for testing the esterase activity of 
the monolayers. Interestingly, 3-O-caffeoylquinic acid was hydrolysed 
approximately 10-fold more rapidly than 5-O-caffeoylquinic acid. 
 
2.5 Discussion and conclusion 
 Amongst a variety of commercially available instant coffees, the caffeinated 
instant coffee made from 35 % green and 65 % roasted beans water extract (GrC) 
had the highest content of free CA and FA. The medium dark roast caffeinated 
coffee (MC) had the highest content of free DHFA, iFA and DHCA and the golden 
roast caffeinated coffee (GoC) had the highest content of 3,4-DMCIN. Additionally, 
when comparing caffeinated and decaffeinated coffees of a same roast, the 
decaffeinated coffees contained less of all free phenolic acids tested. These data 
suggest that not only chlorogenic acids (Clifford, 1999), but also some free 
hydroxycinamic acids decrease with roasting intensity and decaffeination. 
 
 As expected, when compared to the amount of intact chlorogenic acids 
previously reported by Hoelzl et al. (2010), the amounts of free phenolic acids 
present in GrC are substantially lower (Table 2.2). However, free CA and FA are 
readily absorbed through the intestinal wall without further modifications (Stalmach 
et al., 2010) and less abundant compounds could have the potential to contribute 
significantly to the pool of metabolites measured in human fluids. The 
pharmacokinetic simulation suggests that the free phenolic acids are not present in 
sufficient quantities to make a significant contribution to the derived metabolites in 
plasma, even if 100% absorption is assumed. The in vitro esterase experiments using 
pancreatic secretions and small intestinal cells suggest, however, that the hydrolysis 
of chlorogenic acids into free phenolic acids are major contributing mechanisms to 
the early appearance of free phenolic acids in plasma, with a hydrolysis of 5-O-
caffeoylquinic acid by pancreatic enzymes up to 5-fold higher when compared to 3- 
and 4-O-caffeoylquinic acid. The preparation of pancreatic secretions used being a 
complex mixture of lipases, trypsin, peptidases, proteases, RNAses, DNAses, 
amylases and unspecific carboxylesterases, it is not possible at this stage to attribute 
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the hydrolysis to a single enzyme. The hydrolysis of methyl esters in Caco-2 cells 
has been previously reported (Kern et al., 2003) and was used to verify the presence 
of esterase activity in the Caco-2 cell model. The expression of carboxylesterase(s), 
which is believed to be localized on the endoplasmic reticulum (Imai, 2006) has 
been previously characterized in both the Caco-2 cell model and human intestinal 
tissue (Sun et al., 2002). 
 
 The very low rate of hydrolysis of 5-O-caffeoylquinic acid by the intestinal 
model, differentiated Caco-2 cells, is consistent with previous reports, where 
intestine, liver and tissue extracts were unable to hydrolyse 5-O-caffeoylquinic acid 
(Plumb et al., 1999). However, 3-O-caffeoylquinic acid was hydrolysed at a much 
higher rate (~ 10-fold). After hydrolysis, the product caffeic acid, and its methylated 
derivative ferulic acid, are transported differently, probably due to the differing 
lipophilicity of the methyl esters and caffeoylquinic acids, Log D ~ 2 and – 3.5 
respectively (reference: MarvinSketch, 2012; version 5.3.1, ChemAxon). The 
hydrophilic nature of the caffeoylquinic acids and paracellular permeation (Farrell et 
al., 2012) may explain the lower rates of hydrolysis compared to the methyl esters. 
Steric hindrance in the active site of human carboxylesterase-2, the predominant 
isoform in the small intestine (Imai, 2006), has been reported to occur with 
substrates containing a bulky acyl-moiety (representing the phenolic acid part of the 
quinic acid ester) which interfere with the formation of the enzyme-acyl 
intermediate during the first stage of hydrolysis. Steric interference may in part 
explain the differential hydrolysis of caffeoylquinic acids, and the lack of hydrolysis 
of the feruloylquinic acids. Interestingly, these findings may support data from 
human bioavailability studies in vivo which showed that only 5-O-caffeoylquinic 
acid could be detected in plasma after coffee consumption, perhaps suggesting that 
the susceptibility of the 3-acyl isomer to hydrolysis and relative resistance of the 5-
acyl may contribute to the differential amounts of chlorogenic acids observed in 
vivo. An additional site of absorption is the stomach; cultured gastric epithelial cells 
have the capacity to hydrolyse chlorogenic acids into phenolic acids, with the 
esterase action favouring hydrolysis of caffeic and dimethoxycinnamic acid-
containing substrates (Farrell et al., 2011). Several publications have also shown that 
intact chlorogenic acids can pass across the rat stomach and Caco-2 cell monolayers, 
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but only minor hydrolysis into phenolic acids occurred in the rat stomach (Lafay et 
al., 2006, Scherbl et al., 2014). 
 
 In conclusion, these experiments demonstrate that free phenolic acids 
quantified in coffee are not present in sufficient amounts to account for the 
appearance of pre-colonic derived metabolites following the consumption of a 
regular coffee beverage. Further in vitro investigation indicated that the hydrolysis 
of 5-O-caffeoylquinic acid by pancreatic esterases and 3-O-caffeoylquinic acid by 
brush border esterases in the small intestinal could be major alternative contributing 
mechanisms to the early peak of phenolic acids derived metabolites in plasma. A 




































Figure 2.4: Sites of hydrolysis of chlorogenic acids derived from this and previous 
studies. Figure taken from (da Encarnação et al., 2014) 
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Chapter 3  
Validation of methods used for the measurement of health 
biomarkers in human plasma and development of questionnaires 
3.1 Abstract 
 Biomarkers are useful tools to assess the health status of a subject. These can 
be measured in different biological samples, which include tissues or body fluids 
such as urine or blood. Commercially available analytical methods often target the 
measurement of biomarkers in persons at risk of particular diseases and therefore the 
same methods may not be ideal for the measurement of the same biomarkers in 
healthy subjects, as the concentrations may be outside the range provided. For the 
present human study, total aminothiols, glucose, insulin and uric acid concentrations 
were measured in the fasting blood of healthy adults. In order to ensure reliable 
results within the range of interest, the use of reproducible methods guaranteeing the 
accurate quantification of the above-mentioned biomarkers was sought. Therefore, 
based on reliable procedures published in literature, a selection of methods were 
tested. In order to minimize the sample loss, the least plasma pre-treatment was 
wished. The present chapter reports the improvement and validation of the methods 
used for the quantification of the above biomarkers of health, used in later chapters 
to describe the study population recruited. Total aminothiols were measured using a 
chromatographic method with fluorescence detection, glucose and uric acid were 
measured using enzymatic colorimetric methods and insulin was measured by a 
commercial enzyme-linked immunosorbent assay. The plasma pre-treatment was 
limited to a centrifugation with no further need of deproteination or defatting. The 
improved and optimised methods showed a high reproducibility, good linearity 
within the range of interest, good recoveries and were time-efficient. 
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3.2 Introduction 
 The health status of a subject can be assessed by the measurement of 
biological markers (biomarkers). An accurate definition of biomarkers was given by 
the Biomarkers Definitions Working Group, in 2001 as "A characteristic that is 
objectively measured and evaluated as an indicator of normal biological processes, 
pathogenic processes, or pharmacologic responses to a therapeutic intervention" 
(BDWG, 2001). Biomarkers can be measured in diverse biological fluids and 
tissues, but for the current research, the measurements were done in human plasma. 
Commercially available analytical methods such as immunoassays are valuable tools 
for the detection of specific biomarkers of health, however, assays are often 
developed for the analysis of biomarkers in biological samples of people at risk of 
developing a particular condition and therefore the detection range may not be 
appropriate for healthy subjects. In the present study, total aminothiols, glucose, 
insulin and uric acid were measured in fasting plasma samples of a healthy adult 
population, as biomarkers of their general inflammation and cardiovascular health 
status. Although chromatographic, enzymatic and/or colorimetric techniques for 
these biomarkers have been published and some of them validated, not all achieve 
satisfactory results. Particularly for aminothiols, the chromatographic separation is 
often not satisfactory (Jacobsen et al., 1994, Minniti et al., 1998, Ferin et al., 2012, 
Frick et al., 2003). Therefore, in the present chapter, improved methods were sought, 
when possible, for the analysis of the above-mentioned biomarkers, based on the 
literature. 
 
3.2.1 Total aminothiols 
 During normal metabolic processes, reactive oxygen species (ROS) and 
reactive nitrogen species (RNS) are produced. In order to be maintained at 
physiological levels, these need to be neutralized or cleared. For this, scavengers are 
important to maintain a balanced redox status and prevent oxidative stress. 
Aminothiols are thiol-containing amino acids present in cells, but also found in 
plasma unbound (free), as a homodisulfide (e.g. glutathione-glutathione) or as a 
heterodisulfide (e.g. protein-bound aminothiol) and playing an important role in the 
balance of the redox status and hence, in human health. Aminothiols are involved in 
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the transsulfuration pathway, which links methionine to the biosynthesis of 
glutathione (Belalcazar et al., 2014) (Figure 3.1). Malfunction or deficiency of 
cystathione β-synthase, highly abnormal levels of homocysteine in plasma and urine, 
coronary artery disease and other cardiovascular events (Dudman et al., 1996, 
Verhoef et al., 1996, Durand et al., 2001, Mangoni et al., 2013, Robinson et al., 
1994), pancreatitis (Rahman et al., 2009), neurodegenerative diseases (Sabens 
Liedhegner et al., 2012, Tchantchou, 2006) and inflammation (Mangoni et al., 2013) 
are some of the disorders that have been linked to an altered transsulfuration 
pathway. During pregnancy, the aminothiol redox status is also modified, however 
temporarily. Although the affected tissues are numerous in case of pathology, the 
transsulfuration pathway seems to be mainly localized in the liver, pancreas, certain 
lymphoid cells and brain (Rahman et al., 2009, Vitvitsky et al., 2006, Mudd et al., 
1965, Sturman et al., 1980), and recently detected in an in vitro study, in mammary 
epithelial cells (Belalcazar et al., 2014). Levels of aminothiols have been reported to 
vary with the age, and an increase in total homocysteine and cysteine, but not 
cysteinylglycine, was observed in older healthy subjects (Özkan et al., 2002). 
Amongst the factors influencing the plasma concentration of aminothiols is diet. A 
protein-rich meal led to fluctuations of some aminothiols, however, outcomes vary. 
While Ubbink et al. (1992) observed a decrease in plasma homocysteine, 
Guttormsen et al. (1994) and Verhoef et al. (2004) reported a rise of homocysteine, 
in a healthy young adult population. Additionally, Guttormsen et al. reported an 
accompanying decrease in concentrations of cysteine and cysteinylglycine . 
 Although these postprandial variations have been demonstrated and some 
metabolic studies have been done, although mainly focusing on homocysteine, it is 
still not fully understood how the habitual consumption of (poly)phenol-rich foods 
influence the metabolism of aminothiols in healthy adults, and no investigation has 
been done on how these are related to the bioavailability of phenolic acids present in 
coffee. Due to their implication in health and the lack of information, aminothiols 
are good candidates to assess the metabolic redox status by the analysis of plasma. 
 The most frequently studied aminothiol that has been linked to diet and to 
health is homocysteine, but a number of chromatographic methods exist for the 
simultaneous detections of homocysteine, cysteine, cysteinylglycine and glutathione. 
These four were also selected as being of particular interest for the present research 
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to investigate the impact of habitual consumption of (poly)phenol-rich products, 
with emphasis on coffee and other daily habits on the inflammation and 
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Figure 3.1: Transsulfuration pathway. The aminothiols of interest for the present 
study are linked together via the transsulfuration pathway, which occurs 
intracellularly. The enzymes involved in the reactions of the pathway are the vitamin 
B6-dependent cystathionine β-synthase (1) and cystathionine γ -lyase (2), γ-
glutamylcysteine synthetase (3, 7), glutathione synthetase (4), γ-
glutamyltranspeptidase (5),  dipeptidase (6), methionine synthase (8), methionine S-
adenosyltransferase (9), glycine N-methyltransferase (10) and S-
adenosylhomocysteine hydrolase (11). 
 
3.2.1.1 Homocysteine 
 Homocysteine is the starting point in the transsulfuration pathway (Figure 
3.1). It has the ability to inhibit the synthesis of nitric oxide and to promote oxidative 
stress, leading to inflammation (Mangoni and Jackson, 2002). As it has been 
recognized as an independent risk factor for cardiovascular morbidity, the clearance 
of homocysteine in the transsulfuration pathway is important to avoid its 
accumulation. In two randomized cross-over studies, heavy consumption of coffee 
led to increased levels of circulating homocysteine (Grubben et al., 2000, Urgert et 
al., 2000). Later, Olthof et al. (2001) tested in a random order the effect of a 7-day 
exposure of 2 g chlorogenic acid, 4 g black tea solids and 440 mg quercetin-3-
rutinoside on the plasma concentration of homocysteine. When compared to the 
placebo treatment, fasting and 4-5 h postprandial levels of homocysteine 
significantly increased after the period of exposure to each supplement. Along with 
the studies of Urgert et al. and Grubben et al., the results of Olthof et al. suggest that 
chlorogenic acid partly contributes to the observed increase. The administered doses 
of supplement are equivalent to that found in 1.5 L strong coffee (2 g chlorogenic 
acid), 2 L strong black tea (4 g black tea solids) and 13 L black tea (440 mg 
quercetine-3-rutinoside) and are unlikely to be reached by the average population. 
Stolzenberg-Solomon et al. (1999) also reported an increase in fasting serum total 
homocysteine with higher coffee consumption, and a lower fasting total 
homocysteine with increased dietary protein intake, however, the study population 
consisted of elderly subjects with a narrow age range and therefore the influence of 
age could be masked. 
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 The effect of tea consumption on homocysteine is more inconsistent, with 
both positive and negative correlations being reported (Jacques et al., 2001, Olthof et 
al., 2001). In a study of Hodgson et al. (2003), a regular moderate to high black tea 
consumption did not induce significant overall changes in serum total homocysteine, 
but increased the urinary excretion of 4-O-methylgallic acid. Subjects with an 
increase in 4-O-methylgallic acid in the lowest quartile had a significant decrease in 
total homocysteine, while those for which the increase was in the upper quartile had 
a significant increase. These results are consistent with the hypothesis that dietary 
(poly)phenols can elevate homocysteine concentrations by increased methylation 
reactions where a methyl group is transferred from S-adenosylmethionine to 
(poly)phenols (Olthof et al., 2001). Although data from the Hordaland homocysteine 
study reports interesting relations between coffee and tea consumption and other 
lifestyle habits, the analyses were performed on non-fasting blood and therefore the 
previous consumption of food could influence the homocysteine levels (Nygard et 
al., 1997, Nygard et al., 1998). The same observation applies to a few other studies 
(de Bree et al., 2001, Rasmussen et al., 2000). 
 In a study from Edgar et al., fasting total homocysteine in a mid-age male 
population was positively associated with total cysteine and total cysteinylglycine, 
and negatively associated with fruit and vegetable intake (Edgar et al., 2008). 
 
3.2.1.2 Cysteine 
 Cysteine is part of the essential amino acids and is the most abundant 
aminothiol in plasma, with concentrations of 321 μM having previously been 
reported in healthy subjects (Andersson et al., 1999). Cysteine can be obtained from 
the diet and from homocysteine in a two-step transsulfuration process catalyzed by 
two vitamin B6-dependent enzymes, and is a precursor and a rate limiting factor for 
the synthesis of glutathione (Figure 3.1). Results for cysteine are contrasting and 
have led to divergent opinions in regards to its status in regards to the development 
of cardiovascular diseases. In a case-control study, higher levels of total cysteine 
were reported in atherosclerotic vascular disease patients, when compared to the 
control group, and a positive association between cysteine and total homocysteine 
was identified. Total cysteine was also positively associated with age, gender, BMI, 
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cholesterol, apolipoprotein, creatinine, triglycerides and folic acid, and negatively 
associated with smoking. It should be noted that medication and modifications in the 
lifestyle and dietary habits of case subjects may influence the measurements of 
biomarkers in plasma (El-Khairy et al., 2001, Graham et al., 1997). In accordance 
with this outcome, after adjustment for conventional risk factors of coronary heart 
disease, a more recent study reported no association between total cysteine and the 
increase in rate of myocardial infarction amongst postmenopausal women. After 
adjusting for age, fasting total cysteine was correlated with total homocysteine and 
BMI, and inversely with alcohol, in control women (Page et al., 2010). In vitro 
studies have also reported similar results, associating cysteine and homocysteine 
with cytotoxicity and the promotion of the detachment of human arterial endothelial 
cells in culture (Dudman et al., 1991). 
 Moat et al. reported different outcomes in an in vivo study where plasma 
levels of total cysteine and homocysteine were compared in hyperhomocysteinaemic 
patients, their heterozygous parents and healthy subjects. The analyses revealed that 
in case of hyperhomocysteinaemia, the oxidative stress could result not only from a 
direct cytotoxicity from homocysteine, but also from the associated decrease of 
plasma cysteine, and plasma total cysteine was suggested to be an independent 
predictor of plasma total antioxidant capacity in healthy and homocysteinaemic 
subjects (Moat et al., 2001). 
 When compared to homocysteine, little research has focused on the influence 
of dietary habits and lifestyle on plasma total cysteine. Analysis of plasma in the 
Hordaland homocysteine study suggested that coffee consumption was one of the 
main determinants of plasma cysteine, along with age, gender, BMI, diastolic blood 
pressure and total cholesterol. However, as earlier highlighted for homocysteine, 
analyses were done with non-fasting blood samples and previous consumption of 
food may influence the relationships. From the same study, no association was found 
between total cysteine and the risk of hospitalizations and death due to 
cardiovascular disease (El-Khairy et al., 2003). The various outcomes of studies on 
cysteine may be explained by the inconsistent adjustment for confounders. 
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3.2.1.3 Glutathione 
 Glutathione is a major intracellular antioxidant which assists in detoxification 
processes of xenobiotics and/or their metabolites amongst other functions (Wu et al., 
2004). Although it is present in mM ranges in all cells, reaching up to 10 mM in the 
liver, the concentrations found in plasma remain within the μM ranges (Fraga, 
2010). Glutathione plays an important role in the antioxidant defence, the 
metabolism of nutrients and in the regulation of cellular events. Reactive oxygen 
species (ROS) and reactive nitrogen species (RNS), which comprise radical and non-
radical species, are products of normal metabolic processes, such as aging, immune 
response or inflammation, but can also result from the exposure to external stresses 
such as radiation, smoking, pollutants, excessive exercise some drugs (Pham-Huy et 
al., 2008, Lobo et al., 2010). Most free radicals are unstable and very reactive, but 
when present at low concentrations, these are not harmful and are even helpful in the 
defense of the organism for the destruction of pathogens. However, their 
accumulation can lead to a state of oxidative stress, which plays a key role in the 
development of chronic and degenerative diseases, such as diabetes, inflammation or 
cardiovascular diseases (Wu et al., 2004, Pham-Huy et al., 2008). Characteristic 
oxidative stress processes include lipid peroxidation and oxidative DNA damage. An 
example of neutralization of a non-radical species by glutathione (C10H17N3O6S) is 
the formation of two water (H2O) molecules from one molecule of hydrogen 
peroxide (H2O2). In this reaction, two molecules of reduced glutathione are oxidized, 
linked through a disulfide bond and two hydrogen (H
+
) molecules are lost and 
become available for the formation of water, thus avoiding the formation of 2 
hydroxyl radicals (•OH) from H2O2. The reduced form of glutathione is thus 
important to the neutralization or removal of ROS and RNS contributing to the 
balance of the redox status and thus, lower concentrations of glutathione would lead 
to a higher risk of oxidative stress and derived conditions. 
 In a study with male adolescents, serum total glutathione, along with total 
homocysteine, but not total cysteine, predicted parental coronary heart disease 
(Morrison et al., 1999). In an intervention study reported by Esposito et al. (2003), 
the consumption of 5 cups per day coffee (italian style) over a period of 7 days 
significantly increased the total plasma glutathione concentration. Although plasma 
samples were obtained 4 to 5 hrs following the breakfast, which could have an 
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impact on the aminothiol concentration, a subsequent period of coffee abstention of 
7 days did not restore the glutathione concentrations measured before the exposure 
to coffee. This suggests that a coffee, when regularly consumed in moderate to high 
doses, has the potential of increasing the general plasma glutathione when regularly 
consumed. The increase in glutathione was, however, not accompanied by an 
increase in oxidative stress, implying that this was not part of a stress response. 
 
3.2.1.4 Cysteinylglycine 
 Cleavage of glutathione by γ-glutamyltransferase leads to the formation of 
cysteinylglycine (Figure 3.1). Very scarce information is available on this aminothiol 
as a biomarker of health. So far, it has been positively correlated to oxidized LDL 
and myocardial infarction after controlling for some risk factors (Drogan et al., 
2010). Only one publication, which studied the relation of cysteinylglycine, along 
with cysteine and homocysteine, with diet and some cardiovascular disease risk 
factors, was found. In this study, total cysteinylglycine was positively correlated 
with total homocysteine and total cysteine, as well as with diastolic blood pressure, 
and BMI. Contrary to total homocysteine, habitual coffee consumption and smoking 
did not seem to affect the baseline cysteinylglycine (Edgar et al., 2008). 
 
 Most studies with aminothiols have focused on homocysteine and glutathione 
and less or scarce information is known on the relationship of cysteine and 
cysteinylglycine with inflammation, cardiovascular health, diet and other lifestyle 
habits. Due to their implication in inflammation and cardiovascular health, 
aminothiols were interesting compounds to be included in the analyses of this 
research project. As extracellular concentrations of aminothiols may be affected by 
confounders, the identification of these and adjusting for the analysis is important to 
avoid drawing premature conclusions. In the transsulfuration pathway, the substrate-
to-product ratios have been said to be a useful tool to study enzymatic activity, 
therefore the simultaneous analysis of several members of the transsulfuration 
pathway is advised (Mangoni et al., 2013). Unbalances in the transsulfuration 
pathway, as for other conditions, could be partly explained by reduced enzymatic 
activities that accompany aging, as well as an impaired renal function (Wilcken and 
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Gupta, 1979). In the study by Mangoni et al. (2013), the homocysteine-to-cysteine 
and glutathione-to-cysteinylglycine ratios were positively and negatively associated 
with the cardiovascular risk score, respectively, suggesting that a lower conversion 
of homocysteine to cysteine and a higher conversion of glutathione to 




 Normal standards of glycaemia vary slightly depending on the country, 
however, in 2003 the American Diabetes Association, often taken as a reference, 
redefined normal glucose levels. A healthy glycaemia is considered to be < 5.6 mM 
at fasting and < 7.8 mM two hours following a 75 g oral glucose load; this is also the 
cutoff adopted by the World Health Organization (WHO, 2006). Fasting levels of 
5.6 to 7.0 mM typically reflect a pre-diabetic or impaired glucose tolerance state 
while values equal or above 7.0 mM are already defined as diabetes. 
 Circulating glucose derives endogenously from glycogenolysis and 
gluconeogenesis, and exogenously from the intestinal absorption of dietary sugars. 
Although blood glucose fluctuates upon ingestion of food, the range of circulating 
glucose remains relatively narrow as a consequence of the homeostatic events to 
counteract hyper- and hypoglycaemia. Glucose represents the principal source of 
energy for the brain and its homeostasis is thus essential to provide sufficient energy 
and prevent impaired cerebral function. On the other hand, prolonged elevated 
glucose concentrations may lead to cerebral damage and represent a risk for 
cardiovascular morbidity (Shrayyef and Gerich, 2010). 
 The homeostasis of glucose depends on the balance of the rates of increase of 
circulating glucose and the rate of clearance from the circulation. The two main, but 
not only, regulator hormones of blood glucose are glucagon and insulin. In the case 
of low blood glucose (e.g. fasting, physical activity, hypoglycaemia), the secretion 
of glucagon from the pancreatic α-cells into the bloodstream is stimulated by Ca
2+
 
signals. The glucagon present in the bloodstream binds to receptors at the cellular 
surface of target organs, mainly the liver but also in the adipose tissue, triggering a 
series of intracellular reactions that result in an increased production of glucose, 
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through the breakdown of glycogen (glycogenolysis) and the de novo synthesis from 
non-carbohydrate carbon compounds (gluconeogenesis), and subsequent secretion 
into the circulation. Animal studies with dogs, often used due to the high level of 
translation to the human, have demonstrated that the compensatory glucose rise was 
mainly explained by glycogenolysis, rather than through gluconeogenesis 
(Ramnanan et al., 2011). At fast, the liver is the main organ where glycogenolysis 
and gluconeogenesis occur, but in case of extreme starvation, kidneys are also able 
to compensate for the disappearing glucose (Aronoff et al., 2004). Skeletal muscle 
also hosts glycogenolysis, however, due to the high activity of hexokinase present in 
muscle, glucose rapidly undergoes glycolysis to provide the muscle with the 
necessary energy, resulting in little glucose exiting into the circulation. 
 During the postprandial rise in blood glucose, a series of events are triggered 
to help maintain glucose at physiological levels. The increased sensing of glucose by 
pancreatic β-cells stimulates the release of insulin into the bloodstream. The latter 
inhibits the secretion of glucagon and consequently the glycogenolysis and 
gluconeogenesis (Aronoff et al., 2004). Induced by the insulin binding to insulin-
receptors at the surface of skeletal muscles cells and adipose tissue, glucose is 
incorporated into these tissues, further contributing to the regulation of glycaemia. 
Once in the tissues, glucose is either stored as glycogen (glycogenesis) or undergoes 




 Insulin belongs to the hormones regulating circulating glucose levels, and its 
production and secretion by the pancreatic β-cells are stimulated upon ingestion of 
food. Insulin is able to lower blood glucose by the combined action of the inhibition 
the secretion of glucagon by the pancreatic α-cells, the stimulated uptake of 
circulating glucose by insulin-sensitive tissues such as skeletal muscle cells and 
adipocytes, and the induction of glycogenesis in the liver. 
 At fasting, concentration of 12 - 150 pM have been measured in healthy 
subjects (Mercodia) and insulin is only secreted once glycaemia reaches values > 3.3 
mM. Although insulin secretion is mainly controlled by the circulating glucose 
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concentration, plasma concentrations of glucagon like protein-1, gastric inhibitory 
polypeptide or particular amino acids, and parasympathetic stimulation via the vagus 
nerve can also stimulate insulin secretion. 
 Insulin is a relatively small protein constituted of two polypeptide chains 
held together by two disulfide bonds. Methods for analysing insulin comprise liquid 
chromatography linked or not to mass spectrometry, radioimmunoassay, enzyme 
linked immunosorbent assays, luminescent immunoassays, capillary electrophoresis. 
 
3.2.4 Uric acid 
 Uric acid is a heterocyclic organic compound naturally present in the 
circulation. It is the end metabolic product in the catabolism of purine nucleoside 
and free bases in animals. Due to the lack of uricase in humans, the enzymatic 
conversion of uric acid into the highly soluble allantoin is absent and, versus those 
of other animals, high baseline levels of serum uric acid are observed (0.2 – 0.4 mM) 
(Sautin and Johnson, 2008), with males having generally higher levels of uric acid 
(normal high cutoff: < 0.416 mM) than females (< 0.297 mM). Uric acid 
predominantly circulates as monosodium urate due to the high levels of sodium in 
the extracellular fluid. The consequence is a low solubility of approximately 0.4 
mM, when compared to that of uric acid of 7.1 mM (Terkeltaub et al., 2006). Above 
0.4 mM and at 37 °C, the risk of deposition of monosodium urate crystals in the 
joints increases and may chronically lead to the development of gout, a risk factor of 
cardiovascular disease (Richette and Bardin, 2012, Roddy and Doherty, 2010). 
The plasma concentration of uric acid is determined by the balance of its 
endogenous hepatic and to a lesser extent small intestinal synthesis, by its 
production from the reutilization of purine compounds and by the consumption of 
purine-rich diet (i.e. animal-based foods particularly organ meats, anchovies, 
mackerel, seafood), and its clearance (i.e. renal and intestinal uricolysis by gut 
bacteria). The major cause of hyperuricemia and gout is the lower level of uric acid 
renal elimination (Snaith and Scott, 1971, Terkeltaub, 2010, Sautin and Johnson, 
2008, Terkeltaub et al., 2006). Clearance of uric acid is in turn modulated by the 
genetics, aging, medication and by the consumption of certain foods, particularly 
alcohol (Bieber and Terkeltaub, 2004). Little research has been done in regards to 
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coffee consumption and uric acid in plasma and outcomes have been variable 
depending on the type of study conducted. In a study by Natella et al. (2002), an 
acute increase in plasma uric acid was reported after coffee and tea consumption. In 
a more recent research using data from a cross-sectional study with a representative 
sample of US adults (Third National Health and Nutrition Examination Survey, 
NHANES-III), a significant inverse relation was observed, after adjustment for age, 
gender and other covariates, between coffee (but not tea) intake and circulating uric 
acid. In the same study, this relation was not associated with the intake of caffeine 
(Choi and Curhan, 2007), suggesting that compounds present in coffee, other than 
this methylxanthine, would be responsible for this inverse association. Similar 
observations were reported in a study by Kiyohara et al., with a middle-aged 
Japanese male population (Kiyohara et al., 1999). 
 Much of the research has focused on uric acid and gout. However uric acid is 
also associated with the metabolic syndrome and some other risk factors for 
cardiovascular disease (Roddy and Doherty, 2010, Kim et al., 2009, Richette and 
Bardin, 2010, Ruggiero et al., 2006, Gagliardi et al., 2009). The double bonds in the 
structure of uric acid (Figure 3.2) make it a compound with high antioxidant 
capacity but research indicates that it may act as both pro-oxidant and anti-oxidant.  
 
 
Figure 3.2: Structure of uric acid. Structural characteristics of a purine compound 
(i.e. a pyrimidine and an imidazole ring). The double bonds make uric acid a 
compound with high antioxidant capacity. 
 
 Uric acid has been associated with and has been said to predict the 
development of conditions that may lead to cardiovascular events (Johnson et al., 
2003, Alderman et al., 1999), such as hypertension (Johnson et al., 2003, Johnson et 
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al., 2005, Alper et al., 2005), visceral obesity (Masuo et al., 2003, Ogura et al., 
2004), insulin resistance, T2DM (Samant et al., 2012), dyslipidemia (Matsubara et 
al., 2002). High but still physiologically possible concentrations of uric acid 
increased the oxidation of low density lipoproteins and liposomes by peroxynitrite 
(Sautin and Johnson, 2008). Uric acid has also been said to act as an anti-oxidant. In 
a study with rats, uric acid had a protective effect on neuronal cells and decreased 
the brain injury when administered 24 hours prior an acute ischemia induced by 
occlusion of the middle artery. Similar results were observed in vitro, by the same 
group (Sautin and Johnson, 2008). Further in vitro studies have demonstrated the 





OH) (Ames et al., 1981). Several researches have also proposed 
anti-oxidant effects in the central nervous system (Duan et al., 2002, Hooper et al., 
1998, Spitsin et al., 2002). In an animal model, physiological concentrations of uric 
acid improved the impaired functional responses and functional stability of the heart 
due to oxidants (Sautin and Johnson, 2008). 
 The environment and interactions with certain compounds can influence 
whether uric acid has or not a detrimental effect on the organism. Scavenging of 
lipophilic radicals by uric acid is for example impeded in a hydrophobic 
environment, such as within lipid membranes (Muraoka and Miura, 2003), while in 
the hydrophilic environment of plasma, the anti-oxidant ability of uric acid is 
favoured (Frei et al., 1988). As for the interacting compounds, ascorbic acid and 
aminothiols were shown to be necessary to the scavenging activity of uric acid on 
peroxynitrite (ONOO
-
), in the extracellular space (Kuzkaya et al., 2005). Tyrosine 
nitrosylation, a post-translational modification of proteins leading to oxidative 
damage of proteins in the cell, can be inhibited by uric acid. This process is however 
inhibited (Whiteman et al., 2002) in presence of physiological amounts of 
bicarbonate. 
 Overall, research suggests that chronic elevations of uric acid are associated 
with a pro-oxidant property of it and with increased stroke risk (Mazza et al., 2001) 
and acute elevations of the uric acid are associated with its anti-oxidant properties, 
by preventing acute activation of proinflammatory cells in the blood by oxidants. 
Also, its effect will depend on the environment in which it is present and which 
other present compounds it interacts with. 
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 For the measurement of total aminothiols and glucose, improved methods 
were developed based on existing methods (Frick et al., 2003, Pfeiffer et al., 1999, 
Sigma-Aldrich, 2004). For the analysis of insulin, however, a commercially 
available method was used unchanged and tested for its repeatability and recovery. 
The method used for uric acid measurement was improved in the lab (Ms Y. Shi, 
unpublished results), and some modifications were made and reproducibility further 
tested here. The use of fasting plasma for the analyses of the current research reflects 
the general status of a subject, and also eliminates any postprandial influence on the 
measured biomarkers that are known to fluctuate after a meal. Altogether, improved 
method for the analysis of biomarkers in plasma were sought, aiming at a good 
separation (applying to aminothiols, only), repeatability, good recovery and time 
efficiency of analysis. 
 
3.3 Material and methods 
3.3.1 Chemicals 
 The water used was deionized Millipore water, purified in a filtration system 
from Millipore UK Ltd. (Hertfordshire, UK). 
 For the quantification of total thiols, cystamine dihydrochloride, cysteamine 
(≥ 98 %), L-cysteine (≥ 98 %), cysteinylglycine (≥ 85 %), reduced L-glutathione (≥ 
98 %), D,L-homocysteine (≥ 95 %), acetic acid (99 - 100 %), sodium acetate 
(BioXtra, ≥ 99.0 %), boric acid (≥ 99.5 %), trichloroacetic acid, EDTA and PBS 
were purchased from Sigma-Aldrich. Sodium hydroxyde (50 % concentrated 
solution) and SBD-F were obtained from Fluka-analytical, analytical reagent-grade 
hydrochloric acid (~ 36 %) and HPLC-grade methanol from Fisher Scientific, and 
TCEP-HCl from Thermoscientific. 
 For the quantification of glucose in plasma, the glucose hexokinase reagent, 
formic acid, glyceraldehyde and sodium fluoride were purchased from Sigma. D-
glucose, HPLC-grade methanol, HPLC-grade ethanol and Decon 90 were from 
Fisher Scientific. 
 For the quantification of insulin in plasma, the insulin ELISA assay for 10 x 
96 determinations (10-1113-10) and the diabetes antigen controls (10-1134-01) were 
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purchased from Mercodia, HPLC-grade ethanol and Decon 90 were from Fisher 
Scientific. 
 For the quantification of uric acid, potassium monohydrogen phosphate 
(K2HPO4), potassium dihydrogen phosphate (KH2PO4), potassium hexacyanoferrate 
(II) trihydrate (98.5 - 102.0 %), 4-aminophenazone (4-aminoantipyrine), horseradish 
peroxidase, ascorbate oxidase from Cucurbita sp., sodium 3, 5-dichloro-2-
hydroxybenzenesulfonate, lithium carbonate (≥ 99.0 %), uricase from Candida sp. 
and uric acid were all purchased from Sigma. Triton X-100, ethanol and Decon 90 
were from Fisher Scientific. 
 
3.3.2 Methods 
 Prior to each experiment, the working space was covered with a protective 
benchcote, and at the end of each experiment, the working area was cleaned with 
diluted Decon 90 (1:9, V:V) followed by 70 % EtOH. 
 
3.3.2.1 Blood collection and preparation of plasma aliquots 
 To optimise the sample analysis, the procedures were first tested with 
standards in water and later in plasma samples. All blood samples were drawn into 
EDTA-containing vacuum tubes (Vacuette, Greiner Bio-One) by venepuncturing the 
antecubital vein of healthy adult subjects that had fasted for at least 10 hours. Ten 
milliliters of whole blood was collected from each subject. To reduce the ongoing 
metabolism of cells, the blood collection tubes were placed on ice as soon as the 
blood samples were withdrawn. Samples were then rendered acellular within 30 min 
through a 10 min centrifugation at 3,000 g and 4 °C in a 5810R eppendorf 
centrifuge, as frequently done (Ubbink et al., 1992). For the analysis of glucose, 500 
μL EDTA-whole blood was transferred to a microcentrifuge tube containing 
glyceraldehyde and sodium fluoride (see section 3.3.3.4 for the preparation of these 
antiglycolytic agents) (le Roux et al., 2004), within 15 min of venepuncture, well 
mixed by inversion and centrifuged for 10 min, at 3,000 g and room temperature. 
The plasma was carefully separated without disturbing the buffy coat (leucocytes 
and platelets) and the erythrocytes. Two aliquots for the measurement of each 
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biomarker were prepared and each contained the sufficient volume necessary for 
running one assay in triplicate. All aliquots were then stored at -80 °C until analysis. 
 
3.3.2.2 Total aminothiols 
 Principle of the method: Sample processing and aminothiol analysis in this 
research were based on a previously described method by (Pfeiffer et al., 1999), 
however some optimization was done to adapt to the equipment available and 
improve the aminothiol chromatographic separation. In plasma, aminothiols occur as 
a free form or disulfide-bound to other (amino)thiols or proteins, and so, for the 
quantification of total aminothiols in plasma, an initial reduction of the disulfide 
bonds is required. This critical step was achieved by incubating the samples with the 
water-soluble tris (2-carboxyethyl) phosphine hydrochloride (TCEP-HCL) (Figure 
3.3, A). The latter is a thiol-free stable reducing agent having the advantages of 
being odorless, selective to disulfide bonds, irreversible and efficient at room 
temperature (Krijt et al., 2001, Scientific, 2013). Proteins were then acid-precipitated 
and removed from the reduced sample and aminothiols were derivatized with 4-
fluoro-7-sulfobenzofurazan (SBD-F) (Figure 3.3, B). For a better separation and 










- 63 - 
 
Figure 3.3: Reduction of bound aminothiols by tris (2-carboxyethyl) phosphine 
hydrochloride (TCEP-HCL) (A) and derivatization reaction of thiols by 4-fluoro-7-
sulfobenzofurazan (SBD-F) (B). 
 
 Preparation of reagents and solutions: All the reagents other than the 
aminothiols standards were prepared and able to be kept at their ideal storage 
temperature for up to 2 weeks, after which they were discarded, if unused. Aliquots 
and reagents stored at -20 °C were kept for a longer period of a few months. 
Solutions of PBS (9.55 g/L, pH 7.4); borate buffer (0.125 M, pH 9.5); borate buffer 
(0.125 M) containing EDTA (4 mM), pH 9.5; TCA (100 g/L) containing EDTA (1 
mM); HCl (1 M); NaOH (1.55 M); NaOAc (0.1 M) and AcOH (0.1 M) were 
prepared in milliQ water. NaOAc (0.1 M) and AcOH (0.1 M) were used to prepare 
NaOAc/AcOH (0.1 M, pH 4.99) buffer solution, which in turn was used to prepare 
the mobile phase for the chromatographic analysis, NaOAc/AcOH (0.1 M) 
containing MetOH (0.125 %), pH 4.99. EDTA (250 mM) was prepared in NaOH 
(1.5 M). The PBS, EDTA, borate buffers and TCA solutions were stored at 4 °C, 
while NaAc, AcOH, NaAc/AcOH, NaOH and HCl solutions were kept at room 
temperature. TCEP-HCl (100 g/L) aliquots of 1 mL were prepared in milliQ water 
and stored at -20 °C. Aliquots of 50 μl SBD-F (1 g/L) were prepared in borate buffer 
(0.125 M), pH 9.5 and stored at -20 °C until needed for derivatization. Concentrated 
stocks of aminothiol standards were freshly prepared on each day of analysis and 
used for the calibrator curves and plasma samples preparation. For the calibrator 
curves prepared in plasma, stocks of L-cysteine, cysteinylglycine, L-glutathione and 
cystamine dihydrochloride, used as the internal standard, were prepared in milliQ 
water at 37.6, 18.8, 9.4 and 1 mM respectively, while a 9.4 mM stock of D, L-
homocysteine was prepared in HCl (1 M). These stocks, except for the cystamine 
dihydrochloride, were further diluted in either milliQ water or 1 M HCl to final 
concentrations of 18.8 mM L-cysteine, 9.4 mM cysteinylglycine, 4.7 mM L-
glutathione and 4.7 mM D,L-homocysteine. These later stocks were used for the 
preparation of the calibration curves in milliQ water and spiking samples. Cystamine 
dihydrochloride was diluted to a 225.6 μM stock, which was used for the standards 
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and samples preparations. The final concentration of cystamine dihydrochloride in 
the samples was kept constant at 6 μM. 
 Preparation of standard mixes: For each experiment, aminothiol 
calibration curves were prepared in milliQ water as well as in the biological matrix 
(plasma). For the preparation of the calibration curve in plasma, standard mixes were 
prepared by serial dilutions as follows. An intial combined aminothiols stock Mix2x 
4 was obtained by mixing 100 μL of each previously described 37.6 mM L-cysteine, 
18.8 mM cysteinylglycine, 9.4 mM L-glutathione and 9.4 mM D,L-homocysteine 
stocks. From it, serial dilutions with PBS (9.55 g/L, pH 7.4) were done to achieve 
the desired concentrations of Table 3.1. Briefly, Mix2x 3, Mix2x 2 and Mix2x 1 were 
prepared by diluting 30 μL Mix2x 4 with 90 μL PBS (9.55 g/L, pH 7.4), 20 μL Mix2x 
3 with 980 μL PBS (9.55 g/L, pH 7.4) and 10 μL Mix2x 2 with 90 μL PBS (9.55 g/L, 
pH 7.4), respectively. For the preparation of the calibration curve in milliQ water, 
the earlier described Mix2x 4 was diluted 1:1 (v:v) with PBS (9.55 g/L, pH 7.4) to 
obtain the initial combined aminothiol stock Mix1x 4. The latter was serially diluted 
for the preparation of Mix1x 3, Mix1x 2 and Mix1x 1 by mixing 30 μL Mix1x 4 with 90 
μL PBS (9.55 g/L, pH 7.4), 20 μL Mix1x 3 with 980 μL PBS (9.55 g/L, pH 7.4) and 
10 μL Mix1x 2 with 90 μL PBS (9.55 g/L, pH 7.4), respectively. Mix2x 0 and Mix1x 
0, which contained no aminothiol standard, consisted of milliQ water and were used 
for the null concentration calibrator point in both types of calibration curve. Mix1x 4 
was used for spiking the plasma samples. Final concentrations of each aminothiol 
standard (Std 0 - Std 4) are summarized in Table 3.1).  
 
Table 3.1: Concentrations of aminothiol standards in the different mixes (Mix2x 0-4 
and Mix1x 0-4) used for the preparation of the calibration curves in milliQ water and 
in the biological sample (plasma). The aminothiol concentrations obtained in the 
calibration curves are described in the rows Std 0 to Std 4. L-Cys, cysteine; D,L-
HCys, homocysteine; CysGly, cysteinylglycine; L-GSH, glutathione. 
 
 










Mix2x 0/ Mix1x 0 0 0 0 0 
Mix2x 1 4.7 1.175 2.35 1.175 
Mix2x 2 47 11.75 23.5 11.75 
Mix2x 3 2350 587.5 1175 587.5 
Mix2x 4 9400 2350 4700 2350 
Mix1x 1 2.35 0.5875 1.175 0.5875 
Mix1x 2 23.5 5.875 11.75 5.875 
Mix1x 3 1175 293.75 587.5 293.75 
Mix1x 4 4700 1175 2350 1175 
Std 0 0 0 0 0 
Std 1 0.1 0.025 0.05 0.025 
Std 2 1 0.25 0.5 0.25 
Std 3 50 12.5 25 12.5 
Std 4 200 50 100 50 
 
 
 Sample preparation and treatments: For the calibration curve in milliQ 
water, 35 μL PBS (9.55 g/L, pH 7.4), 25 μL cystamine dihydrochloride (225.6 μM), 
40 μL standard mix (Mix1x 0-4) and 10 μL TCEP-HCl (100 g/L) were mixed in five 
microcentrifuge tubes. A pool of combined plasma, prepared by mixing an equal 
volume of each plasma sample to be tested in a batch, was used for the preparation 
of the calibration curve in plasma and for the spiked plasma samples. For the 
calibration curve in plasma, 5 μL PBS, 25 μL cystamine dihydrochloride, 50 μL 
combined plasma, 20 μL standard mix (Mix2x 0-4) and 10 μL TCEP-HCl were 
mixed. The spiked plasma samples were prepared by mixing 5 μL PBS, 25 μL 
cystamine dihydrochloride, 50 μL combined plasma, 20 μL standard mix (Mix1x 4) 
and 10 μL TCEP-HCl. Finally, non-spiked plasma samples were prepared by mixing 
25 μL PBS, 25 μL cystamine dihydrochloride, 50 μL plasma and 10 μL TCEP-HCl. 
All samples were briefly vortex-mixed, spun at 13,000 g for up to 3 seconds and 
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then reduced for 15 min in a 37 °C and 130 rpm shaking waterbath incubation (GLS 
Aqua Plus Grant). Samples were cooled to room temperature, and deproteination 
was achieved by addition of 90 μL TCA (100 g/L) containing EDTA (1 mM) and 
vortex-mixing each sample for 1 min. Precipitated proteins were pelleted in a 10 
min, 13,000 g centrifugation at 4 °C, in a 5810R eppendorf centrifuge. Carefully 
avoiding disturbance of the pellet, 50 μL from the supernatant was added to 50 μL 
SBD-F (1 g/L) and 127 μL borate buffer (0.125 M) containing EDTA (4 mM), pH 
9.5 and 8 μL NaOH (1.55 M). Five randomly picked samples were used to certify 
that the pH for derivatization was between 9 and 10. Samples were subsequently 
briefly vortex-mixed, spun and incubated in the dark for 60 min, at 60 °C and 130 
rpm, in a shaking waterbath. Samples were then allowed to cool down to room 
temperature, centrifuged for 10 min, at 4 °C and 13,000 g. Finally, derivatized 
samples were filtered through a 0.2 Å PTFE filter, into amber vials for HPLC 
analysis. 
 Sample analysis: HPLC analysis was carried out using an Agilent 1200 
series HPLC equipped with a fluorescence detector. Separation of the fluorescent 
SBD-F-aminothiol adducts was achieved on a Spherisorb, ODS1 (C18), 5 μm 
particle size, 4.6 mm internal diameter and 250 mm length, 8 μm pore size analytical 
column from Waters. A volume of 10 μL sample was injected and run at 0.6 mL/min 
using a 22.5 min isocratic gradient of 0.1M NaOAc/AcOH containing 0.125 % 
MetOH, pH 4.99, with the column compartment temperature maintained at 29 °C. 
Detection of the adducts was at the excitation wavelength of 385 nm and emission 
wavelength of 515 nm. The chromatographed standard samples were used to 
construct the calibration curves from which the concentrations of each aminothiol 
were calculated according to the normalized areas under the curve. 
 Limits of detection were calculated as the amount of SBD-F-aminothiol 
adducts for which the signal to noise ratio equals 10. Limits of quantification were 
the amounts of SBD-F-aminothiol adducts for which the signal to noise ratio equals 
3. Recoveries were calculated as the percentage of the ratio of the obtained 
normalized area under the curve to the expected normalized area. 
 Repeatability: The inter-day variability was tested with a same single 
standard sample prepared in milliQ water and run on three consecutive days. To 
keep the conditions identical to those of an analytical run, the samples were stored 
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between the repeatability tests in amber vials and in the HPLC autosampler 
compartment set to 4 °C. As no run lasted more than 48 h, testing the repeatability 
and stability for three days was considered to be sufficient. 
 
3.3.2.3 Glucose 
 Principle of the method: The measurement of glucose was one of the first 
clinical tests available. Techniques such as the analysis of capillary blood collected 
by finger prick analysed on glucose oxidase/peroxidase strips, or an electronic 
device allow oneself to monitor glycaemia. Other methods run in laboratories take 
advantage of different properties of the analyte and include chromatographic, 
reducing, condensation, enzymatic or electrochemical methods (Noiphung et al., 
2013, Schierbeek et al., 2009, Carroll et al., 1970). The method using hexokinase is 
a reliable enzymatic technique often used not only for food, but has also been used 
with biological samples (Giampietro et al., 1982). For the analysis of D-glucose in 
fasting plasma, the glucose hexokinase reagent mix from Sigma was used (Sigma-
Aldrich, 2004). This commercial method is described for the usage of cuvettes, 
requiring a relatively large plasma volume. The method was thus adapted for the 
usage of 96-microwell plates. The hexokinase method was developed by the 
American Association of Clinical Chemistry and Centres for Disease Control and 
has been accepted as the reference method for glucose determination (Schaffer, 
1976). The method is based on the detection of NADH produced at the end of a 
series of reactions, starting with the phosphorylation of glucose into glucose-6-
phosphate, which is subsequently oxidized by glucose-6-phosphate dehydrogenase. 
In this final reaction, an equimolar amount of NAD
+
 is reduced into NADH which is 
then detected at 340 nm (Figure 3.4). The provided hexokinase reagent is available 
as a lyophilized mixture of non-reactive stabilizing agents (i.e. sodium benzoate, 
potassium sorbate), fillers and buffer (pH 7.5), as well as a mixture of 1 mM ATP, 
1,000 U/L yeast hexokinase, 1.5 mM NAD
+
, 1,000 U/L bacterial glucose-6-
phosphate dehydrogenase (Leuconostoc mesenteroides), 2.1 mM Mg
2+
 and sodium 
azide (0.05 %) when reconstituted in the correct volume of milliQ water. 




















Figure 3.4: Reactions involved during the incubation of the glucose-containing 
sample with the hexokinase reagent. ATP, adenosine triphosphate; G-6-P, glucose-6-
phosphate; 6-PG, 6-phosphogluconate; NAD
+
, oxidized nicotinamide adenine 
dinucleotide; NADH, reduced nicotinamide adenine dinucleotide. 
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 Antiglycolytic agents: Once blood is collected, glucose continues 
undergoing glycolysis, unless the reaction is inhibited. A loss of 5 to almost 14 % 
per hour has been measured in whole blood (McMillin, 1990). An underestimation 
of the glycaemia can result from measuring glucose in a plasma sample which has 
not been treated with antiglycolytic agents or not immediately rendered acellular. 
The use of sodium fluoride has long been shown to be inefficient within the first 
hour as an antiglycolytic agent on its own (Chan et al., 1990, de Pasqua et al., 1984). 
In 2004, Le Roux et al. tested a few antiglycolytic agents, and data indicated that the 
use of 11 mM glyceraldehyde with 119 mM sodium fluoride, but not either of them 
alone, appeared to give the best antiglycolytic results. With this combination, 
uncentrifuged blood samples did not show any glucose loss due to glycolysis, even 
after 24 hours incubation at room temperature (le Roux et al., 2004). All the blood 
for this study was drawn into EDTA-vacutainer tubes, but no antiglycolytic agent 
was present (section 3.3.3.1). For this reason, aliquots of glyceraldehyde together 
with sodium fluoride were prepared and dried, so that upon addition of 500 μL 
whole EDTA-blood, 11 mM glyceraldehyde and 119 mM sodium fluoride were 
present in the sample. To minimize the error by weighing small amounts, both 
antiglycolytic agents were weighed out in a quantity that was sufficient to prepare 
200 aliquots. With a solubility of 50 mg/mL (0.55 M) in water, 99.1 mg 
glyceraldehyde were weighed and reconstituted in 6 mL milliQ water. With a 
solubility of 41.99 mg/mL (1 M) in water, 499.7 mg sodium fluoride were weighed 
and reconstituted in 20 mL milliQ water. From these glyceraldehyde and sodium 
fluoride stocks, 30 μL and 100 μL respectively were mixed into microcentrifuge 
tubes and dried in an EZ2+ centrifugal evaporator from Genevac (HCl compatible) 
using the aqueous setting and 35 °C until total evaporation. 
 Original method and applied modifications: The commercially available 
assay from Sigma using hexokinase recommends the usage of cuvettes and a 
spectrophotometer, however, a few trials (data not shown) using the original 
protocol by Sigma (Sigma-Aldrich, 2004) rapidly lead to the conclusion that the use 
of cuvettes was not ideal, due to the duration of the experiment, the irreproducibility 
of the readings as well as the high volumes of sample and reagent required. In order 
to overcome the difficulties encountered with the use of cuvettes, an improved 
method using 96-microwell plates was sought. Running the glucose hexokinase 
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assay in a UV-compatible 96-microwell plate would allow the simultaneous analysis 
of numerous samples. In order to run the hexokinase analysis in a 96-microwell 
plate, a few modifications were done to the procedure recommended by Sigma. The 
latter does not include specifications for the analysis of plasma, however, the sample 
to be analysed should have a glucose concentration comprised between 0.27 to 27.75 
mM (Sigma-Aldrich, 2004). The healthy fasting glucose concentration ranges from 
3.87 to 7.22 mM, therefore no dilution would be required for the analysis of fasting 
plasma from healthy subjects. However, in order to include spiked samples in the 
analyses, a 1:1 (v:v) dilution with milliQ water was implemented. This would still 
allow the diluted samples to be higher than the lower healthy limit, and the spiked 
samples to be lower than the higher healthy limit. 
 If performed in cuvettes, 1 mL hexokinase reagent (or milliQ water, for 
sample blanks) is added to 10 to 200 μL sample (Sigma-Aldrich, 2004). The 96-
microwell plates used (Greiner UV-Star®) had a maximal well volume of 392 μL, 
and the hexokinase reagent and milliQ water volume was reduced to 250 μL, which 
would allow plate shaking avoiding spillage. Due to the limited plasma volume 
available, 10 μL sample volume was used for each reaction. This would correspond 
to using 40 μL sample with 1 mL hexokinase reagent or milliQ water, if cuvettes 
were used, which is within the sample volume required. 
 Plasma pre-treatment: A few preliminary tests were done to determine the 
ideal sample processing leading to the best results with the hexokinase assay. These 
were conducted with D-glucose standard solutions as well as with plasma samples. 
Plasma contains proteins and fatty constituents and, depending on the target 
analytes, the analytical equipment and the chemical reactions, these may interfere 
with some methods of analysis. In the present experiments, the wish was thus to 
precipitate proteins and defat the plasma samples. 
 Protein precipitation: A few methods for precipitating proteins are known, 
including the use of ice cold ethanol, trichloroacetic acid and perchloric acid. For the 
precipitation of proteins, ice cold ethanol was used. It leads to aggregation and 
subsequent precipitation of proteins by increasing the ionic attraction to each other 
(Sedgwick et al., 1991). In addition to being relatively harmless, it can easily be 
eliminated by evaporation, thus avoiding further sample dilution an associated 
measurement errors. The reference method for protein precipitation by ethanol was 
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adapted from a method for DNA cleanup from the International Genetically 
Engineered Machine (IGEM, 2011). Nine volumes of ice cold ethanol (4,500 μL) 
were added for each volume of sample (i.e. plasma) (500 μL), samples were then 
vortex-mixed for 1 min, incubated for 45 min at - 20 °C and centrifuged 15 min, at 
13,000 g and room temperature. The supernatants were carefully recovered and 
dried in an EZ2+ centrifugal evaporator from Genevac (HCl compatible) using the 
HPLC fraction setting until total evaporation. The dried samples were reconstituted 
in a quarter of the original plasma volume (125 μL), centrifuged 15 min at 13,000 g 
and room temperature to remove any particulate matter, and transferred to clean 
microcentrifuge tubes for comparative analysis with and without solid phase 
extraction. 
 Defat: Solid phase extraction was tested as a method for sample defatting. 
Ten milligrams sorbent/mL strata-X 33 μm polymeric reversed phase columns from 
Phenomenex were used. Prior to each experiment, the columns were conditioned 
following the recommendations with 1 mL MetOH (100 %) followed by 1 mL 
milliQ water. A volume of 250 μL sample (5.55 mM D-glucose solution or plasma 
sample) was passed through the SPE column and the fractions of 1 mL MetOH (60 
%) and twice 500 μL formic acid (2 % in MetOH) were collected and analysed.  
 Assessment of sample loss: In order to assess any sample loss and determine 
the best sample processing, a 5.55 mM D-Glc standard solution and a plasma sample 
were subject to SPE. The glucose concentration of all collected SPE fractions was 
measured and compared to that of an untreated 5.55 mM D-Glc standard solution 
and untreated plasma sample used as a reference.  
 Improved modified method: The lyophilized hexokinase reagent was 
reconstituted in the appropriate volume of milliQ water. Each reconstituted reagent 
was stored at 4 °C and used within one week. On the experiment day, the reagent 
was brought to room temperature before preparing the samples in the 96-microwell 
plate. 
 D-glucose standard samples preparation: Aliquots of 8.33 mM D-glucose 
stock solution in milliQ water were prepared and stored at -20 °C until analysis. 
These were thawed once and used to prepare a 6-point standard curve freshly for 
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each analysis. The final concentrations of 8.33, 5.55, 2.78, 1.39, 0.14 and 0 mM 
were prepared as described on Table 3.2 by serial dilutions with milliQ water. 
 








Volume of the 
glucose solution 
used             
(mL) 
Volume of milliQ 
water added  
(mL) (mM) (mg/mL) 
8.33 1.50 8.33 1.00 0.00 
5.55 1.00 8.33 1.00 0.50 
2.78 0.50 5.55 0.50 0.50 
1.39 0.25 2.78 0.50 0.50 
0.14 0.025 1.39 0.05 0.45 
0.00 0.00 0.00 0.00 1.00 
 
 
 Plasma samples preparation: Plasma aliquots containing a combination of 11 
mM glyceraldehyde and 119 mM sodium fluoride were thawed and centrifuged for 
10 min, at 3,000 g and 4 °C. The spiked and non-spiked samples used for the 
calculation of recovery were prepared from a pool of combined plasma from the 
samples analysed in a same batch. A volume of 20 μL from each plasma sample was 
combined after thawing, gently but well mixed, and centrifuged as described above. 
Sixty microliters of the combined plasma was then diluted with an equal volume of 
either milliQ water or D-glucose standard solution (2.75 mM) for the preparation of 
the non-spiked and spiked plasma sample respectively. 
 Analytical procedure: Each plasma sample from the human study was 
analysed in quadruplicate. Duplicates were prepared for each sample on each plate 
and two analyses were done on separate days. Each reaction was prepared directly in 
the 96-microwell plate. A volume of 260 μL milliQ water was used as the blank 
(Bl). The reagent blank (RB) was prepared by adding 250 μL HK reagent to 10 μL 
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milliQ water and the standard and sample blanks (SSB) were prepared by adding 
250 μL milliQ water to 10 μL glucose standard solution or 10 μL plasma, 
respectively. Standard and sample tests (SST) were prepared by adding 250 μL 
hexokinase reagent to either 10 μL glucose standard solution or plasma sample. The 
96-microwell plate was covered with an adhesive sealing membrane, to minimize 
the sample loss by evaporation, and incubated at 30 °C for 15 min. The sealing 
membrane was carefully removed, the plate shaken for 15 sec under medium speed 
and a double-orbital movement setting, and readings were taken at 340 nm in a 
PHERAstar
®
 FS microplate reader. 
 In order to determine the final glucose concentration from each sample, a few 
corrections were made. The reading of the water blank (Bl) was first subtracted from 
all reagent, standard and sample blank as well as standard and sample test readings 
to obtain the corrected values of these, described respectively as RBcorr, SSBcorr and 
SSTcorr. The total blank (Blanktot) resulting from the sum of both SSBcorr and RBcorr 
was subtracted to all SSTcorr values to obtain the final corrected reading (Δ A 340 
nm). The final Δ A 340 nm values from the D-glucose standard solutions were used 
to create the calibration curve, and the equation from the linear regression line was 
used to calculate the sample concentrations taking into account any dilution (1:1, 
V:V for all plasma samples). As the spiked samples were spiked with an equal 
volume of 2.78 mM D-glucose standard, the expected concentration increase was 
equivalent to 1.39 mM.  
The inter-assay variability was assessed using the coefficient of variation calculated 
from the average reading and the standard deviation obtained for one same plasma 
sample assayed on three separate days. 
 
3.3.2.4 Insulin 
 Principle of the method: Due to their specificity and relatively short time of 
analysis, the most commonly used methods for the analysis of insulin are enzyme 
linked immunosorbent assays (ELISAs). For this reason, a commercially available 
and already validated ELISA method was used for the analysis of insulin in the 
fasting plasma samples. Although minimal lot-to-lot variation is guaranteed by 
Mercodia, all the assay kits purchased for the analyses were from the same batch. 
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The detection of insulin in this method is based on the recognition of particular 
antigens specific to insulin. In the sandwich ELISA simultaneous assay used, the 
sample and enzyme-linked detection antibody are incubated simultaneously. The 
insulin-containing samples are first added to a 96-microwell plate precoated with 
primary, coating antibodies, specific to an antigen on the insulin molecule. A 
peroxidase-linked secondary antibody is then added and binding to a different 
antigen on the insulin occurs. The subsequently added 3, 3', 5, 5'-
tetramethylbenzidine reacts with the peroxidase and the resulting chromogenic 
signal is monitored spectrophotometrically at 450 nm. 
 Both the primary and secondary antibodies used in this assay were 
monoclonal, which generally guarantees an analysis of high accuracy and avoids 
cross-reactions with similar molecules, such as pro-insulin, its biosynthetic 
precursor. 
 The reproducibility between assays was monitored by the inclusion of high 
and low concentration insulin controls in the analysis. The limit of detection was 
determined by calibrator 0 and values between calibrator 0 and 1 were described as 
being equal or below the concentration of calibrator 1, rather than given a 
concentration.  
 Preparation of reagents and solutions: The entire ELISA assay kit was 
stored at 4 °C. Except for the enzyme conjugate and the wash buffer, all the reagents 
and solutions were provided as ready-to-use. The enzyme conjugate was prepared 
freshly each time an assay was to be run. After being brought to room temperature, a 
volume of 1 mL of the enzyme conjugate (11 X) stock solution was diluted with 10 
mL ready-to-use enzyme conjugate buffer. Wash buffer was prepared in quantities 
of 735 mL, which was sufficient for the analysis of four complete 96-microwell 
plates. A volume of 35 mL of the room temperature wash buffer (21 X) stock 
solution were mixed with 700 mL milliQ water. At the end of the analysis, the 
remaining 1 x wash buffer was kept at 4 °C and used within two days.  
 Sample preparation and procedure: The frozen plasma aliquots were thawed, 
hand mixed and centrifuged for 10 min at 4 °C and 3,000 g in a 5810R eppendorf 
centrifuge. In parallel to the centrifugation, calibrators 0 to 5 were allowed to 
equilibrate to room temperature. 
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 The required number of 96-microwell plates was taken out of the 4 °C 
environment, after preparation of the solutions and sample centrifugation. A volume 
of 25 μL calibrators (0, 18, 60, 180, 600, 1200 pM), high and low insulin controls, or 
plasma was pipetted in duplicate into each corresponding well, followed by 100 μL 
enzyme conjugate (1 X). The plate was covered with an adhesive film and incubated 
at room temperature (19 - 21 °C) for 1 hour, at 300 rpm on a Stuart, mini orbital 
shaker. This first step allows the insulin present in the sample to bind to the 
antibodies coating the wells and the enzyme conjugate to bind to a different epitope 
on the insulin molecule. The sealing film was then removed and the plate manually 
washed to remove any unbound material and reduce the background signal. The 
content of the wells was discarded and 350 μL wash buffer (1 X) pipetted into each 
well. The plate was inverted to empty the wells and the procedure repeated five 
times. 200 μL 3, 3', 5, 5'-tetramethylbenzidine substrate was then added and allowed 
to react with the enzyme conjugate for 15 min at room temperature and 250 rpm, 
after which the reaction was stopped with 50 μL H2SO4 (0.5 M) -containing STOP 
solution and the optical density monitored at 450 nm, within 10 min after stopping 
the reaction. 
 The duplicate reading of calibrators 1 to 5 were averaged and used for the 
construction of a calibration curve and plotted against the respective concentration in 
a double logarithmic scale chart. 
 
3.3.2.5 Uric acid 
 Principle of the method: The quantification of uric acid in fasting plasma 
was based on a procedure adapted by a colleague, Ms Yuanlu Shi, adapted from a 
previously published method by Fossati et al. (1980). This assay method relies on 
the measurement of a quinoneimine dye resulting from a series of oxidative 
reactions. Uric acid present in the sample is first oxidized in a reaction catalyzed by 
uricase and giving rise to allantoin, carbon dioxide and a molecule of hydrogen 
peroxide. In presence of the latter and in a reaction catalyzed by the horseradish 
peroxidase, 3, 5-dichloro-2-hydroxybenzene-sulfonic acid, a substituted phenol, 
oxidatively couples to 4-aminophenazone to form the red-coloured N-(4-antipyryl)-
3-chloro-5-sulfonate-p-benzoquinone-monoimine that absorbs at 520 nm (Figure 
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3.5). To minimize the interference of bilirubin and ascorbic acid present in plasma, 
ferrocyanide and ascorbate oxidase respectively are added to the reagents in the 
assay. 
 This assay is run in a 96-microwell plate allowing the simultaneous analysis 
of 48 duplicate samples. These include a 6-point calibration curve, spiked and non-
spiked combined plasma samples and 40 plasma samples to measure the uric acid. 
 













Figure 3.5: Series of reactions involved in the detection of uric acid.  The uricase 
first catalizes the oxidation of uric acid into allantoin (A). The formed H2O2 is then 
used in the following reaction catalyzed by the horseradish peroxidase (B) to couple 
3, 5-dichloro-2-hydroxybenzene-sulfonic acid (DHBS) to 4-aminophenazone (APh). 
The resulting N-(4-antipyryl)-3-chloro-5-sulfonate-p-benzoquinone-monoimine 
(ACSBM) is detectable at 530 nm. 
 
 Reagents: To minimize the error due to the repeated preparation of the 
different reagents and solution, each of them was prepared in sufficient amounts to 
allow the analysis of all samples, if the stability of the compounds allowed. 
 Uric acid stock and standard curve preparation: The solubility of uric acid in 
water being lower than the highest concentration desired in the calibration curve, a 
- 77 - 
stock of uric acid (10 mM) containing lithium carbonate (13.8 mM), to increase its 
solubility, was prepared. A 10 min incubation in a 60 °C waterbath ensured 
complete dissolution of the uric acid. Aliquots of 5 mL were prepared and stored at -
20 °C. To avoid degradation of the uric acid, the aliquots were protected from light 
in aluminium foil and thawed only once. The samples for a 6 point-calibration curve 
were prepared by diluting 100, 80, 60, 40 and 20 μL of the uric acid (10 mM) 
containing lithium carbonate (13.8 mM) standard solution in 900, 920, 940, 960 and 
980 μL milliQ water, respectively. Final concentrations ranged from 0.0 to 1.0 mM 
uric acid with milliQ water being used as the null concentration. 
 Uricase: A solution of uricase was prepared in milliQ water at a 
concentration of 6 kU/L. The original bottle containing 50 mg of solid at 5 U/mg 
solid, 12 mg of the enzyme powder were dissolved in 10 mL milliQ water and stored 
at 4 °C until needed. 
 Potassium phosphate buffer: Solutions of K2HPO4 (1 M), KH2PO4 (1 M), 
potassium hexacyanoferrate (II) trihydrate (4 mM), 4-aminophenazone (0.33 M), 
horseradish peroxidase (> 100 kU/L) and ascorbate oxidase (> 100 kU/L) were 
prepared in milliQ water and used for the preparation of a buffer/enzyme/4-
aminophenazone (BEA) buffer solution. 17.41 g K2HPO4 and 13.60 g KH2PO4 were 
dissolved each in 100 mL milliQ water in separate recipients and potassium 
phosphate buffer was prepared by mixing 100 mL K2HPO4 (1 M) with 60 mL of 
KH2PO4 (1 M). The pH was then adjusted to 7.0 by further adding KH2PO4 (1 M) 
dropwise. 
 Potassium hexacyanoferrate (II) trihydrate and 4-aminophenazone: 
Potassium hexacyanoferrate (II) trihydrate (4 mM) and 4-aminophenazone (0.33 M) 
were prepared by dissolving 7.0 mg in 24.91 mL milliQ water and 134.1 mg in 2 mL 
milliQ water, respectively. 
 Horseradish peroxidase: The original bottle of horseradish peroxidase 
contained 96.2 mg of solid at 52 purpurogallin U/mg solid and 4 mg of the enzyme 
were dissolved in 2 mL milliQ water for a final concentration of at least 100 kU/L. 
 Ascorbate oxidase: The original bottle of ascorbate oxidase contained 6.9 mg 
of solid at 161 U/mg solid and the entire content was therefore dissolved in 10 mL 
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milliQ water to achieve a final concentration of at least 100 kU/L. Aliquots of 1.5 
mL ascorbate oxidase (≥ 100 kU/L) were stored at -20 °C. 
 Buffer/enzyme/4-aminophenazone (BEA) buffer solution: A volume of 600 
mL of the BEA reagent was prepared and stored for 7 days at 4 °C. This was 
sufficient for the analysis of the totality of the plasma samples, including that of 
some test samples for validation. 120 mL potassium phosphate buffer (1 M, pH 7.0), 
6 mL potassium hexacyanoferrate (II) trihydrate (4 mM), 0.6 mL 4-aminophenazone 
(0.33 M), 1.2 mL horseradish peroxidase (> 100 kU/L) and 1.2 mL ascorbate 
oxidase (≥ 100 kU/L) were mixed and supplemented with 471 mL milliQ water. The 
final BEA reagent composition was 0.2 M potassium phosphate buffer, 0.04 mM 
potassium hexacyanoferrate (II) trihydrate, 0.33 mM 4-aminophenazone, > 0.2 kU/L 
horseradish peroxidase and > 0.2 kU/L ascorbate oxidase. Although it is stable for 6 
weeks if stored between 2 and 8 °C, the BEA reagent was used within 6 days and 
stored at 4 °C. 
 3, 5-dichloro-2-hydroxybenzene-sulfonic acid (DHBS) reagent: The DHBS 
reagent consisted of 212.3 mg sodium 3, 5-dichloro-2-hydroxybenzenesulfonate and 
500.3 mg Triton X-100 mixed with milliQ water to a final 100 mL volume. To avoid 
the formation of bubbles due to Triton X-100 and later interference in the optical 
density reading, the reagent was mixed gently. 
  
 Sample preparation and procedure: 
 Sample preparation: To evaluate the strength of the method, uncentrifuged, 
centrifuged, non-spiked, spiked, non-fasting and fasting plasma samples were 
compared to ensure that the calibration curve would include concentrations that were 
expected and to test whether or not centrifugation would significantly influence the 
results. Uncentrifuged samples were used for the assay once thawed, without 
centrifugation and centrifuged samples were subject to a 10 min centrifugation at 
3,000 g and 4 °C prior to being assayed. A "combined" pool of plasma made from an 
equal volume of each plasma sample to be analysed was used for the preparation of 
non-spiked and spiked plasma samples. Spiked samples were prepared by mixing 40 
μL "combined" plasma with 20 μL uric acid standard (0.6 mM) or 18 μL 
"combined" plasma with 6 μL uric acid standard (0.8 mM). 
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 For the measurement of uric acid in the fasting plasma of the human study, 
the following samples were included in each 96-microwell plate; a 6-point 
calibration curve, including the null concentration used as the blank, a non-spiked 
and a spiked "combined" plasma sample prepared by mixture of either 40 μL 
"combined" plasma with 40 μL milliQ water or 40 μL "combined" plasma with 40 
μL 0.4 mM uric acid standard solution, respectively; and 40 plasma samples. Each 
plasma sample was analysed twice in duplicate so that averages were calculated 
from 4 replicates. The inter-assay variability was assessed using the coefficient of 
variation calculated from the average reading and the standard deviation obtained for 
the 0.4 mM uric acid standard from the nine standard curves prepared for the 
measurements of the human study. 
 Prior to setting up the 96-microwell plate, a working reagent containing 24 
mL BEA reagent, 8 mL DHBS reagent and 320 μL uricase solution was prepared 
freshly (prior to each set of analysis). The mixture was protected from light with 
aluminium foil and brought to 25 °C in a 130 rpm shaking waterbath. 
 Analytical procedure: The assay was initiated by adding to each 
corresponding well, 8 μL of sample (blank, calibrators, spiked or non-spiked 
plasma) followed by 320 μL working reagent. The plate was incubated at 20 °C for 




 In order to determine the final uric acid concentration in each sample, the 
absorbance reading of the water blank was first subtracted from the other sample 
readings to obtain the corrected values which were used to construct a calibration 
curve. The corresponding equation from the linear regression line was used to 
calculate the sample concentration taking into account any dilution (2:1, V:V for all 
plasma samples). For the calculation of uric acid in the fasting plasma of the 
participants taking part in the present study, the individual calibration curves of each 
assay were averaged and plotted into a single calibration curve. 
 
For all the biomarkers studied, the recovery was estimated as the percentage, upon 
comparison of obtained and expected concentration of spiked plasma samples. The 
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obtained concentration was then divided by the recovery to take the latter into 
account for the calculation of the final concentration of each biomarker in plasma. 
3.4 Results  
3.4.1 Total aminothiols 
3.4.1.1 Repeatability 
 An excellent peak separation was achieved with the chromatographic 
conditions used. The chromatographic profile illustrated on Figure 3.6 does not only 
indicate a good repeatability of the method in term of the retention times of each 
aminothiol, but also that the SBD-F-aminothiol adducts were stable for the maximal 
analytical time (i.e. 48 h). The coefficients of variations presented in Table 3.3 were 
calculated with data from 6 standard curves prepared and chromatographed on 
different days. The values indicate a decrease in repeatability towards the lower 
concentrations, but overall, considering the amount of sample processing, these 
coefficients are regarded as indicating a good inter-day repeatability of the method. 
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Figure 3.6: Chromatographic profile of aminothiols standards on three different 
days. Excellent peak separation was achieved. In order of retention time, the peaks 
represent 1, L-cysteine (50 μM); 2, D,L-homocysteine (12.5 μM); 3, 
cysteinylglycine (25 μM); 4, L-glutathione (12.5 μM) and 5, cystamine 
dihydrochloride (6 μM) as the internal standard.  
 
Table 3.3: Inter-assay coefficients of variation for each aminothiol analysed. Data 
from 6 standard curves prepared and analysed on different days were used for the 
calculation of the coefficients. The coefficients of variation are estimated low with 






Inter-assay CV % 
(n = 6) 
L-Cys 2.0 14.44 
 0.5 15.27 
 0.01 16.20 
 0.001 17.10 
D,L-HCys 0.5 21.47 
 0.125 21.06 
 0.0025 13.68 
 0.00025 22.16 
CysGly 1.0 17.91 
 0.25 16.34 
 0.005 13.48 
 0.0005 14.19 
L-GSH 0.5 19.64 
 0.125 20.09 
 0.0025 37.16 
 0.00025 35.47 
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 A typical chromatographic profile of SBD-F-aminothiol adducts in fasting 
plasma of a healthy subject is represented in Figure 3.7. Cysteine (peak 1) and 
cysteinylglycine (peak 3) are most abundantly present (Figure 3.7, A) and easily 
visible, however after magnification, homocysteine (peak 2) and glutathione (peak 
4) are clear and integration of the peaks can be done precisely (Figure 3.7, B). 
 


























































Figure 3.7: Typical chromatographic profile of aminothiols in 0.53 μL of fasting 
plasma in a healthy adult. Window B represents an amplified section of the 
chromatogram in window A, for better visualization of D,L-homocysteine (2) and L-
glutathione (4). Peaks 1, 3 and 5 are the L-cysteine, cysteinylglycine and cystamine 
dihydrochloride, respectively. 
 
- 83 - 
3.4.1.2 Standard curves 
 The equations for the regression lines were very similar for the calibration 
curve prepared in milliQ water and in plasma (Figure 3.8). The calibration curves 
prepared in milliQ water were compared to the calibration curves prepared in plasma 
and used to verify the quality of the chromatography. To avoid influence of the 
biological sample background, the equations from calibration curves prepared in 
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Figure 3.8: Total aminothiols calibration curves prepared in milliQ water and PBS 
(A), and prepared in plasma (B). The calibration curves prepared in both 
environments are very similar and the R
2
 values of both types of calibration curves 
are indicative of a good linearity within the range of interest. Coloured marks 
represent measurements of twelve participants for cysteinylglycine (red), D,L-
homocysteine (green), L-glutathione (blue) and L-cysteine (yellow). AUC, area 
under the curve. 
 
3.4.1.3 Limits of detection and quantification 
 Details of the obtained limits of detection (LOD) and quantification (LOQ), 
recoveries, average total aminothiol concentrations and example of healthy 
concentrations, as reported in the literature, are presented in Table 3.4. 
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Table 3.4: Limits of detection (LOD) and quantification (LOQ) for each aminothiol 
of interest. Recoveries and averages obtained were calculated with the samples from 
all the human study participants (n = 62). L-Cys, cysteine; D,L-HCys, 
homocysteine; CysGly, cysteinylglycine; L-GSH, glutathione. §, (Pimková et al., 
2014); 
†
, (Guttormsen et al., 1994); 
††
, (Andersson et al., 1999); 
‡
, (Christensen et al., 
2001); 
‡‡
, (Wu et al., 2004). 
 
 
LOD LOQ Recovery 
(% ± SD) 
Mean 
concentration in 





(μM ± SD) 
 
(nmol) 
L-Cys 0.002 0.007 93 ± 6 257 ± 25 219 ± 14 
§
, 
 256 ± 17 
†
, 
321 ± 50 
††
 
D,L-HCys 0.001 0.0036 94 ± 4 9.4 ± 3.5 9.45 ± 0.43 
§
, 
9.9 ± 2.4 
‡
, 
14.1 ± 4.9 
††
 
CysGly 0.0006 0.002 94 ± 4 30.5 ± 5.6 24.4 ± 4.5 
††
, 
39.71 ± 4.86 
§
 
L-GSH 0.001 0.0058 67 ± 13 7.7 ± 1.5 2-20 
‡‡,
 
5.69 ± 1.33 
††
, 




3.4.2.1 Sample pre-treatment 
 In order to have an overview of the best sample processing with the least 
sample loss, the glucose concentration was measured in the samples presented in 
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Table 3.5 and Table 3.6. Data presented in part A of  Table 3.5 are from an untreated 
plasma sample, an SPE-treated (30 mg sorbent/mL) non-spiked plasma sample with 
corresponding collected SPE-fractions, and an SPE-treated spiked plasma sample 
with the corresponding collected SPE-fractions. All three samples were prepared 
from the same plasma aliquot. The untreated sample was used as a reference to have 
an indication of the glucose loss in the SPE column. These data are suggestive of a 
loss of material when the sample is subject to solid phase extraction. 
To determine whether this could be explained by a loss of glucose, the experiment 
was repeated with a standard D-glucose solution. Results presented in part B of 
Table 3.5 are from an untreated 5.55 mM D-glucose solution and an SPE-treated 5.5 
mM D-glucose solution with the corresponding collected SPE-fractions. Data 
confirm that there is some loss of glucose during the passage through the solid phase 
extraction column. The reading obtained with the 60 % MetOH fraction was not 
explained by the fact that it is an organic solvent, because 100 % and 60 % MetOH 
samples read at 340 nm gave null readings after correction for blanks. This however 
suggests that some glucose is retained in the column and is eluted with MetOH. 
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Table 3.5: Concentration of plasma (A) and D-glucose standard samples (B) subject 
to different pre-treatments. The glucose concentrations are duplicate measurements 
of single samples.  
A 




Untreated, non-spiked plasma 
(200 μL plasma + 50 μL milliQ water) 
5.61 
SPE-treated, non-spiked plasma, flow-through fraction 
(200 μL plasma + 50 μL milliQ water) 
2.28 
60 % MetOH fraction from SPE-treated, non-spiked plasma 
- 0.28 
2 % formic acid fraction 1 from SPE-treated, non-spiked plasma 
- 0.56 
2 % formic acid fraction 2 from SPE-treated, non-spiked plasma 
- 0.44 
SPE-treated, spiked plasma, flow-through fraction 
(200 μL plasma + 50 μL D-Glc (27.75 mM)) 
8.05 
60 % MetOH fraction from SPE-treated, spiked plasma 0.44 
2 % formic acid fraction 1 from SPE-treated, spiked plasma 
- 0.56 
2 % formic acid fraction 2 from SPE-treated, spiked plasma 
- 0.61 
B   
Untreated 5.55 mM D-Glc standard solution 5.83 
SPE-treated, 5.55 mM D-Glc standard solution, flow-through 
fraction 
4.88 
60 % MetOH fraction from SPE-treated, 5.55 mM D-Glc standard 
solution 
0.22 
2 % formic acid fraction 1 from SPE-treated, 5.55 mM D-Glc 
standard solution 
0 
2 % formic acid fraction 2 from SPE-treated, 5.55 mM D-Glc 
standard solution 
0 
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 Data presented in Table 3.6 shows the effect of deproteination and defatting 
through SPE passage. In the same experiment, non-spiked plasma samples; SPE-
treated, non-spiked plasma samples; protein-precipitated, non-spike plasma samples; 
and SPE-treated, protein-precipitated, non-spiked plasma samples were compared 
(Table 3.6). When comparing the non-spiked samples, the untreated, non-spiked 
plasma gave the highest concentration of glucose (5.44 mM), as expected. The 
plasma sample with either SPE cleaning or protein precipitation, only, showed 
similar values of 4.44 mM and 4.55 mM, while the samples with the combined SPE 
passage and protein precipitation resulted in the highest loss (89 % recovery) and 
lowest glucose concentration (3.83 mM). The repetition of this experiment 
confirmed the outcome. All the subjects recruited for the study were in general good 
health and therefore, glycaemia values within the normal range (3.9 - 5.6 mM) were 
expected. Performing a protein precipitation and or defating the sample would thus 
result in an underestimation of the effective glycaemia of the participants.  
 
Table 3.6: Samples compared simultaneously in order to determine the best sample 
pre-treatment for D-glucose analysis by the hexokinase assay. 
Sample type and description D-Glc concentration 
(mM) 
Untreated, non-spiked plasma 
(30 μL original plasma + 30 μL milliQ water) 
5.44 
SPE-treated, non-spiked plasma 
(62.5 μL original plasma + 62.5 μL milliQ water + SPE 
treatment) 
4.44 
Protein-precipitated, non-spiked plasma 
(30 μL precipitated plasma + 30 μL milliQ water) 
4.55 
SPE-treated, protein-precipitated, non-spiked plasma 
(62.5 μL precipitated plasma + 62.5 μL milliQ water + 
SPE treatment) 
3.83 
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 Deproteination and defatting plasma samples presented numerous 
disadvantages. The loss of glucose following a sample pre-treatment by ethanol 
precipitation and solid phase extraction would underestimate the glycaemia 
measured. The loss in the SPE method may have been reduced with higher sample 
volumes, however, little plasma was available for the glucose analysis and 
increasing the sample volume was not an option. 
 As in the hexokinase assay by 96-well microwell plate the plasma sample 
volume required is very little (< 2 % of the reaction volume), and proteins and fat 
are unlikely to interfere with the hexokinase reagent, the decision was taken not to 
proceed to any further sample pre-treatment other than a centrifugation following 
sample thawing. This approach was also supported by another Hexokinase-based 
method not tested in the present PhD experiments, namely the Infinity
TM
 Glucose 
Hexokinase Liquid Stable Reagent from ThermoScientific, in which it is 
recommended to use plasma without protein removal for routine laboratory use 
(ThermoScientific, 2008). 
 
3.4.2.2 Improved method for the glucose quantification 
 The analysis of plasma samples, with no sample pre-treatment other than a 
centrifugation, gave results that were comparable to those from glucose samples that 
were analysed by HPLC, by a former colleague (Dr. Samantha Sutulic, data not 
shown). The inter-assay variation was 1.01 %, wich indicates a very good 
repeatability. Recoveries ranged from 93 % to 101 % with an average ± standard 
deviation of 98 ± 2 %. A good linearity was obtained up to 8.33 mg/mL, as shown in 
Figure 3.9. A calibration curve combining duplicate measurements of 25 calibration 
curves is presented in Figure 3.10. This was also the calibration curve used for the 
quantification of glucose in all the plasma samples from the human study. 




















Figure 3.9: D-glucose calibration curves showing the linearity up to 8.33 mM (1.5 
mg/mL). Healthy fasting glucose concentrations are expected to be between 3.9 and 
5.6 mM and < 7.8 mM following 2 hours after a 75 g oral load of glucose. 
Therefore, calibration curves were prepared to include 8.33 mM as the highest 
standard point. 


















D-Glc concentration (mM)  
Figure 3.10: Representative combined calibration curve of 25 duplicate 
measurements. The derived equation was used to calculate the concentrations of 
glucose in the fasting plasma of the participants that took part in the human study. 
 
3.4.3 Insulin 
 As for the D-glucose analysis, the standard curves between assays were very 
close and therefore combined to do the analysis of the human study plasma samples. 
The inter- and intra-assay repeatability is described by the coefficients of variation 
obtained with the readings of the low and high insulin controls, between and within 
assay, respectively. The average ± SD coefficients of variation within assays were 
2.9 ± 2.8 % for the low insulin control, and 1.4 ± 0.8 % for the high insulin control. 
The coefficients of variation between assays were 7.6 % for the low insulin control 
and 8.0 % for the high insulin control. These values indicate a good repeatability 
achieved with this method. The combined standard curve obtained from the 9 
measurements is illustrated in Figure 3.11. A good linearity was confirmed for the 
range of interest (2 - 25 mU/L). The small error bars are further indicative of a good 
reproducibility. 


















Figure 3.11: Calibration curve used for the calculation of insulin in fasting plasma. 
The measurements of 9 separate calibration curves were averaged and combined into 
one curve. The reproducibility between assays was monitored by the inclusion of 
high (red triangles) and low (green squares) concentration insulin controls in the 
analysis. 
 
3.4.4 Uric acid 
 Upon analysis of samples used for validation, no significant difference was 
measured between uncentrifuged and centrifuged samples. In order to maintain the 
same sample pre-treatment as for the analysis of total aminothiols, glucose and 
insulin, all subsequent samples were only subject to centrifugation prior to analysis. 
To reduce the manipulation of the pipetting volumes and have a consistent spiking 
value, the spiked samples were thereafter prepared with 40 μL combined plasma 
spiked with 40 μL uric acid standard (0.4 mM). An increase of absorbance 
equivalent to that of 0.2 mM was thus expected. The inclusion of the non-fasting 
samples in the tests confirmed that the range of the calibration curve was sufficient 
in case of higher concentrations of uric acid (Figure 3.12). 
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Figure 3.12: Comparison of different samples tested to verify the strength of the 
method and whether centrifugation influences the concentration of uric acid in 
plasma. All samples tested were within the calibration curve range. The sequence of 
samples in the observed range was as suspected: uncentrifuged and centrifuged 
fasting diluted plasma (1, 7) were at the lower end of the concentration range, 
followed by uncentrifuged and centrifuged fasting non-diluted plasma (5, 11), 
uncentrifuged and centrifuged non-fasting diluted plasma (3, 9), uncentrifuged and 
centrifuged non-fasting non-diluted plasma (6, 12), uncentrifuged and centrifuged 
fasting spiked plasma (2, 8) and finally uncentrifuged non-fasting spiked plasma (4, 
10).  
 
 As for the analyses of glucose and insulin, the standard curves between 
assays were very close and therefore combined to do the analysis of the human study 
plasma samples (Figure 3.13). The standard deviations of standard curve were very 
low, ranging from 0.00 to 0.01 and the coefficient of variation between assays was 
1.8 %, supporting a good repeatability of this method. The average recovery of 95 % 
was obtained indicating little sample loss. Also, as seen on the chart, excellent 
linearity (R
2
 = 1) was achieved within (0.2 - 0.4 mM) and beyond the range of 
analysis. 
- 94 - 









0.0 0.2 0.4 0.6 0.8 1.0 1.2








Figure 3.13: Calibration curve used for the calculation of uric acid in fasting plasma 
and constructed from the average of the 9 calibration curves obtained during the 9 
individual assays.  
 
3.5 Discussion and conclusion 
 Biomarkers can be a valuable tool to assess the health of subjects. These 
however, need to be good indicators of the health condition or status of interest but 
also need to be quantified by the appropriate reliable methods. In the present 
chapter, the improvement and validation of the methods used for the quantification 
of total aminothiols, glucose, insulin and uric acid in fasting plasma of healthy adult 
subjects was described.  
 The method described by Pfeiffer et al. (1999) was used as a reference to 
develop an improved method for the quantification of total aminothiols. The 
improved method demonstrates, despite the important sample treatments, that 
excellent recoveries are achieved and that the SBD-F-aminothiol adducts are stable 
for at least 48 h when stored at 4 °C. Although some methods allow a faster 
detection of aminothiols, they also compromise the good chromatographic 
separation of the compounds. The new chromatographic conditions used for the 
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quantification of total aminothiols result in an improved and optimal separation of 
the SBD-F-aminothiol adducts in a 22 min run. Finally, good repeatability and 
linearity of the calibration curves was obtained for both the calibration curve 
prepared in milliQ water and the calibration curve prepared in plasma. 
 The improved method for the quantification of glucose made use of the 
glucose hexokinase assay (Sigma-Aldrich, 2004). The replacement of cuvettes and 
spectrophotometer by a UV-compatible 96-microwell plate and microplate reader 
offered the advantage of reducing the sample and hexokinase reagent volumes. Also, 
duplicates of 17 samples and a 6-point standard curve can be processed and analysed 
simultaneously within 3 hours. The use of the hexokinase assay permits the analysis 
of the sample with little pre-treatment (i.e. centrifugation and dilution) and 
minimizes the risk of glucose loss by any treatment due to plasma modification, 
also, methods for sample deproteination may concentrate the plasma sample, so that 
the measurement of glucose may be overestimated. Finally, deproteination of the 
samples is time consuming and although glucose is a stable component of plasma, it 
is desirable to process samples as rapidly as possible. The little sample pre-treatment 
resulted in a good recovery of the glucose. 
 For the insulin, the already commercially available Mercodia ELISA assay 
for human insulin determination was used (Mercodia). Lot-to-lot variations was 
avoided by purchasing sufficient supplies from the same batch. As guaranteed by the 
producer, linearity within the range of interest and the reproducibility were high. 
Finally, uric acid was quantified by using an enzymatic colorimetric method 
developed by a colleague (Ms Yuanlu Shi). The strength of the method was verified 
and confirmed with an excellent linearity within the desired range and 
reproducibility. 
 Overall, the methods described in the present chapter have shown to be 
reliable methods for the measurement of the corresponding biomarkers in fasting 
plasma of healthy adult subjects. With the exception of the aminothiols, for the 
lower-end extreme values, these methods would also be suitable for the detection of 
more extreme values, as the linearity ranges were good, even beyond the desired 
range. 
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Chapter 4  
Human study and analysis of the food frequency questionnaire 
4.1 Abstract 
 The present observational human study focused on the impact of general 
(poly)phenol-rich dietary habits, with an emphasis on coffee, tea and cocoa-
containing beverages, on the biomarkers of general inflammation and cardiovascular 
health. The current chapter describes the study design and analyses the consumption 
habits of the study population regarding these beverages. The influence of age and 
gender was analysed and the likelihood for a subject with a high consumption of 
particular (poly)phenol-rich product to consume other (poly)phenol-rich foods was 
examined. The minimal sample size for a statistical power of 80 % was calculated to 
be 52 based on the variables for the biomarker of interest requiring the most 
participants (i.e. homocysteine). Sixty two participants were recruited and completed 
1 out of 3 possible visits. Data indicate that the study population had a slightly 
higher consumption of coffee and tea than the average consumption in the UK. The 
weekly consumption of coffee and cocoa-beverages was not gender- or age-
dependent. Amongst the tea brews, only green tea and herbal infusions were gender- 
and age-dependent, respectively. The consumption of green tea was also positively 
associated with the consumption of selected coffee brews. The (poly)phenolic intake 
from coffee, tea and cocoa preparations was analysed in a semi-quantitative manner 
by the introduction of indexes representative of the (poly)phenolic content. A 
positive association between the intake of coffee and tea (poly)phenols was detected. 
The consumption of fruits was positively associated with that of tea, cocoa-
containing beverages, vegetables, herbs and spices, and the intake of supplements, 
and the consumption of tea was associated with the use of herbs and spices. 
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4.2 Introduction 
 In two recent studies from Renouf et al., large inter-individual variations in 
plasma metabolites were reported following coffee and green tea ingestion (Renouf 
et al., 2010a, Renouf et al., 2013). It is still unknown why such substantial 
differences exist between subjects, but genetics, microflora, general nutrition and 
other life habits can play significant roles. Research studying the effects of coffee 
consumption and other phenolic-rich foods has led to variable outcomes. This can be 
explained by different study designs, the amount of administered dose or 
confounders. 
 The daily recommendations in the UK for the consumption of fruits and 
vegetables are currently 5 servings (1 serving defined as 80 g or the equivalent of a 
fist-size) (http://www.nhs.uk/Livewell/5ADAY/Pages/Portionsizes.aspx). At this 
level of consumption, meta-analyses have reported a decreased risk in death from all 
causes, when compared to no consumption of fruits and vegetables (Wang et al., 
2014). Also, for subjects increasing their daily consumption from < 3 to > 5 
servings, a 17 % decrease in the incidence of coronary heart disease was reported 
(He et al., 2007). A recent meta-analysis by Li et al. (2014), with 10 prospective 
cohort studies (n = 434,342 participants, of which 24,013 developed T2DM during 
the 4.6 to 23-year follow-up) focusing on the effect of fruit and/or vegetable 
consumption on the incidence of T2DM indicated a lower risk of T2DM with the 
consumption of fruit or green leafy vegetables. A dose-response analysis further 
indicated a 6 % and 13 % decrease of T2DM incidence for each additional 1 and 0.2 
fruit or green leafy vegetable serving (1 serving defined as 106 g), respectively. Li et 
al. (2014) could not exclude any residual confounding by unmeasured factors, also 
incidence of T2DM may have been underestimated as the the information was 
obtained using a questionnaire. The main possible limitations of the above-
mentioned meta-analyses are a difference in the classification of fruits and 
vegetables (Wang et al., 2014) with the possibility of missclassification (He et al, 
2007); the lack of adjustment for some dietary and lifestyle factors (He et al., 2007; 
Li et al., 2014); a dietary assessment done at baseline only for numerous studies, 
thus not taking into account possible dietary changes (He et al., 2007); and the older 
age of the majority of the studies included in the meta-analyses (Wang et al., 2014; 
He et al., 2007; Li et al., 2014) 
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 No minimal recommendations for the consumption of coffee or tea exist, 
likely due to the fact that the consumption of these beverages has shown outcomes, 
which cannot lead to clear conclusions. In a meta-analysis by van Dieren et al. a 
beneficial effect of tea (mainly black) and coffee consumption on the incidence of 
T2DM, with the lowest hazard ratios for a consumption of > 5 cups tea and 4.1 - 6.0 
cups coffee per day, respectively, was reported (van Dieren et al., 2009). These 
represent relatively high levels of tea and coffee consumption and not necessarily 
obtainable in an average population. In this report, however, no association with 
biomarkers of T2DM was detected. A similar study investigation on the incidence of 
cardiovascular diseases and associated deaths reported a beneficial effect of tea 
(mainly black) and coffee consumption on the incidence of coronary heart disease, 
with the lowest hazard ratios for a consumption of 1 - 6 cups tea and 2.1 - 3.0 cups 
coffee per day, respectively (de Koning Gans et al., 2010). No associations were 
identified in this report with the incidence of stroke or death from coronary heart 
disease, stroke or from all causes. Of note, only a small percentage of the analysed 
population died from coronary heart disease and therefore the statistical power was 
reduced for the detection of associations which included coronary heart disease. 
 The 3 countries with the highest consumption of coffee between May 2013 
and June 2014 were Finland (12 kg green coffee equivalent), Austria (8.5 kg) and 
Sweden (7 kg), as reported by the European Coffee Federation (http://www.ecf-
coffee.org/about-coffee/coffee-consumption-in-europe). Taking into account that the 
coffee beans lose 8.48 - 24.74 % (averaged to 16.61 %) of their weight during 
roasting (Sualeh et al., 2014), the above mentioned consumptions are equivalent to 
approximately 10, 7 and 6 kg per capita per year, respectively, and thus, 
approximately 3, 2 and 1.5 cups per day, assuming a preparation with 10.3 g coffee 
(averaged from 10 to 10.6 g) (http://www.blackbearcoffee.com/resources/83, Illy 
and Pizano, 2004). In 2012, the average UK consumption was estimated to be 0.74 
cups per day, taking into account the 2.8 kg per capita consumed during that year 
(http://www.ecf-coffee.org/images/European_Coffee_Report_2013-14.pdf) and 
assuming that one cup is prepared with 10.3 g coffee. The average consumption of 
tea in the UK was estimated to be 2 - 3 cups per day, as calculated from the weight 
consumed weekly in households in 2009 (29 g) and the tea contained in tea bags (1.5 
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- 2 g) (http://www.statista.com/statistics/284484/weekly-household-consumption-of-
tea-in-the-united-kingdom-uk/). 
 The beneficial effects of coffee, tea, cocoa, fruits and vegetables have often 
been attributed to the constituent (poly)phenols and therefore, the assessment of the 
(poly)phenolic intake with each product, and not only the amounts of product 
consumed, is of major interest if associations with health are sought to be tested. 
Food frequency questionnaires are extensively used for the self-assessment of food 
intake. In the present study, a food frequency questionnaire was created based on a 
questionnaire for estimating caffeine exposure in pregnant women, the caffeine 
assessment tool (Boylan et al., 2008). Included in the questionnaire was the 
assessment of exposure to (poly)phenol-rich products including coffee, tea, cocoa, 
fruit and vegetables; foods consumed during the main daily meals (i.e. breakfast, 
lunch, dinner) and as snacks; and the consumption of supplements and vitamins. An 
initial section, the health assessment questionnaire, mainly used for participant 
selection purposes, contained information about anthropometrics, medication intake, 
medical history, the bowel movement and in general, blood donation, habits of 
physical activity, weekly alcohol consumption, smoking as well and bowel 
movement. 
 In the present chapter, the calculations of the population size for the present 
investigations and the study design are described. When doing human studies, the 
number of participants involved is important in order to ensure sufficient statistical 
power of the obtained outcome. For the present study, the minimal number of 
participants required was based on published and personal data obtained during the 
analysis of the biomarkers of interest in plasma samples. Also, the study population 
is characterized in terms of the consumption of popular (poly)phenol-rich products, 
such as coffee, tea, cocoa beverages as well and fruits and vegetables and the 
(poly)phenolic intakes of coffee, tea and cocoa beverages. Finally, the correlations 
between the consumption of each beverage, as well as with other sources of 
(poly)phenols, such as fruits, vegetables, herbs and spices, and dietary supplements, 
were subsequently tested. The data were analysed as a whole population, by gender 
and by age group. 
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4.3 Materials and method 
4.3.1 Ethics and eligibility 
 The study was approved by the joint faculty research ethics committee under 
the reference number MEEC 10-035. The participants were recruited in Leeds, in an 
area that included the University of Leeds campus. After written informed consent 
was obtained, the candidates were provided with a health assessment questionnaire 
destined to assess their suitability for participating in the study. The questionnaire 
collected data on gender, age, weight, height, general health status, medication, 
recent blood donation, smoking and alcohol consumption habits, habits of physical 
activity and bowel movement.  
 The subjects were eligible if they were in general good health, between 18 
and 70 years of age, had a body mass index between 18.00 and 29.00 kg/m
2
, were 
not diagnosed with any chronic disease, haemophilia or had not previously 
undergone a gastrointestinal tract operation, were not under any long-term 
prescribed medication, except for any form of contraceptive medication (i.e. pill, 
injection, subcutaneous chip), were not pregnant or lactating, were non-smokers or 
were smoking < 5 cigarettes per day and consumed ≤ 4 units of alcoholic beverages 
on a daily and regular basis. If the participant had or was going to donate blood in 
the 4 weeks before or after completion of the questionnaire, the visit was arranged so 
that there were at least 4 weeks elapsed since the last blood donation or 4 days 
before the next blood donation. The suitable subjects were provided with a self-
assessed food frequency questionnaire to be completed at home and brought back for 
the first visit. To keep their identity anonymous, the subjects were assigned a code, 
which was used for processing all the collected data and biological samples. 
 
4.3.2 Sample size 
 In order to ensure sufficient power, the sample size was computed with the 
following variables: μ0, the expected values for the biomarkers of interest at fast, 
which were based on the data obtained from test measurements performed for the 
method validation; μ1, the known values, and σ, the known standard deviation which 
were based on data reported in the literature; α, the probability of falsely rejecting a 
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true null hypothesis, which was set to 0.05 (i.e. 5 %), and the desired power, the 
probability of correctly rejecting a false null hypothesis which was set to 0.8 (i.e. 80 
%) (http://www.statisticalsolutions.net/pss_calc.php). The primary outcome variable 
was total homocysteine, but the sample size was also calculated using the variables 
from the measurement of total cysteine, total cysteinylglycine, total glutathione, 
glucose, insulin and uric acid. 
 
4.3.3 Study design 
 The present study consisted of three visits during which the participants were 
asked to undergo a 36-hour washout period prior to their visit at the School of Food 
Science and Nutrition at the University of Leeds, and a 36-hour period with the same 
diet restrictions, upon attendance to the appointment. The regimen was 
(poly)phenol-poor and excluded the consumption of alcohol, any form and type of 
coffee, tea and cocoa-containing products, most fruits and vegetables, wholemeal 
(wheat) products and any form of fruit- or vegetable-based food supplements. To 
facilitate the choice of food during the study, participants were supplied with some 
meal suggestions and a list of allowed foods. The latter included any non-spiced 
meat and fish, rice, pasta, noodles, eggs, any form of non-spiced peeled potato, 
white bread, non-wheat cereals, some vegetables in small amounts (i.e. mushrooms, 
peeled cucumber, peeled courgette, asparagus, lettuce, pumpkin and lentils), one 
banana and one kiwi per day, milk and any other non-cocoa or -fruit containing 
dairy product, water, squash drinks and sodas, white chocolate, non-cocoa or -fruit 
based sweets and cakes, some seasoning in moderation (i.e. salt, pepper, olive oil, 
aromatic herbs and salad dressing), peeled nuts and vitamins. A notification was sent 
to each participant as a reminder of the commencement of the restricted diet period. 
A 72-hour dietary record was used to certify the compliance of the participant with 
the diet restrictions. In this diary, the participants described the type and quantities 
of all the consumed foods and beverages, other than water, during the period of 
dietary restriction. 
 On the morning of the first study visit, the participants arrived in a fasting 
state, from 10 pm on the evening before, however, they were allowed to drink water 
ad libitum. During the examination, the identity and the dietary compliance of the 
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participant were first verified. If the diet had been breached, the participant was 
asked to repeat the washout period. If the dietary restrictions had been respected, the 
participant was offered to drink some water and 10 mL of fasting blood was 
withdrawn by venepuncturing the antecubital vein (see section 3.3.3.1). The blood 
samples used at a later time point for the quantification of selected biomarkers of 
health (chapters 3, 5, 6 and 7). Anthropometrics (i.e. weight, height, waist and hip 
circumference) followed by the measurement of blood pressure were then recorded 
(chapter 5). To avoid the influence of stress on the blood pressure, the latter was 
always measured a few minutes after the blood had been collected and when the 
subject was relaxed. The measurement was repeated 3 times, and when possible, on 
the opposite arm used for blood collection. The subjects collected a baseline urine 
sample which was used for compliance purposes, as well as the baseline for the later 
pharmacokinetics. The fast was finally broken with a (poly)phenol-poor breakfast, 
which consisted of two slices of white toast bread with butter and cheese, one 
banana or one kiwi, along with a cup of 4 g "Green Blend" Nescafé instant Coffee 
(Nestlé) dissolved in approximately 300 mL boiling water. It was ensured that all the 
coffee had been consumed. The nutrient information of the breakfast products are 
presented in Table 4.1.  
 
Table 4.1 Nutrient content of the foods provided at breakfast, for the participants. 
Food Nutrient information 
Banana  








Energy (89 cal) 
Total Fat (0.3 g) 
    Saturated fat (0.1 g) 
    Monounsat. fat (0.0 g) 
    Polyunsat. fat (0.1 g) 
Cholesterol (0 mg) 
Protein (1.1 g) 
Vit A (64.0 IU) 
 
Vit C (8.7 mg) 
Calcium (5 mg) 
Iron (0.3 mg) 
Magnesium (27 mg) 
Phosphorus (22 mg) 
Potassium (358 mg) 
Sodium (1 mg) 
Zinc (0.2 mg) 
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Banana  
(continued) 
Total Carbohydrate (22.8 g) 
    dietary fiber (2.6 g) 
    starch fiber (5.4 g) 
    Sugars (12.2 g) 
 
Copper (0.1 mg) 
Manganese (0.3 mg) 
Water (74.9 g) 
Kiwi  
(per 100 g) 
Energy (61 cal) 
Total Fat 0.5 g 
    Saturated fat (0.0 g) 
    Monounsat. fat (0.0 g) 
    Polyunsat. fat (0.5 g) 
    Cholesterol (0 mg) 
Total Carbohydrate (14.7 g) 
    dietary fiber (3.0 g) 
    starch fiber (0.0 g) 
    Sugars (9.0 g) 
Protein (1.1 g) 
Vit A (87.0 IU) 
Vit C (92.7mg) 
Vit E (1.5 mg) 
Calcium (34 mg) 
Iron (0.3 mg) 
Magnesium (17 mg) 
Phosphorus (34 mg) 
Potassium (312 mg) 
Sodium (3 mg) 
Zing (0.1 mg) 
Copper (0.1 mg) 
Manganese (0.1 mg) 
Water (83.1 g) 
 
Bread  
(per 2 slices) 
Energy (0.23 cal) 
Fat (1.8 g) 
    Saturated fat (0.6 g) 
Carbohydrates (41.6 g) 
    Fibre (2.4 g) 
    Sugars (2 g) 
Protein (9.4 g) 




(per 10 g) 
Energy (70 kcal) 
Fat (7.7 g) 
    Saturated (3.1 g) 
    Monounsat. (2.9 g) 
    Polyunsat. (1 g) 
Carbohydrates (0.03 g) 
    Sugars (0.03 g) 
Sodium (0.11g) 
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Coffee, Green 
blend Nescafé  
(per 4 g) 
Energy (2.36 kcal) 
Protein (0.35 g) 
Carbohydrates (0.22 g) 
    Sugars (0.22 g) 
Fat (8 mg) 
    Unsaturated (4 mg) 
 
Fibre (1.2 g) 
Sodium (4 mg) 
Salt equivalent (12 mg) 
Antioxidants (0.88 g) 
    Polyphenols (0.35 mg) 
Mini Babybell  
(per unit) 
Energy (61 kcal) 
Fat (4.8 g) 
    Saturated (3.2 g) 
Carbohydrate (traces) 
Protein (4.5 g) 
Sodium (0.36 g) 
Calcium (140 mg) 
 
 After finishing breakfast, the participant was free to leave and collected all 
the urine produced during the following 36 hours. Five containers for urine 
collection were provided for all the urine produced from 0 - 4, 4 - 8, 8 - 12, 12 - 24 
and 24 - 36 hours after the coffee consumption. At the end of the 36 hours of urine 
collection, the containers were returned to the School of Food Science and Nutrition 
at the University of Leeds and the urine samples were centrifuged, aliquoted and 
stored at -20 °C until analysis. All the urine samples were processed and analysed by 
former colleague, Mr. Nicolai U. Kraut, and details other than the relevant data for 
the present thesis will not be discussed in this manuscript (chapter 7). The second 
and third visits consisted of the same procedures performed during the first visit, 
however, the food frequency questionnaire was not asked to be filled in again. A 
period of at least 4 - 8 weeks was left between each visit. This allowed for a change 
in the biomarkers profile to be detecable, if there was any. Also, a 4 week-range 
gave some freedom to the participants in case these were not available during a 
suggested date. During this time, the subjects were allowed to follow their regular 
diet. The participants were compensated with £10 for each completed visit. A 
schematic representation of the study design is shown in (Figure 4.1). 
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Ethical submission





- Filling in of HAQ
Creation of documents
HAQ, FFQ, consent form, food





- Diet restriction 
with record
Appointment at the School of FS&N
(at fast from 10 pm the night before)
- Collection of the FFQ (destined to the 
analysis of dietary habits) (chap. 4)
- Checking of identy and compliance to the 
diet
- Measurement of anthropometrics (chap. 5)
- Collection of baseline blood (destined to the 
quantification of aminothiols, glucose, insulin
and uric acid) and urine (destined to the 
measurement of major chlorogenic acid
metabolites). (chap. 3, 5, 6, 7)




- Diet restriction with record
-Collection of the totality of the 
urine produced after consumption
of the coffee at the School of 
FS&N. Fractions collected: 0-4, 4-
8, 8-12, 12-24, 24-36 hours
(destined to the measurement of 
major chlorogenic acid
metabolites). (chap. 7)
SETTING UP OF THE HUMAN STUDY
VISIT 2: repetition of procedures done during visit 1, except for the collection of the FFQ
VISIT 3: repetition of procedures done during visit 2
4 to 8 weeks of regular diet
4 to 8 weeks of regular diet
Immediate start
Monetary compensation: £ 10 for each completed visit
 
Figure 4.1: Study design. Summarizing chart with the major steps in the study, from 
the preparation of the documents for the participants to the different procedures in 
the study. Chap., chapter; HAQ, health assessment questionnaire; FFQ, food 
frequency questionnaire; FS&N, School of Food Science and Nutrition at the 
University of Leeds. 
 
4.3.4 Analysis of the food frequency questionnaire 
 The data collected from the food frequency questionnaire was semi-
quantitative and provided information on the consumption of coffee, tea, cocoa and 
alcohol, as well as the general habits of fruit, vegetables, herbs, spices, supplements 
and vitamins consumption, and on the frequency and types of foods consumed 
during the main meals (i.e. breakfast, lunch and dinner) and snacks. In order to 
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ensure the appropriate comprehension and consequent filling out of the food 
frequency questionnaire as well as the food diary, both were submitted to persons 
that were not familiar with the research area. A few improved versions were 
progressively created. The difficulty of data interpretation for the subsequent use for 
statistical analysis was equally taken into account. 
 
4.3.4.1 Information on coffee, tea and cocoa preparations habits 
 Questions were asked on how long participants had been consuming coffee, 
tea and cocoa, in months or years. For coffee, details of consumption of caffeinated, 
decaffeinated, strong, medium, weak, instant, filtered, espresso, cappuccino, latte, 
turkish, arabic or other (with specification) were asked. For tea, details for the 
consumption of decaffeinated black tea, caffeinated black tea, instant black tea, 
black tea in form of tea bags, black tea in form of leaves, black tea in form of 
commercial iced tea, green tea, rooibos, chai, herbal infusion, fruit infusion or other 
(with specification) were asked. For cocoa, details on the consumption of dark, milk, 
white, bitter or other type of chocolate beverage was asked. The information was 
reported as the number of cups consumed in 7 days and was obtained by multiplying 
by 7 the number of cups consumed in one day. For each of these beverages there 
were 6 options of answers, ranging from "none" to "more than 8 cups per day". If a 
subject had a regular consumption of 1 - 2 cups of black tea in a day, the 
consumption in a week was calculated as the average, 1.5 cups per day, multiplied 
by 7, that is, 10.5 cups of black tea in a week. For the option "more than 8 cups per 
day", the value of 9 was multiplied by 7. Additionally, for each of the three types 
beverages, information on whether sugar, sweetener, milk or anything else was 
added to it and how much was asked. 
 
4.3.4.2 Information on other dietary habits 
 For alcoholic beverages, the questionnaire asked information on the amount 
of units of beer, cider, wine, spirits, alcopops or other were consumed in a week. 
There were 5 possible answers ranging from "none" to "more than 4 units per days". 
As for coffee, tea and cocoa, if a subject consumed 3 - 4 units of beer in a day, the 
total beer consumption in a week was calculated as the average, 3.5 units per day, 
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multiplied by 7. The total alcohol consumption in a week was obtained from the sum 
of the weekly consumption of each type of alcoholic drink. 
 Information on the frequency of consumption of common snack products (i.e. 
fruit, yoghurt, dried fruits, nuts, crisps, chocolate, cake, crackers) was asked. There 
were 6 possible answers to select and ranging from "none" to "more than twice a 
day". 
 For the consumption of fruit and vegetables, only the most commonly used 
products in the UK were included. Comprised in the list of common vegetables were 
salad, cruciferous vegetables, green beans and peas, carrot, sweet corn, tomato and 
potato in any form. Included in the common fruits consumed were any berries, citrus 
fruits, kiwi, grape, peaches and nectarines, apple, banana and any dried fruit. The 9 
given options of consumption for vegetables and fruits ranged from "none" to "more 
than 5 times daily" and the unit was a portion, which was defined as the amount of 
product that was the size of the fist of the participant. 
 As for the main meals (i.e. breakfast, lunch, dinner), the most common 
products consumed during these periods were included. For breakfast, cereals, 
porridge, muesli, white bread, wholemeal bread, yoghurt, fruit, dairy milk, soy milk, 
tea, coffee, eggs and bacon or sausage were included. For lunch and dinner, salad, 
soup, sandwich, pizza, pasta, burger and chips, meat or fish, rice or potatoes and 
curries were within the common list. The 6 options for the type of food consumed at 
the specific meals ranged from "never" to "daily". 
 Information on the spices and herbs regularly consumed was also included in 
the food frequency questionnaire and included pepper, chilli, cumin, saffron, ginger, 
cardamom, star anise, cinnamon, turmeric, cloves mint, coriander, thyme and 
rosemary. The final category asked information on the frequency of usage of 
supplements and vitamins and subjects completed the information for berry-based 
supplements, seed-based supplements, non-berry of seed-based supplement, 
minerals and trace elements and vitamins. There were 6 possible answers for the 
consumption of spices, herbs, supplements and vitamins, ranging from "never" to 
"daily". 
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 For all the foods and drink categories, an open-ended section was used for 
reporting frequently consumed items which were not included in the food frequency 
questionnaire. 
 
4.3.4.3 (Poly)phenolic intake with coffee, tea and cocoa beverages 
 The estimation of the (poly)phenolic intake from (poly)phenol-containing 
beverages, such as coffee, tea and cocoa, is a challenging task. Several factors, 
including the environmental growing conditions, processing and the brewing 
method, influence the (poly)phenolic composition of these beverages. In the food 
frequency questionnaire completed by the participants, besides the information 
asked regarding the overall coffee consumption at different strengths, the possible 
choices of coffee beverages were instant, filtered, espresso, cappuccino, latte, 
Turkish and Arabic. The information collected on the consumption of the different 
brews of coffee was limited to the number of cups consumed per week, but did not 
provide information on the factors influencing the (poly)phenolic content of the 
beverage. In order to obtain an accurate individual (poly)phenolic intake due to the 
consumption of the above-mentioned beverages, the analysis of each consumed 
beverage should have been conducted, which was realistically not feasible. 
 Total phenolic content is often estimated by the method of Folin-Ciocalteu. 
This colorimetric method is based on the reducing properties of the phenol group 
and is easily performed, however, it is susceptible to interferences from other non-
phenolic constituents in the sample, such as ascorbic acid, for which the 
measurement can be corrected. The most accurate method for total phenolic analysis 
is chromatography, followed by the sum of all the phenolic compounds analysed. 
However, many (poly)phenols are difficult to analyse by chromatography and these 
include theaflavins, thearubigens, some procyanidins, tannins or complex 
melanoidins. No information exists on the total phenolic composition of coffee, tea 
and chocolate beverages determined by chromatography and which includes an 
exhaustive list of the constituent (poly)phenols. A rich database of foods with 
(poly)phenolic composition determined by different methods exists, but not all the 
foods of interest are reported (http://phenol-explorer.eu/). In 2010, a list of the 100 
products highest in (poly)phenols was generated, and the (poly)phenolic 
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composition determined by chromatography was compared to the antioxidant 
content determined using the Folin-Ciocalteu assay (Perez-Jimenez et al., 2010a). 
The latter was, for the majority, higher when compared to the results obtained by 
chromatography, however, the (poly)phenolic composition of foods remains 
incomplete and the phenolics that are missing from the chromatographic analysis 
would possibly partly explain the difference. 
 Taking these reflexions into account, the (poly)phenolic intake from coffee, 
tea and cocoa in the present study was based, when possible, on published data 
obtained by Folin-Ciocalteu analyses. Briefly, the beverages were attributed an 
index and ranked within their category (i.e. coffee, tea or cocoa beverages) from 
lowest to highest according to their total (poly)phenolic contents of per serving. 
 
4.3.4.4 (Poly)phenolic intake from coffee  
 Two new variables were introduced for the non-quantitative evaluation and 
comparison of (poly)phenolic intake from coffee between subjects. The first 
variable, the "coffee level", which did not take into account the consumption of 
specific brews, was calculated from the total weekly consumption of coffee and its 
strength, according to what participants had reported. The strength referred to the 
amount of coffee, rather than the intensity of the roast. An index of strength was 
attributed to each strength of coffee, namely "1" for weak, "2" for medium, and "3" 
for strong. To determine the total "coffee level" per week for a participant, the index 
was then multiplied by the number of cups of the corresponding strength consumed 
on a weekly basis, and if the participant consumed coffee at variable strengths, the 
values obtained from the multiplication of the strength index by the number of cups 
consumed per week were summed. Assuming that a stronger coffee provides more 
(poly)phenols, a higher "coffee level" index indicates a higher intake of 
(poly)phenols. 
 The second variable for the intake of coffee (poly)phenols, the "coffee 
(poly)phenolic index", was created to estimate the total weekly (poly)phenolic intake 
from the ingestion of different coffee brews (e.g. filtered coffee or cappuccino). In a 
research by Sánchez-Gonzalez et al. (2005), the analysis of filtered, espresso and 
freeze-dried (instant) coffee revealed that, per serving, filtered coffee provided the 
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most (poly)phenols, closely followed by espresso. In this study, the serving volume 
of filtered coffee was 111 mL and that of the espresso was 45 mL, however, twice as 
much ground coffee was used for the preparation of filtered coffee, resulting in a 
similar ground coffee to water ratio (0.025 g/mL and 0.031 g/mL, respectively). The 
lowest (poly)phenolic content was measured in a serving of freeze-dried coffee 
(Sánchez-González et al., 2005). As lattes and cappuccinos are prepared from 
espresso shots, these brews were attributed the same index as espresso in the present 
study. The volume of espresso shots most frequently varies between 30 and 60 mL, 
but no information was asked in the food frequency questionnaire on the strength of 
specific coffees, therefore no distinction was made for this purpose. Due to the lack 
of information regarding the content of total (poly)phenols and chlorogenic acids in 
Turkish and Arabic coffee, and as only 2 participants were regular consumers of 
Turkish coffee (10.5 cups/week), and an additional 2 were low consumers of Arabic 
coffee (1.5 cups/week), those brews were regarded as regular coffee and considered 
to contain the same quantity of total (poly)phenols as a serving of espresso coffee. In 
conclusion, the following "coffee (poly)phenolic indexes" were attributed to the 
different brews: "1" for instant coffee, "2" for espresso, latte, cappuccino, Turkish 
and Arabic coffee, and "3" for filtered coffee. 
 
4.3.4.5 (Poly)phenolic intake from tea and infusions 
 For tea and cocoa beverages, the created variables were "tea (poly)phenolic 
index" and "cocoa (poly)phenolic index", respectively. These, as for coffee, were 
based on information reported in the literature. Along with coffee, tea and cocoa are 
listed amongst the 50 products with the highest contents of (poly)phenols per serving 
(Perez-Jimenez et al., 2010a, Perez-Jimenez et al., 2010b). Green tea infusion is 
frequently reported to contain more (poly)phenols than black tea infusion (Chan and 
Lim, 2006, Anesini et al., 2008, Almajano et al., 2008, Atoui et al., 2005, Horžić et 
al., 2009, Fukushima et al., 2009), although there is some disagreement depending 
on the source (Gorjanovic et al., 2012). Both brews are preparations from the same 
plant species (Camellia sinensis), however, leaves used for green tea are not subject 
to oxidation, as opposed to those used for black tea. Once the leaves have dried, 
(poly)phenol oxidase is inhibited, maintaining (poly)phenols in their monomeric 
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non-oxidised forms (Anesini et al., 2008, Pekal et al., 2011), and resulting in a 
different (poly)phenolic profile (Almajano et al., 2008). Green tea contains more 
catechins which are absorbed and black tea (poly)phenols need microflora 
degradation before absorption. Chai tea is classified as flavoured black tea as it is a 
preparation from black tea with spices added to it. The latter include cinnamon, 
cloves, star anise, ginger, cardamom, peppercorn, nutmeg and fennel, which are 
chiefly products that contain high amounts of (poly)phenols (Perez-Jimenez et al., 
2010a). A single publication which includes the simultaneous total phenolic analysis 
of commercially available and popular fruit infusions, flavoured black teas and black 
tea was found (Pekal et al., 2011). In a later publication from the same first author, 
Indian Chai tea was included in the analysis of flavoured black tea infusions (Pekal 
et al., 2012). Combined, the results of both studies indicate that fruit tea infusions 
provide the least total phenols, followed by the flavoured black tea infusions, while 
black tea provided the most total phenols. In 2011, Fu et al. compared the total 
phenolic composition of 28 herbal infusions and 23 tea infusions from China. Large 
variations were observed within the herbal infusions, and the highest total phenolic 
contents were observed within this category, but overall, the average of the herbal 
infusions (0.41 g gallic acid equivalent/L) was lower than that obtained from the 
analysis of the tea infusions (0.56 g gallic acid equivalent/L) (Fu et al., 2011). 
Similar results were previously obtained by other groups (Almajano et al., 2008, 
Atoui et al., 2005, Chan and Lim, 2006). In a study by Almajano et al. (2008), in 
which 13 types of teas were tested, the analysis of Rooibos infusion indicated a 
lower total phenolic composition when compared to that of black and green tea 
infusions, which is in agreement with a previous publication (Erickson, 2003). In the 
same research by Almajano et al., the other herbal infusions tested (i.e. peppermint 
and nettle) had a total phenolic content that was lower than that obtained from the 
Rooibos infusion (Almajano et al., 2008). The attribution of indexes reflecting the 
total phenolic composition of the different tea beverages was based on the 
information above. As no comparative information was found on the total phenolic 
composition of fruit and herbal infusions, these were joined and given the index of 
"1". Rooibos tea, as a herbal tea, with a higher total phenolic content, was given the 
index of "2". Chai tea, as a fragrant black tea, with a lower total phenolic content 
than black tea, was given the index of "3", black tea was given the index of "4", and 
green tea, the index of "5". 
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4.3.4.6 (Poly)phenolic intake from cocoa beverages 
 Finally, for cocoa, the participants provided information on the number of 
cups of cocoa beverages consumed in 7 days, with the options of consuming bitter, 
dark, milk or white chocolate beverages. These are characterised by a different 
percentage of cocoa and therefore, a different total (poly)phenolic content (Vinson et 
al., 1999). The latter increases with the cocoa percentage of the chocolate product 
and a crescent index was attributed to each chocolate beverage accordingly: "0" for 
white, "1" for milk, "2" for dark and "3" for unsweetened bitter chocolate.  
 
4.3. 5 Statistics 
 Statistical analyses were performed using the Microsoft Office Excel 2007 
and IBM SPSS statistics 20 softwares. All averaged values are expressed as the 
mean ± standard deviation unless otherwise stated. Normality of the variables was 
assessed by a Shapiro-Wilk test. Outliers were systematically included in the 
statistical analysis as they were genuine data points. Most often, non-parametric tests 




4.4.1 Sample size 
Amongst the biomarkers of interest, the sample size obtained when using variables 
from total homocysteine was the largest, with 52 subjects as shown in Table 4.2. 
This was also the minimal sample size aimed at for the present study. A total of 62 
participants were recruited and successfully completed one visit. Due to dropouts, 49 
subjects completed two visits and 40 completed the three possible visits. The main 
motive behind the drop outs were dietary restrictions, lack of availability and the 
small monetary compensation. A few subjects with higher regular consumption of 
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coffee complained about headache and lower level of energy during the diet 
restriction. 
 
Table 4.2: Variables used for the calculation of the sample size. μ0, are the expected 
values, expressed as the mean ± standard deviation (SD). Known values, μ1, and 
known SD, σ, were based on data reported in publications and are expressed as the 
mean ± SD (σ). n.d., not determined. † (Pfeiffer et al., 1999), ††(Urgert et al., 2000), 
‡ (Pimkova et al., 2014), ‡‡ (Levitzky et al., 2008), ‡ ‡ ‡ (Ruggiero et al., 2006) 
 
Biomarker μ0 ± SD μ1 (± σ) N (sample size) 
Total cysteine 251 ± 10 289 ± 31 † 6 
Total homocysteine 7.4 ± 2 8.5 ± 1.8 † 
8.1 ± 1.8 †† 
22 
52 
Total cysteinylglycine 37 ± 4 32 ± 6 ‡ 12 
Total glutathione 7.9 ± 0.6 9.07 ± 1.55 ‡ 14 
Glucose 4.7 ± 0.3 5.3 ±1.3 ‡‡ 37 
Insulin 7.3 ± 1.9 9.6 ± 3.1 15 
Uric acid 0.26 ± 0.06 0.3 ± 0.07 ‡‡‡ 25 
 
4.4.2 Analysis of the food frequency questionnaire, emphasis on 
(poly)phenol-rich beverages 
 Not all the participants provided complete information on their dietary habits. 
In these cases, data were excluded pair-wise, explaining the variable number of data 
available for some analyses. 
 
4.4.2.1 Habits of coffee consumption 
 Total coffee consumption: As expected, the years of coffee consumption 
increased with the age of the participant (data not shown). The average weekly 
consumption of coffee in the UK was estimated to be 5 cups (0.74 cups per day) as 
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explained in section 4.2. When compared to the level of consumption in the UK, the 
average level of coffee consumption of the study population was higher. This can 
easily be explained by the fact that coffee had a central role in the present study and 
subjects disliking coffee or those that were not regular consumers were less likely to 
participate in the research. The studied population had an average of total coffee 
consumption of 13 ± 14 cups per week (Table 4.3). Medium and strong preparations 
were the most popular, with 8 ± 10 and 5 ± 10 cups consumed per week, 
respectively. The difference of the preference in the strength of coffee preparation 
was confirmed by running a non-parametric Friedman's test; X
2
 (2) = 31.89, p < 
0.0005. Pairwise comparisons were performed with a Bonferroni correction for 
multiple comparisons and the significant differences are shown in table 4.3. Post hoc 
analysis revealed statistically significant differences in preference between weak 
(Mdn = 0.00) and medium coffee (Mdn = 1.5), p < 0.0005; between weak and strong 
coffee (Mdn = 0.00), p = 0.012; but not between medium and strong coffee, p = 
0.182.  
 The effect of gender on the consumption of coffee was assessed by analysing 
the significance of the difference between groups, rather than using a method for 
analysing the associations. A Mann-Whitney U test was therefore run. The 
distributions of the coffee level between gender were similar, and the median coffee 
level was not statistically significantly different between females (Mdn =10.5) and 
males (Mdn =10.5); U = 318.5, z = - 0.395, p = 0.693. No significant association 
between the total coffee consumption and the age of the participants was detected, as 
assessed by running a Spearman's rank-order correlation test; rs (52) = 0.073, p = 
0.599. 
 
Table 4.3: Coffee consumption of the study population. Data are expressed as the 
average cups consumed in 7 days (means ± standard deviation, SD) for the total 
coffee consumption and that of the individual strength of coffee. From the 62 
recruited participants 54 provided complete information. A Friedman's test was used 
to assess the significance of the difference in preference for a particular strength of 
coffee preparation, within the whole population and the differences of preferences 
between gender were assessed by running a Mann-Whitney U-test due to the 
presence of outlier(s) and a non-normal distribution within both group. 





Weak Medium Strong 
 
cups/week ± SD 
All population (n=54) 13 ± 14 0 ± 1 †, †† 8 ± 10 † 5 ± 10 †† 
Gender 
 
Female (n=34) 13 ± 13 0 ± 2 9 ± 12 4 ± 7 
Male (n=20) 13 ± 16 0 ± 0 6 ± 7 7 ± 14 
Age range  
18 - 22 (n=15) 12 ± 12 0 ± 1 7 ± 9 5 ± 8 
23 - 29 (n=22) 10 ± 10 0 ± 0 7 ± 10 3 ± 4 
30 - 53 (n=17) 18 ± 19 1 ± 3 9 ± 13 8 ± 16 
The same symbol indicates a statistically significant difference between the marked 
groups. 
 
 Preferences for selected coffee brews: Only 8 out of the 56 participants that 
provided information on the matter, consumed decaffeinated coffee, and the 
population average was 1 ± 4, against 12 ± 13 cups consumed weekly for caffeinated 
coffee. When the consumption of particular coffee brews was compared, an evident 
preference for instant coffee was noticed (Table 4.4). The population had an average 
of 7 ± 12 cups of instant coffee consumed per week. Espresso and filtered coffee 
were the second most consumed coffee brews, followed by latte and cappuccino, and 
by Arabic and Turkish coffee brews. The little popularity of the two latter 
preparations is likely to be due to the ethnicity of the majority of the study 
population. A Friedman test was run to compare the difference in preference for 
particular coffee brews and results confirmed that the difference was significant, X
2
 
(6) = 78.64, p < 0.0005. Pairwise comparisons with a Bonferroni correction for 
multiple comparisons indicated that the difference in preference was significant 
between filtered and Turkish coffee (p = 0.034), instant and Turkish coffee (p < 
0.0005), Arabic and instant coffee (p < 0.0005), espresso and instant coffee (p < 
0.0005) and latte and instant coffee (p = 0.037). No other statistical difference was 
observed (p > 0.05). 
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 Although the weekly consumption was similar, females were in general 
higher consumers of instant coffee and latte (Table 4.4). These associations were 
tested by means of a Mann-Whitney U test and the results indicate that only the 
consumption of latte was significantly different between genders (U = 229.5, z = - 
2.8, p = 0.05). There was no influence of the age on the preference for any coffee 
brew, as assessed by a Friedman's test (p > 0.1). 
 
Table 4.4: Weekly consumption of individual coffee brews, expressed as mean ± 
standard deviation (SD). Overall, there were little variations amongst gender and 
with age, but some differences were revealed to be statistically significant. The 
significance of the differences in preference for particular brews, within the whole 
population, were assessed by running a non-parametric Friedman test, and the 
differences between gender were assessed by running a non-parametric Mann-
Whitney U-test due to the presence of outliers and a non-normal distribution within 
both groups. Esp., espresso; Capp, cappuccino. 
Coffee brews 
 Instant Esp. Latte Capp. Filtered Arabic Turkish 
 
cups/week ± SD 
All population 
(n=56) 
7 ± 12 
**, †, ††, §
 
2 ± 7
†† 1 ± 4§ 1 ± 3 2 ± 5* 0 ± 0† 0 ± 2*, ** 
Gender 
Female (n=35) 8 ± 10 2 ± 7 2 ± 5 1 ± 3 2 ± 6 0 ± 0 0 ± 2 
Male (n=21) 6 ± 14 2 ± 6 1 ± 2 1 ± 3 2 ± 4 0 ± 0 1 ± 2 
Age range 
18 - 22 (n=15) 5 ± 8 2 ± 7 3 ± 7 1 ± 3 4 ± 8 0 ± 0 0 ± 0 
23 - 29 (n=22) 8 ± 9 1 ± 3 1 ± 2 2 ± 3 1 ± 3 0 ± 0 1 ± 2 
30 - 53 (n=19) 8 ± 16 4 ± 9 1 ± 2 1 ± 3 2 ± 4 0 ± 0 1 ± 2 
The same symbol indicates a statistically significant difference between the marked 
groups. 
 
- 117 - 
4.4.2.2 Habits of tea consumption  
 As for the habits of coffee consumption, the time a subject had been a 
consumer of tea increased with the age of the participant (data not shown). The 
average consumption of tea was 17 ± 16 cups/week, which corresponds with the 
average tea consumption in the UK 14 - 21 cups/week (2 - 3 cups/day), as estimated 
as described in section 4.2. Black tea was most popular (8 ± 13 cups/week), 
followed by green tea (3 ± 6 cups/week), herbal infusions (2 ± 4 cups/week), fruit 
infusions (2 ± 3 cups/week), rooibos tea (1 ± 4 cups/week) and chai tea (1 ± 2 
cups/week) (Table 4.5). 
 To assess the influence of age on the level of tea consumption and on the 
preference for different tea preparations, a Spearman's rank-order correlation was 
performed. Total tea consumption was not found to be age-dependent, and other than 
the herbal infusion, which was positively associated with age (rs (55) = 0.265, p = 
0.046), no other tea preparation was found to be associated with age (p > 0.6). The 
differences in tea consumption between females and males were tested by running a 
Mann-Whitney U test. The distributions of the different tea preparations for females 
and males were similar, as assessed by visual inspection. The median consumption 
of green tea was significantly different between females (Mdn = 1.5) and males 
(Mdn = 0.0); U = 252, z = - 2.122, p = 0.034. The median consumption between 
females and males was not significantly different for the other preparations ( p > 
0.43). A positive association was detected between the consumption of green tea and 
herbal infusion (rs (55) = 0.348, p = 0.008), green tea and fruit infusion (rs (55) = 
0.455, p < 0.0005), and fruit infusion and herbal infusion (rs (55) = 0.667, p < 
0.0005). Finally, a negative association was measured between the consumption of 
black tea and that of chai tea (rs (55) = - 0.313, p = 0.018). However, since only two 
subjects were regular consumers of Chai tea, this association cannot be considered. 
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Table 4.5: Tea consumption in the study population. Data are expressed as the 
average cups consumed in 7 days (means ± standard deviation, SD) for the different 
tea preparations and the total tea consumption. The latter was obtained from the sum 
of the average consumption of each individual tea and infusion preparation. The 
difference of preferences between gender was assessed by running a non-parametric 
Mann-Whitney U-test due to the presence of outliers and a non-normal distribution 
within both groups. inf., infusion.  
 













Cups / week ± SD 
All population 
(n=57) 
8 ± 13 3 ± 6 2 ± 4 2 ± 3 1 ± 4 1 ± 2 17 ± 16 
Gender 
       
Female (n=36) 7 ± 12 4 ± 6
†
 2 ± 3 2 ± 4 1 ± 5 1 ± 2 17 ± 15 
Male (n=21) 10 ± 15 3 ± 7
†
 3 ± 6 1 ± 3 1 ± 3 1 ± 2 18 ± 17 
Age range 
       
18 - 22 (n=16) 9 ± 13 4 ± 9 2 ± 5 2 ± 4 2 ± 7 0 ± 1 19 ± 17 
23 - 29 (n=22) 8 ± 11 3 ± 5 3 ± 4 2 ± 4 1 ± 2 1 ± 3 17 ± 16 
30 - 53 (n=19) 8 ± 15 3 ± 5 2 ± 4 1 ± 2 1 ± 3 1 ± 2 16 ± 16 
The same symbol indicates a statistically significant difference between the marked 
groups. 
 
4.4.2.3 Habits of cocoa consumption 
 When compared to the consumption of coffee and tea, the consumption of 
cocoa beverages was the lowest. Independently of the cocoa contents of the 
beverage, the study population consumed a total average of 2 ± 4 cups/week, with 
milk chocolate beverages largely accounting for the cocoa (poly)phenolic intake 
(Table 4.6). The study population had an average of milk chocolate beverage intake 
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of 2 ± 4 cups/week, with female (Mdn = 1.5) subjects tending to consume more milk 
chocolate drink than the male (Mdn = 0) subjects. This difference between genders 
was, however, not statistically significant, as assessed by the non-parametric Mann-
Whitney U test; U = 269.5, z = -1.838, p = 0.066. A Spearman correlation test did 
not indicate any association of the consumption of cocoa-containing beverages, with 
the age, rs (56) = 0.006, p = 0.965. 
 
Table 4.6: Cocoa beverage consumption in the study population. Data are expressed 
as the average ± standard deviation (SD) cups consumed in 7 days for the different 
chocolate preparations. The difference of preferences between gender was assessed 
by running a non-parametric Mann-Whitney U-test due to the presence of outliers 
and a non-normal distribution within both groups. 
 
 Chocolate preparations 
 White Milk Dark Bitter unsweetened 
 Cups / week ± SD 
All population 
(n=58) 0 ± 0 2 ± 4 0 ± 1 0 ± 0 
Gender 
    
Female (n=37) 0 ± 0 3 ± 5 0 ± 1 0 ± 0 
Male (n=21) 0 ± 0 1 ± 2 0 ± 1 0 ± 1 
Age range 
    
18 - 22 (n=17) 0 ± 0 2 ± 3 0 ± 0 0 ± 0 
23 - 29 (n=22) 0 ± 0 3 ± 6 0 ± 1 0 ± 0 
30 - 53 (n=19) 0 ± 0 1 ± 2 0 ± 1 0 ± 0 
 
4.4.3 (Poly)phenolic intake from coffee, tea and cocoa-beverages 
 The (poly)phenolic indexes attributed to each beverage are summarized in 
Table 4.7 and were used to calculate the final score representative of the total 
(poly)phenol consumption from all the beverages of a same category (i.e. coffee, tea 
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or cocoa). As for the "coffee level" variable, the number of cups of a particular 
beverage, reported to be consumed by each participant on a weekly basis, was 
multiplied by the corresponding (poly)phenolic index of Table 4.7. For example, a 
participant consuming 6 cups of cappuccino per week would have a total score of 
(poly)phenolic intake from coffee beverages of 12, if no other coffee beverage was 
consumed. When participants consumed beverages which were attributed a different 
score, but that were within the same category, the multiplied indexes were summed. 
Thus if the earlier mentioned subject had also reported to consume 4 cups of filtered 
coffee per week, the total score of (poly)phenolic intake from coffee beverages 
would increase to 24. The scores obtained for each participant are representative of 
their weekly level of total (poly)phenols ingestion from the 3 different sources of 
beverages. 
 
Table 4.7: Polyphenolic (PP) indexes representative of the level of (poly)phenols 
ingested with each beverage. A higher index indicates higher amounts of total 
phenolic content as assessed by the Folin-Ciocalteu method. The 3 categories of 
beverages are treated independently and the same value of an index does not 














Instant 1 Fruit inf. 1 White 0 
Espresso 2 Herbal inf. 1 Milk 1 
Latte 2 Rooibos 2 Dark 2 
Cappuccino 2 Chai 3 Bitter 
unsweetened 
3 
Turkish 2 Black 4   
Arabic 2 Green 5   
Filtered 3     
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4.4.3.1 Correlations between (poly)phenolic indexes 
 When the total level of (poly)phenolic ingestion was analysed between the 3 
categories of beverages, there was a significant positive correlation between the total 
(poly)phenolic intake from coffee and from tea, with a correlation factor rs (55) = 
0.348, p = 0.006, as assessed by a Spearman's correlation test. This indicates that the 
subjects consuming either a high amount of coffee preparations or coffee 
preparations higher in total (poly)phenols also tend to consume more tea 
preparations, or tea preparations that are richer in (poly)phenols, such as green tea. 
There was no significant correlation identified between the total (poly)phenolic 
intake from coffee and cocoa beverages (rs (55) = - 0.008, p = 0.955) or between the 
total (poly)phenolic intake from tea and cocoa beverages (rs (55) = 0.059, p = 
0.662). 
 
Table 4.8: Introduced variables, which allowed for the comparative analysis of 
(poly)phenolic intake from different sources. The coffee level took into account the 
strength and the quantity of coffee consumed in a week. The total (poly)phenolic 
(PP) indexes of coffee, tea and cocoa beverages took into account the level of 
(poly)phenols present in a particular brew and the quantity of the corresponding 
brew consumed in a week. The difference between gender of polyphenolic intake 
caracterized by the coffee level and total PP index variables, was assessed by 
running a non-parametric Mann-Whitney U-test, due to the presence of outliers 
and/or a non-normal distribution within both groups. 















Cups / week ± SD 
All population 31 ± 36 25 ± 33 41 ± 41 3 ± 5 
Gender 
    
Female 30 ± 30 26 ± 35 42 ± 41 4 ± 5 
Male 32 ± 45 23 ± 28 40 ± 44 2 ± 3 
Age range 
    
18 - 22 29 ± 30 26 ± 48 44 ± 35 2 ± 3 
23 - 29 22 ± 22 20 ± 19 41 ± 35 4 ± 7 
30 - 53 44 ± 51 29 ± 30 39 ± 35 2 ± 3 
 
4.4.3.2 Influence of age and gender on (poly)phenolic intake 
 Coffee level vs. age and gender: The influence of age on the coffee level 
was analysed by running a non-parametric Spearman's test. No association was 
detected; rs (52) = 0.027, p = 0.848. A non-parametric Mann-Whitney U test 
revealed no gender effect on the coffee level. The distributions of the coffee level for 
females and males were similar and the difference in the median of the coffee level 
between females (Mdn = 21.00) and males (Mdn = 21.00) was not significant; U = 
339.5, z = - 0.009, p = 0.993 (Table 4.8). 
 
 (Poly)phenolic index vs. age and gender: Analysis of the level of 
(poly)phenolic ingestion due to the consumption of coffee, tea and cocoa 
preparations did not reveal any association with age, as assessed by a Spearman's 
correlation test. The correlation factors, rs (55), for the coffee, tea and cocoa 
(poly)phenolic ingestion level with age were 0.136 (p = 0.314), 0.075 (p = 0.579) 
and 0.020 (p = 0.884), respectively. The outcome did not change when age was 
analysed as categories. Females had, in general, higher values of (poly)phenolic 
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indexes (Table 4.8), but the difference was not significant as assessed by a Mann-
Whitney U test. The distributions of (poly)phenol ingestion from the 3 sources were 
similar for females and males. For coffee, the median total (poly)phenolic ingestion 
of the female population was 11.75, and that of the male population was 10.5 with U 
= 430, z = - 0.148, p = 0.883. For tea, the median total (poly)phenolic ingestion of 
the female population was 28.5 and that of the male population 22.5 with U = 405.5, 
z = - 0.509, p = 0.611. Finally, for cocoa beverages, the difference between the 
median total (poly)phenolic index for cocoa beverages of the female population was 
1.5, and that of the male population, 0.75, was not significant; U = 293, z = - 1.604, 
p = 0.109. 
 
4.4.4 Likelihood of consumption of other (poly)phenols 
 As a method of testing whether the answers from the food frequency 
questionnaire were pertinent, the correlation between "coffee level" and "total coffee 
(poly)phenolic index" was tested. As expected, both variables were strongly 
correlated (rs (52) = 0.839, p < 0.0005), as assessed by the Spearman's correlation 
test. This reassuring result indicates that participants did not provide random 
answers in the food frequency questionnaires. 
 In the study population, the average weekly consumption of fruit was 23 ± 14 
fist-size portions with reported individual consumptions ranging from 1 - 67 portions 
per week. The average weekly consumption of vegetables (excluding potatoes) was 
21 ± 15 fist-size portions with reported individual consumption ranging from 2 - 78 
portions per week. Finally, the average combined weekly consumption of fruit and 
vegetables (excluding potatoes) was 45 ± 25 fist-size portions with reported 
individual consumption ranging from 10 - 100 portions per week, which is 
equivalent to a daily consumption of 6.4 portions, higher than the recommended 5 
portions per day in the UK (Carter et al., 2010). Of note, 23 subjects had a 
consumption lower than this recommendation. The consumption of supplements was 
relatively low in the study population, with an average ± standard deviation weekly 
consumption of 3.5 ± 5.5 supplements. 
 A Spearman's correlation test was performed to test any associations between 
the intake of (poly)phenols from coffee, tea and cocoa beverages, and the intake of 
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fruit or vegetables, herbs and spices, and supplement consumption. There were 
strong positive associations between the weekly consumption of coffee 
(poly)phenols and that of fruit, rs (55) = 0.569, p < 0.0005; vegetables, rs (53) = 
0.437, p = 0.001; but no associations with the consumption of herbs and spices, rs 
(55) = 0.203, p = 0.130 or supplements, rs (55) = - 0.139, p = 0.301. The intake of 
(poly)phenols from tea preparations was not associated with the consumption of 
fruit; vegetables, herbs and spices or supplements, p > 0.091. There were positive 
associations between the weekly consumption of tea and that of fruit, rs (55) = 
0.361, p = 0.004; and herbs and spices, rs (55) = 0.323, p = 0.01; but no significant 
association was detected with the consumption of vegetables, rs (53) = 0.205, p = 
0.133; or the intake of supplements, rs (55) = 0.161, p = 0.211. There were positive 
associations between the consumption of (poly)phenol from cocoa beverages and 
fruit consumption, rs (55) = 0.285, p = 0.032; as well as with the intake of 
supplements, rs (55) = 0.427, p < 0.001; but no significant association was detected 
with the consumption of vegetables, rs (53) = - 0.177, p = 0.196; or herbs and spices, 
rs (55) = 0.023, p = 0.867. 
 When (poly)phenol sources other than coffee, tea and cocoa beverages were 
tested for their association, some strong positive correlations were found. These 
were between the consumption of fruits and vegetables, rs (53) = 0.476, p < 0.0005; 
fruits and herbs and spices, rs (55) = 0.525, p < 0.0005; and vegetables and the use 
of herbs and spices, rs (53) = 0.436, p = 0.001. A moderate positive association was 
detected between the consumption of fruits and the intake of supplements, rs (55) = 
0.297, p = 0.019; and no significant association was found between the intake of 
supplements and the consumption of vegetables, rs (53) = - 0.017, p = 0.902; or the 
use of herbs and spices (rs (55) = 0.107, p = 0.406). 
 
4.5 Discussion 
 The details regarding the type of coffee, the frequency and amounts of 
consumption provided important information and with it, some challenges for the 
interpretation of the data. Information on the caffeination, strength, brew and any 
additive added to the coffee, tea and cocoa-containing beverage regularly consumed 
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was collected from a food frequency questionnaire. For the analysis of the data, the 
information on the ingredients (i.e. milk, sugar or sweetener) added to a beverage 
was not taken into account.  
 In the present observational study, the average total coffee consumption from 
the study population was above that of the average consumption per capita in the UK 
with no significant difference between gender or influence of age. The participants 
were mainly consumers of medium and strong caffeinated preparations, and when 
individual coffee brews were analysed, instant coffee was clearly the mostly 
consumed preparation. This could be explained by the practicality and low-cost of 
instant coffee, when compared to the other brews. Arabic and Turkish coffee 
preparations were the least consumed and this could be explained by the ethnicity of 
the study population, which was in majority from Occidental countries. Gender, but 
not age, had an effect on the choice for a particular coffee brew. The average 
consumption of tea was higher than that of coffee and was similar to the average 
consumption in the UK. Apart from the consumption of herbal infusions, which was 
age-dependent, and green tea, which was gender-dependent, total tea consumption 
and the consumption of particular tea brews was not influenced by either variable. 
The consumption of cocoa-containing beverages was the lowest when compared to 
coffee and tea, but amongst them, milk chocolate beverages were the most 
consumed. No association was found between age or gender with the consumption 
of cocoa-containing beverages. 
 A quantitative estimation of the (poly)phenolic intake from coffee, tea and 
cocoa sources was not possible and therefore, within a category, products were 
attributed an index representative of their (poly)phenolic content for the comparative 
statistical analysis of (poly)phenolic intake. The (poly)phenolic index was not 
comparable between categories, as the indexes did not necessarily correspond to the 
same level of (poly)phenols. The coffee level and coffee (poly)phenolic index were 
not influenced by gender, nor by age. The female and male populations were 
estimated to have a similar intake of (poly)phenols from coffee, tea and cocoa. There 
was a significant association between the (poly)phenolic index from coffee and from 
cocoa tea. Some significant associations were detected between the consumption of 
(poly)phenols from other sources. These were namely positive between the intake of 
coffee (poly)phenols and fruit and vegetables; there was a positive association 
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between tea consumption and fruit, and herbs and spices; a positive association 
between the intake of (poly)phenols from cocoa beverages and the consumption of 
fruit, and the intake of supplements; and a strong positive association between fruits 
and vegetables; fruits and herbs and spices; vegetables and herbs and spices; and 
fruits and the intake of supplements. 
 Unfortunately not all the study population (n = 62) provided complete 
information on their general dietary habits and consistently completed the food 
frequency questionnaire, resulting in a variable number available for statistical 
analysis. 
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Chapter 5  
Study population characteristics and consistency at baseline 
5.1 Abstract 
 The target study group in the present study was a healthy adult population. 
Anthropometrics, blood pressure and selected biomarkers of health in fasting plasma 
were recorded in all the participants (n = 62) in order to characterize the study 
population and verify the health status of the participants, as well as to assess the 
consistency of their metabolism. The influence of gender and age on the target 
variables was investigated. To assess the general health status of the study 
population, 7 biomarkers of health in fasting plasma, anthropometric variables and 
general daily habit were analysed for each subject at baseline. The averages ± 
standard deviation for the investigated biomarkers were 257 ± 25 μM for total 
cysteine, 9.5 ± 3.5 μM for homocysteine, 30.5 ± 5.6 μM for total cysteinylglycine, 
7.7 ± 1.5 μM for total glutathione, 4.7 ± 0.3 mM for glucose, 55.5 ± 16.6 pM for 
insulin and 0.26 ± 0.06 mM for uric acid. These were consistent with reported values 
in the literature, for healthy subjects, thus confirming that the study population was 
in general good health and that the corresponding data were appropriate to undergo 
further statistical analysis. The study population was relatively young with an 
average ± standard deviation of 28 ± 8 years old. On average, when compared to the 
female participants, the male participants were taller, heavier, had a larger waist 
circumference and waist-to-hip ratio, were more active and had higher levels of 
plasma total cysteine, homocysteine, cysteinylglycine and uric acid. Age only was 
associated with a few variables, namely the waist circumference, the diastolic blood 
pressure, the total cysteinylglycine and the glucose concentration. Overall, the 
variables of interest were consistent throughout the completed visits. Total 
cysteinylglycine and glutathione concentrations varied between visits and the 
outcome for insulin was inconsistent, depending on the choice of the statistical test 
performed. However, the coefficients of variation were considered to be low for all 
the biomarkers analysed, therefore suggesting that overall, the analysed biomarkers 
have a stable metabolism over a period of at least 8 weeks. 
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5.2 Introduction 
 Characterizing a recruited study population is important in order to ensure 
that the population will be adequate to test a hypothesis. Biomarkers of health are 
primary indicators of the health status of a person. They have long been used as 
indicators of the general health status or the progression of particular diseases 
(Alderman et al., 1999, Alper et al., 2005, Alvarez et al., 2009, Andersson et al., 
1999, Burack et al., 1985, Vasan, 2006). In numerous human studies investigating 
the effects of coffee and other (poly)phenol-rich foods on health, various biomarkers 
of health have been measured in biological samples (Agardh et al., 2004, Ahmed et 
al., 2009). As the consumption of coffee and other (poly)phenol-rich products has 
been linked to a reduced risk of inflammation and cardiovascular health (Andersen 
et al., 2006, Bohn et al., 2012, Bonita et al., 2007, Cano-Marquina et al., 2013), a 
few reliable biomarkers in fasting plasma that are indicators of these two health 
statuses were selected for analysis in the population of the present study. 
 In the present study, a healthy adult population was targeted in order to 
investigate the impact of a habitual consumption of coffee and other (poly)phenol-
rich products, as well as non-dietary habits on the general health status in healthy 
subjects. The weight and height were recorded to measure the body mass index 
(BMI) of each participant. The BMI is a useful measure for characterizing the 
dimension of a person, however it may be misinterpreted. Typical BMI values for 
both genders and at any age are < 18.50 kg/m
2
 for underweight, from 18.50 - 24.99 
kg/m
2
 for healthy, ≥ 25.00 kg/m
2 
for overweight and ≥ 30.00 kg/m
2
 for obese 
subjects (WHO, 2014). For the present study, participants were eligible if they had a 
BMI of 18.00 - 29.00 kg/m
2
. Subjects practicing sport at higher level have a more 
significant muscular mass, resulting in a higher BMI value and a misclassification of 
the subject. Therefore, the waist-to-hip ratio variable was recorded as a 
complementary variable to the BMI. The waist-to-hip ratio is often used as a 
measure of visceral obesity and has been significantly correlated with myocardial 
infarction risk (Yusuf et al., 2005). Individuals with a waist-to-hip ratio ≥ 0.85 for 
females and ≥ 0.90 for males are considered to suffer from visceral obesity and be at 
a substantially increased risk of metabolic syndrome and consequent complications 
including Type 2 diabetes Mellitus (Alberti and Zimmet, 1998). 
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 As circulating biomarkers of inflammation and cardiovascular health, the 
aminothiols cysteine, cysteinylglycine, homocysteine and glutathione, as well as 
glucose, insulin and uric acid were chosen (chapter 3). 
 In the present chapter, the study population was characterized in terms of 
certain non-dietary lifestyle habits, anthropometrics, blood pressure and selected 
biomarkers of health. The consistency of the measured biomarkers was then 
evaluated in order to assess the consistency of the metabolism of the study 
participants. 
 
5.3 Materials and methods 
5.3.1 Assessment of selected non-dietary lifestyle habits 
 Information on smoking habits, frequency of bowel movements and 
exercising habits were obtained from a health assessment questionnaire filled in 
once by each participant and used to assess their suitability in taking part in the 
present study (chapter 3). The number of cigarettes smoked per week was obtained 
by multiplying the number of cigarettes reported to be smoked in one day by 7. For 
the frequency of bowel movement, the participants had the options of reporting a 
movement "once every three days or less", "once every two days", "once per day" or 
"more than once per day". The corresponding weekly bowel movements were 2.5 
(rounded up from 2.33), 3.5, 7 and 14 weekly bowel movements, respectively. It is 
clear that half bowel movements are not possible and therefore these values were 
considered as bowel movement scores and used to order the variable on an ordinal 
scale for the statistical analyses. For the habits of physical activity, the participants 
were first asked to provide the information on whether they generally never 
exercised, whether they exercised "once", "twice", "three to four times" per week or 
"once a day or more". Physical activity was then categorised into light, moderate, 
strenuous, muscle gain exercise or other, with each category containing a few types 
of activity. Participants were asked to assess how many hours of each category they 
were exercising per week. For the interpretation of data, each exercise category was 
attributed a score that was representative of its intensity. The hours reported by the 
participants were then multiplied by the score of the corresponding activity. These 
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scores were "1" for physical activities of light intensity (e.g. walking, yoga), "2" for 
physical activities of moderate intensity (e.g. fast walking, easy swimming, easy 
cycling) and "3" for strenuous physical activities (e.g. running, vigorous swimming, 
high impact aerobics) and muscle gain. If a subject reported multiple activities of 
different scores, the multiplied scores were summed up. Therefore, if a subject 
reported on a weekly basis to practice 3 hours of a moderate intensity physical 
activity and 5 hours of a light intensity physical activity, the final physical activity 
score was 11. The same score could be obtained by a subject practicing 7 hours of a 
light physical activity and 2 hours of a moderate physical activity weekly. For the 




 The anthropometrics of each participant were recorded once during each 
visit. Before the measurements, the participants were asked to remove their shoes 
and any other objects and accessories susceptible to influence the measurements (i.e. 
belt, watch, wallet, coins, keys, heavy upper body outer clothing). The weight was 
measured on a calibrated portable electronic scale from Seca (SECA 877) to the 
nearest 0.1 kg. The height was measured with a Leicester manual portable 
stadiometer from Seca (SECA 214) that was placed against a wall. To have an 
accurate measure of the distance between the vertex and the bottom of their feet, the 
participants were asked to keep an upright posture, with the feet close together, the 
back against the stadiometer and the head in the Frankfurt plane. The reading was 
taken to the nearest 0.1 cm, however, the averages were rounded to the nearest cm. 
Both the weight and height were used to calculate the BMI by dividing the weight 
(kg) by the squared height (m
2
). Hip and waist circumferences were measured with a 
flexible, but resistant to stretch, measuring tape. For both measurements, the 
participants were asked to keep their arms down and maintain a relaxed but straight 
posture. For the lower body part, the participants kept their clothing on, but for the 
upper body part, any thicker clothes were asked to be removed so that there was no 
more than the thickness of a t-shirt on top of the skin. The hip circumference was the 
distance recorded around the widest part of the buttocks and the waist circumference 
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was the abdomen girth measured at its narrowest point, between the lowest ribs and 
the iliac bone crest (WHO, 2008). 
 
5.3.3 Blood pressure 
 When the participant was in a relaxed state, the blood pressure was measured 
using a portable cuffless upper arm blood pressure monitor with elbow support 
(Panasonic). The measurement was performed in triplicate, and when possible, on 
the opposite arm from which the blood had been withdrawn and with the hand in a 
supine position. If the participant was wearing clothes that were tightening their arm, 
they were asked to remove the arm from the sleeve. 
 
5.3.4 Blood sampling and processing 
 The participants were seated for the blood collection. Ten milliliters of blood 
was withdrawn by venepuncture of the antecubital vein in the opposite arm to the 
one used for writing. The blood was collected in previously ice-cooled EDTA-
containing tubes from BD Vacutainer
®
. In order to slow down the cellular 
metabolism, the tubes with the collected blood were placed on ice immediately after 
venepuncture. The samples were then rendered acellular within 30 min through a 10 
min centrifugation at 3,000 g and 4 °C, as frequently done (Ubbink et al., 1992). The 
plasma was carefully separated from the cellular fraction, aliquots were prepared and 
the samples were stored at - 80 °C until analysis. For the analysis of glucose, 500 μL 
of freshly drawn EDTA-whole blood was mixed with two antiglycolytic agents, 
glyceraldehyde and sodium fluoride at a final concentration of 11 and 119 mM, 
respectively (chapter 3). 
 
5.3.5 Measurement of the biomarkers in plasma 
 All the selected biomarkers of inflammation and cardiovascular health were 
measured in fasting plasma from the blood collected on each visit. For all the 
biomarkers analysed, the fasting plasma was thawed, centrifuged for 10 min, at 
3,000 g and 4 °C and processed and analysed as described in chapter 3. For all 
biomarkers, spiked and non-spiked plasma samples were compared for the 
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calculation of recoveries. These were prepared with a pool of a combination of 
plasma from all samples that were included in a set of analysis. The plasma samples 
were mixed in equal volumes. 
 
5.3.5.1 Total aminothiols 
 Total cysteine, homocysteine, cysteinylglycine and glutathione were 
measured in plasma of all the completed visits. Two calibration curves containing 
the four aminothiols were prepared. One was a milliQ water-based matrix and the 
other a plasma-based matrix. Both had the same final concentrations ranges for the 
selected aminothiols, from 0 - 200 μM for cysteine, 0 - 50 μM for homocysteine, 0 - 
100 μM for cysteinylglycine and 0 - 50 μM for glutathione. Cystamine 
dihydrochloride was used as the internal standard and kept at a constant final 
concentration of 6 μM. Calibration curves were constructed from the normalized 
areas under the curves plotted against the prepared concentrations of aminothiols on 
a double-logarithmic scale. To calculate the total aminothiol concentrations in 
plasma, only the matrix-matched calibration curves were used. 
 The procedure detailed in section 3.3.3.2 was followed for the preparation of 
reagents, standards and samples as well as for the sample analysis. 
 
5.3.5.2 Glucose 
 The glucose measurement in fasting plasma was performed using the 
hexokinase assay reagent from Sigma following the improved modified method 
described in chapter 3 (section 3.3.3.3) (Sigma-Aldrich, 2004). 
 For each participant, two technical replicates were prepared on two different 
days. The average fasting glucose for each completed visit is therefore based on the 
analysis of 4 sets of data. 
 
5.3.5.3 Insulin 
 The quantification of insulin in the fasting plasma was by done by ELISA, 
using an assay in the form of a kit, from Mercodia (Mercodia). The protocol 
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described in detail in section 3.3.3.4 was used for the sample preparation and 
subsequent analysis. 
 The calibration curve was constructed on a double-logarithmic scale. For 
each participant, two technical replicates were prepared on two different days. The 
average fasting insulin for each completed visit is therefore based on the analysis of 
4 sets of data. 
 
5.3.5.4 Uric acid 
 Uric acid was quantified by an enzymatic colorimetric method run in a 96-
microwell plate and adapted from a previously published procedure by Fossati et al. 
(Fossati et al., 1980). For each experiment, the reagents and solutions were prepared 
as described in section 3.3.3.5. The sample preparation and subsequent analysis were 
carried out as described in section 3.3.3.5.  
 Each plasma sample was analysed twice in duplicate so that averages were 
calculated from 4 technical replicates. 
 
5.3.6 Statistics 
 Along with the information obtained on selected lifestyle habits, the averaged 
anthropometrics, blood pressure measurements and concentrations of the selected 
biomarkers for each participant (n = 62) and all corresponding completed visits (i.e. 
1 to 3) were used to characterize the study population at baseline. Any link between 
the variables measured and the gender and age were tested with an appropriate 
statistical test for the analysis of differences between groups and inter-variable 
associations, respectively. To evaluate the consistency of the measured 
anthropometrics, blood pressure and biomarkers of health, only data from the 
participants who completed three visits (n = 40) were included. The average 
measurements obtained for each visit were analysed and compared between visits by 
conducting the appropriate statistical tests for repeated measures. 
 Normality of distribution was assessed by a Shapiro-Wilk test and the 
presence of outliers by visual inspection of box plots. Unless otherwise stated, 
genuine outliers were included in the statistical analysis and non-parametric tests 
were used only when significant outliers were present and the variables did not 
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follow a normal distribution. All averaged values are expressed as the mean ± 
standard deviation unless otherwise stated. Statistical analyses were performed using 
the Microsoft Office Excel 2007 and IBM SPSS statistics 20 softwares.  
 
5.4 Results  
5.4.1 Baseline characteristics of the study population (n = 62) 
 The study population consisted of 40 females and 22 males (chapter 4) 
ranging from 18 - 53 years old. The average age was 28 ± 8 years old and was 
similar between female (28 ± 8) and male (29 ± 9) participants (Table 5.1). The 
young study population is easily explained by the fact that the present study was 
advertised and participants were recruited in an area which included the University 
of Leeds campus. 
 
5.4.1.1 Non-dietary lifestyle habits 
 The study population was relatively active, with an average physical activity 
score of 12.3 ± 12.6. In general, males (15.5 ± 9.9) were more active than females 
(10.5 ± 13.7). Three outliers were detected and the distribution was similar but non-
normal for both genders. A non-parametric Mann-Whitney U-test was run to 
determine the impact of gender on physical activity. The analysis revealed 
significantly different medians for the female (Mdn = 8.0) and male (Mdn = 18.0) 
study population, U = 538, z = 2.422, p = 0.015. A non-parametric Spearman's 
correlation test indicated no association with age, rs (56) = - 0.022, p = 0.868. 
 The average bowel movement score reported by the study population was 7.9 
± 2.9 and was very similar for the female (7.8 ± 3.3) and male (7.9 ± 2.5) subjects. A 
Mann-Whitney U-test confirmed that the difference between females (Mdn = 7.00) 
and males (Mdn = 7.00) was not statistically significant and no association with age 
was detected either when a Spearman's correlation test was conducted, rs (60) = 
0.110, p = 0.404. 
- 135 - 
 As only 6.65 % and 4.83 % were current and former smokers, respectively, 
no statistical analysis was performed with this lifestyle habit variable. The majority 
of the female participants (75 %) reported being under contraceptive medication 
(Table 5.1). 
 
Table 5.1 : Age and non-dietary habits characteristics of the study population (n = 62) at baseline. The variables are expressed as means ± 
standard deviations (SD). The differences between gender were assesse by running a non-parametric Mann-Whitney U-test due to the presence of 
outliers and a non-normal distribution within both group. Statistically significant differences between gender are marked with an asterisc in the 
"mean ± SD" column for the total population. 
a)
 Four female participants did not provide information on their habits of physical activity. 
b)
 One 
female participant did not provide information on the bowel movement and the frequency of another female subject was once per week and 
assumed to be wrongly reported and therefore excluded from the analysis.n.a. (not applicable). 
 
 Total population (n = 62)  Female population (n = 40)  Male population (n = 22) 
 Mean ± SD Range  Mean ± SD Range  Mean ± SD Range 
Age (years) 28 ± 8 18 - 53  28 ± 8 20 - 53  29 ± 9 18 - 49 
Exercise score (per week)
a)
 12.3 ± 12.6 
*
 0.5 - 85.0  10.5 ± 13.7 0.5 - 85.0  15.5 ± 9.9 3.0 - 40.5 




7.9 ± 2.9 3.5 - 14.0  7.8 ± 3.3 3.5 - 14.0  7.9 ± 2.5 7 - 14 
Smokers (%) 6.65 n.a.  2.5 n.a.  13.63 n.a. 
Former smokers (%) 5 n.a.  3 n.a.  9 n.a. 
Contraceptive medication (%) n.a. n.a.  30 n.a.  n.a. n.a. 
*
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5.4.1.2 Anthropometrics and blood pressure 
 The detailed anthropometric characteristics of the present study population at 
baseline are summarized in Table 5.2. The average weight of the study population 
was 66.7 ± 11.2 kg, females (62.7  ± 9.7 kg) weighing on average less than the males 
(73.9 ± 9.9 kg). A non-parametric Mann-Whitney was used to assess the influence of 
gender on the weight of a participant. One genuine outlier was present and the 
variable was not normally distributed but was similar for females and males. The 
difference between the median weight for females (Mdn = 61.4 kg) and males (Mdn 
= 73.2 kg) was statistically significant, U = 697.5, z = 3.789, p < 0.0005. There was 
however, no association between the weight and the age, as assessed by a non-
parametric Spearman's correlation test, rs (60) = 0.172, p = 0.1781. 
 The average height of the study population was 1.69 ± 0.08 m and the female 
population (1.65 ± 0.06 m) was on average shorter than the male population (1.77 ± 
0.05 m). No outliers were detected in the height variable and the latter followed a 
normal distribution within both gender groups, so that a parametric independent T-
test was used to analyse the difference between genders. The variances within both 
groups were equal, as assessed by a Levene's test for equality of variances (p = 
0.469). The difference of the means was - 0.12 (95 % CI, - 0.15 to - 0.09), with the 
female population being statistically significantly shorter than the male population, t 
(60) = - 7.710, p < 0.0005. As for the weight, a Spearman's correlation test showed 
no correlation between the height and the age, rs (60) = - 0.0013, p = 0.921. 
 The average BMI of the study population was 23.3 ± 3.1 km/m
2
, with very 
similar values for the female (23.1 ± 3.2 kg/m
2
) and male participants (23.7 ± 2.8 
kg/m
2
). Conforming to the World Health Organization standards, from the 62 study 
participants, 2 were classified as underweight (BMI ≤ 18.50), 41 were within the 
normal range (BMI 18.50 to 24.99) and 19 were classified as overweight (BMI ≥ 
25.0). No outlier was present within both gender groups but the variable which had a 
similar distribution for females and males did not follow a normal distribution, so 
that a non-parametric Mann-Whitney U test was run to study the influence of gender 
on the BMI. Results indicated that the median for the female (Mdn = 22.5 kg/m
2
) 
and male (Mdn = 23.3 kg/m
2
) subjects was not statistically significantly different, U 
= 505, z = 0.957, p = 0.339. A correlation analysis with a Spearman's correlation test 
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did not reveal any association between the BMI and the age, rs (60) = 0.242, p = 
0.058. 
 The study population had an average waist circumference of 75.3 ± 8.1 cm. 
The average obtained for females (72.3 ± 6.0 cm) was below the average of the total 
population and that obtained for males (80.6 ± 8.8 cm) was above. One outlier was 
present and the variable did not follow a normal distribution but was similar for both 
genders. A non-parametric Mann-Whitney U test was conducted to assess the 
influence of gender on the waist circumference and revealed that the median for 
females (Mdn = 71.5 cm) was statistically significantly lower than that for males 
(Mdn = 79.3 cm), U = 711, z = 3.990, p < 0.0005. A positive correlation was 
detected between the waist circumference and the age, as assessed by a non-
parametric Spearman's correlation test, rs (60) = 0.283, p = 0.026. 
 Inversely to the waist circumference, the female population had a higher hip 
circumference (99.4 ± 7.7 cm) than the male population (98.1 ± 5.9 cm) and than the 
average obtained for the study population (98.9 ± 7.1 cm). The significance of the 
difference was tested by an independent T-test. A Levene's test revealed equal 
variances in both gender groups (p = 0.292) and the difference of the means between 
genders, 1.3 (95 % CI, -2.5 to 5.1), was not significant, t (60) = 0.671, p = 0.505. A 
non-parametric Spearman's correlation test did not detect any association between 
the hip circumference and age, rs (60) = 0.105, p = 0.418. 
 The average waist-to-hip ratio within the study population was 0.76 ± 0.06 
cm and females (0.73 ± 0.03 cm) had a slightly lower average than males (0.82 ± 
0.06 cm). No female but two male subjects had a waist-to-hip ratio higher than the 
cutoff point adopted by the World Health Organization to classify someone as 
visceral obese (ratio ≥ 0.85 for females and ≥ 0.90 for males). For both gender 
groups, no outliers were present and the distribution was similar but non-normal. A 
Mann-Whitney U-test was therefore conducted to determine if there was a difference 
in waist-to-hip ratio between genders and revealed that the median for the female 
(Mdn = 0.73 cm) and male subjects (Mdn = 0.80 cm) was statistically significantly 
different, U = 839, z = 5.875, p < 0.0005. When a non-parametric Spearman's 
correlation test was run to assess the association with age, however, no significant 
correlation was detected, rs (60) = 0.194, p = 0.130. 
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 The blood pressure could not be recorded for one female participant due to 
the small diameter of the arms. The average blood pressures were therefore based on 
data of 61 participants for the total population, and on data of 39 participants for the 
female population. The average systolic and diastolic blood pressures within the 
total population were 114 ± 9 and 71 ± 8 mmHg, respectively, with similar pressures 
observed in female (Syst.: 113 ± 10 mmHg, Diast.: 71 ± 9 mmHg) and male (Syst.: 
116 ± 9 mmHg, Diast.: 70 ± 7 mmHg) subjects. These values are classified as 
healthy (http://www.heart.org/) and are lower than the reported average in the UK. 
Five and three outliers were present in the systolic and diastolic blood pressures, 
respectively. The distribution of the systolic and diastolic blood pressures was 
similar for both genders but was non-normal. A Mann-Whitney U-test was run to 
assess the effect of gender on both blood pressures and results indicate that the 
median blood pressures for females (Syst.: Mdn = 113 mmHg, Diast.: Mdn = 70 
mmHg) and for males (Syst.: Mdn = 117 mmHg, Diast.: Mdn = 71 mmHg) were not 
statistically significantly different (Syst.: p = 0.166, Diast.: p = 0.741). The influence 
of age was different for both blood pressures. When a Spearman's correlation test 
was run, no influence of age on the systolic blood pressure was detected, rs (59) = - 
0.105, p = 0.419, but a strong positive association with the diastolic blood was 
detected, rs (59) = 0.315, p = 0.013. 
 
Table 5.2 : Anthropometric characteristics of the study population (n = 62) measured in fasting plasma at baseline. The variables are expressed 
as means ± standard deviations (SD). Except for the hip, the differences between gender were assessed by conduction of a Mann-Whitney U-test 
due to the presence of outliers and/or a non-normal distribution between both groups. Statistically significant differences are marked with the 
corresponding number of asteriscs in the "mean ± SD" column for the total population. a) The average of the total population and female 
population did not include the measurement of one female subject for which the arms were too thin to obtain a blood pressure record. BP: blood 
pressure. 
 
 Total population (n = 62)  Female population (n = 40)  Male population (n = 22) 
 Mean ± SD Range  Mean ± SD Range  Mean ± SD Range 
Weight (kg) 66.7 ± 11.2 
***
 47.1 - 95.6  62.7  ± 9.7 47.1 - 82.9  73.9 ± 9.9 56.6 - 95.6 
Height (m) 1.69 ± 0.08 
***
 1.51 - 1.89  1.65 ± 0.06 1.51 - 1.77  1.77 ± 0.05 1.65 - 1.89 
BMI (kg/m
2
) 23.3 ± 3.1 17.7 - 29.6  23.1 ± 3.2 17.7 - 29.4  23.7 ± 2.8 17.7 - 29.6 
Waist (cm) 75.3 ± 8.1 
***
 63.5 - 104.5  72.3 ± 6.0 63.5 - 85.5  80.6 ± 8.8 66.0 - 104.5 
Hip (cm) 98.9 ± 7.1 86.5 - 117.0  99.4 ± 7.7 86.5 - 117.0  98.1 ± 5.9 87.0 - 111.5 
Waist to Hip ratio 0.76 ± 0.06 
***
 0.67 - 0.95  0.73 ± 0.03 0.67 - 0.83  0.82 ± 0.06 0.75 - 0.95 
Systolic BP (mmHg)
a)
 114 ± 9 89 - 134  113 ± 10 91 - 134  116 ± 9 89 - 129 
Diastolic BP (mmHg)
a)
 71 ± 8 54 - 107  71 ± 9 56 - 107  70 ± 7 53 - 83 
*
 p < 0.05, 
**
 p < 0.005, 
***
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5.4.1.3 Biomarkers of inflammation and cardiovascular health 
 One of the study subjects did not come in a fasting state on the first visit. 
This participant reported to have eaten a banana prior to the examination. The first 
data set for the biomarkers of this participant were therefore not included in the 
calculation to obtain the study population average. All the selected biomarkers of 
inflammation and cardiovascular health measured in fasted plasma were within the 
expected healthy ranges. Detailed concentrations are presented in Table 5.3. 
 The average concentration of total cysteine in the present study population 
was 257 ± 27 μM, the female participants (250 ± 26 μM) having a lower average 
when compared to the male population (270 ± 23 μM). These values are similar to 
previously reported concentrations in healthy subjects (Guttormsen et al., 1994, 
Andersson et al., 1999). No outliers were present and the distribution was similar 
and normal for both genders. An independent t-test was run to assess the influence 
of gender on the total fasting plasma cysteine. The variances in both groups were 
equal, as assessed by an initial Levene's test (p = 0.650) and the difference of the 
means was - 20.86 (95 %, - 34.28 to - 7.44) and statistically significant, t (60) = -
3.111, p = 0.003 (Figure 5.1, A). When total cysteine was analysed by age, the 
distribution was non-normal and a non-parametric Spearman's correlation test 
revealed no significant association between both variables, rs (60) = 0.099, p = 
0.448. 
 The average fasting total homocysteine concentration was 9.6 ± 4.0 μM for 
the study population, which is similar to fasting values reported by Christensen et al. 
in a healthy adult population (Christensen et al., 2001). In the present study, the 
female population had a lower average (8.5 ± 2.4 μM) than the male population 
(11.7 ± 5.5 μM). Three outliers were present and the distribution of homocysteine 
within both genders was similar and non-normal so that the influence of gender on 
this biomarker was assessed by a Mann-Whitney U-test. The results indicated that 
the median obtained for the females (Mdn = 7.94 μM) was statistically significantly 
different than that obtained for the males (Mdn = 10.77 μM), U = 622, z = 3.06, p = 
0.002 (Figure 5.1, B). When a non-parametric Spearman's correlation test was 
conducted to assess the association with age, no significant association between both 
variable was detected, rs (60) = - 0.208, p = 0.108. 
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 An average of 31.3 ± 6.8 μM was obtained for total cysteinylglycine, for the 
study population, which is close to previously reported concentrations in healthy 
adults (Guttormsen et al., 1994). The female study population (30.1 ± 6.6 μM) had a 
lower average concentration than the male study population (33.7 ± 6.8 μM). The 
significance of the difference was tested by an independent t-test. An initial Levene's 
test indicated the variances within both groups to be equal (p = 0.782) and the 
difference of the means between genders was - 3.59 (95 % CI, - 7.18 to - 0.004) and 
significant, t (60) = - 1.999, p = 0.05 (Figure 5.1, C). When total cysteinylglycine 
was analysed by age, no bivariate normality was observed and a non-parametric 
Spearman's correlation test revealed a negative association between total 
cysteinylglycine and age, rs (60) = - 0.348, p = 0.006 (Figure 5.1, E). 
 The fasting plasma concentration of total glutathione in the study population 
was 8.4 ± 2.4 μM, with a neglectable difference between the female (8.4 ± 2.2 μM) 
and the male population (8.5 ± 2.9 μM). The extracellular concentration of 
glutathione can range from 2 to 20 μM (Wu et al., 2004). In the study by Guttormsen 
et al. earlier referenced, an average of 5.69 ± 1.33 μM was reported for healthy 
adults (Guttormsen et al., 1994). The concentrations obtained in the present study 
thus fit in this range. A Levene's test indicated equality of variances in both gender 
groups (p = 0.205). The mean difference between genders was - 0.03 (95 % CI, - 
1.36 to 1.30) and an independent sample t-test confirmed the non-significance of the 
difference, t (60) = - 0.44, p = 0.965. No significant association between total 
glutathione and the age was detected when a Spearman's correlation test, rs (60) = - 
0.223, p = 0.09. 
The average fasting glucose concentration in the study population was 4.7 ± 0.4 
mM, with similar values for females (4.7 ± 0.4 mM) and males (4.9 ± 0.5 mM). 
These values are considered healthy, as defined by the American Diabetes 
Association (healthy glycaemia at fast: < 5.6 mM), often taken as a reference and 
whose cutoff the World Health Organization has also adopted (ADA, 2010, WHO, 
2006). A Levene's test indicated equality of variances in both gender groups (p = 
0.589) and the mean difference between both genders was - 0.19 (95 % CI, - 0.43 to 
0.03). This difference was not significant, as assessed by an independent sample t-
test, t (60) = - 1.703, p = 0.094. When glucose was analysed by age, no bivariate 
normality was observed and a non-parametric Spearman's correlation test was 
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conducted to assess the association with age. Glucose was not significantly 
associated with the age, rs (60) = 0.142, p = 0.276. 
 The average fasting insulin concentration in the study population was 55.2 ± 
19.3 pM, with very similar concentrations obtained for females (55.6 ± 17.8 pM) 
and males (54.5 ± 22.3 pM). As for the other biomarkers measured, these values are 
considered to be healthy, as reported by Mercodia that measured a range of 12 - 150 
pM insulin in 137 apparently healthy adults (Mercodia). Three outliers were present 
and the distribution was similar within both genders but did not follow normality. A 
non-parametric Mann-Whitney U-test was therefore run and indicated no 
statistically significant difference between the median for females (Mdn = 52.65) 
and males (Mdn = 49.90), U = 369, z = - 0.767, p = 0.443. A non-parametric 
Spearman's correlation test was conducted to assess the association with age and no 
significant association with age was identified for insulin, rs (60) = - 0.085, p = 
0.514.  
Using the fasting glucose and insulin variables, the pancreatic β-cell function, the 
insulin sensitivity and the insulin resistance were estimated using the HOMA 
calculator available online, from the University of  Oxford 
(https://www.dtu.ox.ac.uk/homacalculator/download.php). The average β-cell 
function was 108 ± 22 % for the total study population, 112 ± 21 % for the female 
population and 101 ± 22 % for the male population. The average insulin sensitivity 
was 108 ± 30 % for the total study population, 106 ± 27 % for the female population 
and 111 ± 35 % for the male population. The insulin resistance was normal in the 
study population, with values of 1.03 ± 0.37 for the total study population, 1.05 ± 
0.34 % for the female population and 1.01 ± 0.43 % for the male population. For 
these three variables the difference between genders was non-significant (p > 0.05) 
and only the β-cell function was negatively associated with the age rs (60) = - 0.258, 
p = 0.045 (Figure 5.1, F). 
As well as for the above mentioned biomarkers of health, the average fasting uric 
acid for the total study population (0.26 ± 0.06 mM) was within the expected normal 
range (Sautin and Johnson, 2008). The average for the female population (0.23 ± 
0.04 mM) was lower than for the male population (0.31 ± 0.06 mM). A Levene's test 
revealed equality of variances between gender (p = 0.063). The difference of the 
means was - 0.08 (95 % CI, - 0.11 to - 0.06) and as assessed by the independent 
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sample t-test the difference was significant, t (60) = - 6.362, p < 0.0005 (Figure 5.1, 
D). No bivariate normality was observed when uric acid was analysed by age and a 
non-parametric Spearman's correlation test was conducted to assess the association 
with age. No significant association between uric acid and the age was detected, rs 
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Figure 5.1: Biomarkers for which a statistically significant difference between 
gender or an association with age was identified at baseline. tCys, total cysteine; 
tCysGly, total cysteinylglycine; UA, uric acid; tHCys, total homocysteine; : non-
extreme outlier (the data point is > 1.5 box-length away from the corresponding 
plotted box edge), *: extreme outlier (the data point is > 3 box-lengths away from 




Table 5.3 : Selected inflammation and cardiovascular biomarkers of the study population (n = 62) measured in fasting plasma at baseline. The 
variables are expressed as means ± standard deviations (SD). All biomarkers measured were within ranges that have previously been reported in 
healthy subjects. For the biomarker-gender pairs with no outlier, a normal distribution and equal variance between groups (i.e. tCys, tCysGly, 
tGSH, Glc, UA). The differences between gender for the remaining biomarkers were assessed by conduction of a Mann-Whitney U-test, due to 
the presence of outliers and/or a non-normal distribution between groups. Significant differences between gender are marked with asteriscs. tCys, 
total cysteine; tHCys, total homocysteine; tCysGly, total cysteinylglycine; tGSH, total glutathione; Glc, glucose; Ins, insulin; UA, uric acid. 
 Total population (n = 62)  Female population (n = 40)  Male population (n = 22) 
 Mean ± SD Range  Mean ± SD Range  Mean ± SD Range 
Total thiols (μmol/L) 
        
tCys 257 ± 27 
**
 185 - 310  250 ± 26 185 - 308  270 ± 23 225 - 310 
tHCys 9.6 ± 4.0 4.4 - 31.3  8.5 ± 2.4 4.4 - 15.4  11.7 ± 5.5 4.6 - 31.3 
tCysGly 31.3 ± 6.8 
*
 19.6 - 46.8  30.1 ± 6.6 19.6 - 43.4  33.7 ± 6.8 22.7 - 46.8 
tGSH 8.4 ± 2.4 4.9 - 17.25  8.4 ± 2.2 5.17 - 15.3  8.5 ± 2.9 4.9 - 17.3 
Glc (mmol/L) 4.7 ± 0.4 3.9 - 6.4  4.7 ± 0.4 3.9 - 5.6  4.9 ± 0.5 4.2 - 6.4 
Ins (pmol/L) 55.2 ± 19.3 30.6 - 134.7  55.6 ± 17.8 31.0 - 134.7  54.5 ± 22.3 30.6 - 129.5 
UA (mmol/L) 0.26 ± 0.06 
***
 0.14 - 0.43  0.23 ± 0.04 0.14 - 0.30  0.31 ± 0.06 0.19 - 0.43 
HOMA, B (%) 108 ± 22 67 - 163  112 ± 21 76 - 163  101 ± 22 67 - 149 
HOMA, S (%) 108 ± 30 39 - 178  106 ± 27 40 -178  111 ± 35 40 - 176 
Insulin resistance, IR 1.03 ± 0.37 0.57 - 2.52  1.05 ± 0.34 0.64 - 2.49  1.01 ± 0.43 0.57 - 2.52 
*
 p < 0.05, 
**
 p < 0.005, 
***
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5.4.2 Consistency of the baseline variables 
5.4.2.1 Anthropometrics and blood pressure 
 The consistency of the anthropometric (i.e. weight, height, BMI, waist and 
hip circumference, waist-to-hip ratio) and blood pressure measurements taken 
between the three visits was tested by conducting a one way ANOVA with repeated 
measures. Outliers were present for the waist circumferences (n = 1), the waist-to-
hip ratio (n = 3) and the systolic pressure (n = 5), but due to the likelihood of their 
genuine nature, these were not excluded. A Shapiro-Wilk test indicated that data 
were not normally distributed at each visit for the waist circumference (visit 1: p = 
0.012, visit 3: p = 0.043), the waist-to-hip ratio (visit 1: p = 0.007) and the diastolic 
blood pressure (visit 2: p = 0.007). Due to the considerable robustness of the 
ANOVA with repeated measures test to deviations of normality, this test was still 
used for the analysis of consistency.  
 The variances of the differences between the possible pair combinations 
between the three visits were not equal for the weight (X
2
 (2) = 10.097, p = 0.006), 
BMI (X
2
 (2) = 7.654, p = 0.022), waist circumference (X
2
 (2) = 17.93, p < 0.0005) 
and hip circumference (X
2
 (2) = 8.477, p = 0.014), as assessed by a Mauchly's test of 
sphericity. The Mauchly's test is not very robust to deviations of normality and it is 
mostly conventional to perform a Greenhouse-Geisser correction regardless of 
whether the sphericity has or has not been violated (Moulton, 2010). Therefore, a 
Greenhouse-Geisser correction, in which the degrees of freedom are altered, was 
performed. The Greenhouse-Geisser epsilon values obtained for the weight (ε = 
0.811), height (ε = 0.924), BMI (ε = 0.846), waist circumference (ε = 0.727), hip 
circumference (ε = 0.833), waist-to-hip ratio (ε = 0.919), systolic blood pressure (ε = 
0.988) and diastolic blood pressure (ε = 0.882) were used to correct the one-way 
ANOVA with repeated measures. The resulting adjusted data did not indicate any 
significant difference of measurement between the three visits (Table 5.4), for 
weight, F (1.622, 63.243) = 0.664, p = 0.488, partial η
2
 = 0.017; height, F (1.847, 
72.034) = 0.949, p = 0.386, partial η
2
 = 0.024; BMI, F (1.691, 65.966) = 0.927, p = 
0.387, partial η
2
 = 0.023; waist circumference, F (1.453, 56.680) = 0.257, p = 0.703, 
partial η
2
 = 0.007; hip circumference, F (1.667, 65.003) = 0.044, p = 0.934, partial η
2
 
= 0.001; waist-to-hip ratio F (1.838, 71.678) = 0.241, p = 0.768, partial η
2
 = 0.006; 
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systolic blood pressure, F (1.976, 77.074) = 0.312, p = 0.731, partial η
2
 = 0.008; and 
diastolic blood pressure, F (1.765, 68.818) = 0.519, p = 0.575, partial η
2
 = 0.013. 
 The outcome did not change when, for comparative purposes, the alternative 
Friedman's test was run to test the consistency of the variables which had outliers 
and/or, which did not follow a normal distribution. These variables were the waist 
circumference, waist-to-hip ratio, systolic blood pressure and diastolic blood 
pressure. The measurements of the waist circumference (Mdn visit 1 = 73.25, Mdn 
visit 2 = 75.2, Mdn visit 3 = 73.75), waist-to-hip ratio (Mdn visit 1 = 0.755, Mdn 
visit 2 = 0.760, Mdn visit 3 = 0.760), systolic blood pressure (Mdn visit 1 = 116.0, 
Mdn visit 2 = 116.0, Mdn visit 3 = 114.50) and diastolic blood pressure (Mdn visit 1 
= 71.0, Mdn visit 2 = 73.5, Mdn visit 3 = 70.0) throughout the three visits of the 
human study were statistically not significantly different, with Chi square (degrees 
of freedom) values of X
2
 (2) = 2.471, p = 0.291, X
2
 (2) = 0.870, p = 0.647, X
2
 (2) = 
0.039, p = 0.980 and X
2
 (2) = 2.554, p = 0.279, respectively. 
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Table 5.4 : Average anthropometrics and blood pressure obtained with the 
participants that completed the three possible visits (n = 40). Data are presented for 
each visit as the average ± standard deviation (SD). All the anthropometric and 
blood pressure measurements were consistent between visits (p > 0.05) as assessed 
by an parametreic ANOVA with repeated measures test. WHR, waist-to-hip ratio; 
n.d.: not determined. 
 
 
Average ± SD ANOVA RM,     
p-value 
 Visit 1 Visit 2 Visit 3 
Weight (kg) 65.9 ± 10.1 66.1 ± 9.7 66.3 ± 9.8 0.488 
Height (m) 1.69 ± 0.09 1.69 ± 0.09 1.69 ± 0.09 0.386 
BMI (kg/m
2
) 23.13 ± 2.96 23.19 ± 2.90 23.28 ± 3.08 0.387 
Waist (cm) 75.2 ± 8.4 75.5 ± 7.3 75.2 ± 7.7 0.703 
Hip (cm) 98.1 ± 6.9 98.2 ± 6.6 98.1 ± 6.8 0.934 
WHR 0.77 ± 0.07 0.77 ± 0.06 0.77 ± 0.06 0.768 
Systolic BP 
(mmHg) 
116 ± 8 114 ± 7 115 ± 9 0.731 
Diastolic BP 
(mmHg) 
71 ± 6 72 ± 6 71 ± 6 0.575 
 
 
5.4.2.2 Biomarkers of inflammation and cardiovascular health 
 Although 40 subjects completed three visits, the analysis of consistency for 
the biomarkers of inflammation and cardiovascular health was performed on the data 
of 38 participants. One of the two excluded data belonged to a subject which, due to 
fear of needles, had no blood withdrawn on the first visit. The second data set 
excluded belonged to a subject that had consumed a banana in the morning, prior to 
the first visit and for which glucose and insulin measurements would be influenced. 
Although the consumption of a banana is unlikely to significantly influence the 
measurements for the other biomarkers, the complete data set was excluded as a 
precaution.  
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 As for the anthropometrics and blood pressure measurements, some outliers 
were detected by visual inspection of boxplots in the data set for total homocysteine 
(n = 1), total cysteinylglycine (n = 3), total glutathione (n = 3), glucose (n = 3), 
insulin (n = 2) and uric acid (n = 1) and all were included in the statistical analyses. 
Also, a Shapiro-Wilk test indicated that total homocysteine (visit 1, 2 and 3: p < 
0.0005), total glutathione (visit 1: p = 0.007), insulin (visit 2: p = 0.038, visit 3: p = 
0.001) and uric acid (visit 3: p = 0.004) did not follow a normal distribution in all the 
visits. 
 As assessed by a Mauchly's test of sphericity, the variances of the differences 
between the possible pair combinations between the three visits for total glutathione 
only were not equal, X
2
 (2) = 18.411, p < 0.0005. For the same reason as previously 
mentioned, a Greenhouse-Geisser correction was performed for all the biomarkers of 
health variables and not only for glutathione. The Greenhouse-Geisser epsilon 
values obtained for the total cysteine (ε = 0.958), total homocysteine (ε = 0.961), 
total cysteinylglycine (ε = 0.913), total glutathione (ε = 0.714), glucose (ε = 0.922), 
insulin (ε = 0.876) and uric acid (ε = 0.996) were used to correct the one-way 
ANOVA with repeated measures. After correction, the means of the dependent 
variables were similar between visits for total cysteine, F (1.917, 70.919) = 0.039, p 
= 0.962, partial η
2
 = 0.001; total homocysteine, F (1.923, 71.135) = 1.247, p = 0.293, 
partial η
2
 = 0.033; glucose, F (1.844, 68.225) = 0.970, p = 0.378, partial η
2
 = 0.026 
and uric acid F (1.991, 73.678) = 0.204, p = 0.815, partial η
2
 = 0.005. A statistically 
significant difference between visits was however detected for total cysteinylglycine, 
F (1.827, 67.591) = 7.849, p = 0.001, partial η
2
 = 0.175; total glutathione, F (1.428, 
52.844) = 11.515, p < 0.0005, partial η
2
 = 0.237 and insulin, F (1.753, 64.861) = 
3.333, p = 0.048, partial η
2
 = 0.083. For those three variables, further investigation 
was undertaken to identify the cause of the statistical significance. Post hoc analysis 
with a Bonferroni adjustment revealed that the total cysteinylglycine concentration 
was statistically significantly higher in visit 1, when compared to visit 2, with a 
mean difference of 3.249 μM (95 % CI, 1.118 to 5.380), p = 0.001. For total 
glutathione, the concentration obtained in visit 1 was statistically significantly higher 
when compared to visit 2 and visit 3, with mean differences of 1.500 μM (95 % CI, 
0.611 to 2.390), p < 0.0005 and 1.537 μM (95 % CI, 0.3871 to 2.687), p < 0.006, 
respectively. Finally, the average concentration obtained for the insulin during visit 
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1 was statistically significantly lower when compared to visit 3, with a mean 
difference of - 5.932 μM (95 % CI, -10.971 to -0.892), p = 0.016. 
 When the alternative non-parametric Friedman's test was run to analyse the 
consistency of the variables which had outliers and/or were not normally distributed, 
the results indicated that the concentration of total cysteinylglycine obtained 
throughout the three visits were statistically significantly different, X
2
 (2) = 11.692, 
p = 0.003. Pair-wise comparisons with a Bonferroni correction for multiple 
comparisons indicated that the concentrations were statistically significantly 
different between visit 1 (Mdn = 32.150) and visit 2 (Mdn = 28.465), p = 0.002. The 
concentrations of total glutathione were also statistically significantly different 
between the three visits, X
2
 (2) = 20.667, p < 0.0005, and pair-wise comparisons 
with a Bonferroni correction for multiple comparisons indicated that the 
concentrations were statistically significantly different between visit 1 (Mdn = 8.75) 
and visit 2 (Mdn = 7.34), p < 0.0005 and between visit 1 (Mdn = 8.75) and visit 3 
(Mdn = 7.41), p = 0.001. On the contrary, when the consistency of the insulin 
concentrations was tested with the Friedman's test, no statistically significant 
difference was detected, X
2
 (2) = 5.842, p = 0.54. 
 To further examine the intra-individual variation, the coefficient of variation 
for each biomarker was calculated for each participant. The average for each 
biomarker was then calculated for the total population and is presented in Table 5.5. 
The relatively low values support the idea that the metabolism of the selected 
biomarkers of health is stable over a period of at least 8 weeks. 
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Table 5.5 : Average concentrations and coefficients of variation of the biomarkers 
of inflammation and cardiovascular health obtained for the participants that 
completed the three possible visits. The comparisons included data from 38 
participants. Data are presented for each visit as the average ± standard deviation 
(SD). A parametric ANOVA with repeated measures test indicated that not all 
biomarkers were consistent for the studied period, but the low coefficients of 
variation suggest otherwise. tCys, total cysteine; tHCys, total homocysteine; 
tCysGly, total cysteinylglycine; tGSH, total glutathione; Glc, glucose; Ins, insulin; 
UA, uric acid. 
 
 Average ± SD 
Average CV   
(%) ± SD 
ANOVA RM,          
p-value 
 Visit 1 Visit 2 Visit 3 
tCys 
(μmol/L) 
260 ± 27 261 ± 25 260 ± 26 3.9 ± 1.9 0.962 
tHCys 
(μmol/L) 
9.9 ± 4.7 9.3 ± 3.9 9.5 ± 4.0 15.1 ± 8.1 0.293 
tCysGly 
(μmol/L) 
32.8 ± 6.4 29.5 ± 5.3 30.4 ± 6.6 11.3 ± 6.3 0.001 
tGSH 
(μmol/L) 
8.9 ± 2.6 7.4 ± 1.4 7.4 ± 1.8 18.4 ± 10.6 < 0.0005 
Glc 
(mmol/L) 
4.7 ± 0.3 4.8 ± 0.4 4.8 ± 0.4 4.6 ± 2.4 0.378 
Ins 
(pmol/L) 
52.1 ± 14.1 55.0 ± 16.4 58.0 ± 18.4 15.7 ± 7.3 0.048 
UA 
(mmol/L) 
0.26 ± 0.06 0.26 ± 0.05 0.26 ± 0.08 8.6 ± 4.5 0.815 
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5.5 Discussion and conclusion 
 As for the analysis of the food frequency questionnaire discussed in chapter 
4, the totality of the study participants (n = 62) did not always provide complete 
information on certain life habits, such as bowel movements or physical activity. 
 Also, some data could not be measured or considered for some participants. 
This resulted in an unequal number of data available depending on the statistical 
analyses performed. Ideally, the weight measurement would have been recorded on 
the participants wearing their underwear only, however, all the participants 
underwent the measurement under the same conditions and the excess weight 
estimated to be < 200 g would be very similar amongst the participants, thus still 
allowing the comparative measurements. 
 The age range of the study population was broad (18 - 53 years), but the 
majority of the population was young, resulting in an average of 28 ± 8 years. This 
relatively young average could be explained by the fact that the recruiting area 
included the University of Leeds campus. The male population was on average taller 
and heavier than the female population, but both genders had similar BMI averages. 
Age did not influence any of these three variables. The female population had an 
average waist circumference that was lower than that of the male population and the 
waist circumference increased with age. No influence of gender or age on the hip 
circumference was detected. The waist-to-hip ratio was lower in the female subjects, 
but age did not have any influence on the variable. Two male subjects were 
considered to possess visceral obesity but the corresponding data was still 
considered for the analyses. The study population had in general a healthy blood 
pressure which was gender-independent, but diastolic blood pressure was positively 
associated with age. Although few subjects were in the older age rage, the blood 
pressure is known to increase with age. The excess consumption of certain dietary 
components such as sodium, alcohol, fat, the reduction of physical activity with the 
age and the long-term effect of stress, are examples of factors contributing to 
structural modifications in the arteries leading to an increasing stiffness and 
subsequent resistance, a major cause of increase of blood pressure (Pinto, 2007). 
Males were in general more active than females but the physical activity was not 
influenced by age. The bowel movement was not influenced by either the gender or 
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age. A low percentage in the population smoked or had smoked in the past and 
therefore no statistical analyses were performed on the variable. 
 Overall, the recruited study population was confirmed to be in general good 
health with regards to inflammation and cardiovascular health, as assessed by the 
selected biomarkers measured at fast in plasma and when compared to values 
previously reported for healthy adult subjects (Wu et al., 2004, Guttormsen et al., 
1994, Christensen et al., 2001, Mercodia, Sautin and Johnson, 2008). The observed 
concentrations in the present study are all consistent with those reported in a recent 
study carried out by Pimková at al. (2014). In this study, Pimková et al. compared 
aminothiol concentrations in healthy subjects and Myelodysplastic Syndrome 
patients. Healthy subjects had lower levels of cysteine, homocysteine and 
cysteinylglycine (total, reduced and oxidized), while higher levels of glutathione 
(total and oxidized) were reported in healthy subjects, when compared to the patient 
group. Of note, Pimková et al. did not specify whether the blood was collected at 
fast or not. The lower cysteine concentrations obtained in the female population of 
the present studyare consistent with a previous report by El-Khairy et al. (2001) but 
not by Bates et al. (2002). In the study by El-Khairy et al. (2001), the healthy 
subjects were < 60 years, but no details on the age range is provided. Similarly, the 
lower homocysteine levels measured in the female population are consistent with a 
report by Powers et al. (2002), in which105 healthy adult females and males of 
different age categories (pre- and postmenopausal females, but with no specified age 
for either gender) were subject to analysis., Bates et al. did not report any difference 
between genders in subjects < 15 years old, in subjects aged 15 to 18 years old 
(Bates et al., 2002, Powers et al., 2002). Both biomarkers were independent from 
age, in the present research. In the same study by Bates et al. and Powers et al., older 
subjects had higher levels of homocysteine. This different outcome could, however, 
be explained by the fact that the recruited population in the present study was mainly 
composed of young adults with only one subject > 50 years old. The female 
population also had a lower concentration of cysteinylglycine than the males in the 
study, and the biomarker was negatively associated with age. These observations are 
consistent with the report of Bates et al. (2002). Glutathione concentrations were not 
gender- or age-dependent. The higher levels of cysteine, homocysteine and 
cysteinylglycine in males could suggest that the estrogens have an effect on the 
metabolism of aminothiols. This would be supported by several researches. In a 
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study with post-menopausal women, a 6-month treatment with estrogen decreased 
the homocysteine levels by 21.7 %, when compared to the values prior to the 
treatment. The female group receiving a placebo for the same period increased the 
homocysteine values by 16.5 %, when compared to the values prior to the treatment 
(Lakryc et al., 2015). Since the subjects in the present study were in general good 
health an unbalance in the transsulfuration pathway was not expected. It would 
therefore be expected that a healthy subject with higher homocysteine levels would 
also have a more active transsulfuration pathway, starting with a higher rate of 
catalysis of homocysteine into cystathione and subsequent hydrolysis into cysteine. 
Glucose was positively associated with age, but not gender. Insulin was also gender-
independent but as there was a positive association between glucose and age, the 
same was expected between glucose and insulin, which was not the case. This could 
suggest that there is a tendency towards reduced response of the pancreatic β-cells 
towards glucose with increasing age. Uric acid was gender- but not age-dependent. 
As for the aminothiols, the gender difference could be explained by the sex 
hormones. In an in vivo experiment using a murine model, Takiue et al. (2011) 
investigated the effect of a hormone replacement treatment with oestradiol and 
progesterone on the regulation of the renal uric acid transporters expression in 
female mice that were or not subject to bilateral ovariectomy. In both groups, the 
mice were injected subcutaneously with either estradiol dipropionate (2.5 or 0.025 
mg/kg), progesterone (2.5 mg/kg), estradiol (0.025 mg/kg) with progesterone (2.5 
mg/kg), or the vehicle medium, i.e. sunflower oil. The mRNA of four uric acid 
trasporters was quantified, namely, Urat1, Glut9, Smct1 and Abcg2 and no change 
was significant between the different mice and treatments. When the protein levels 
were quantified, when compared to the ovariectomized mice with no hormone 
treatment, the hormone treatment with estradiol only significantly lowered the 
protein levels of Urat1, Glut9 and Abcg2, and th treatment with progesterone only 
decreased the Smct1 levels. Both hormones thus are able to reduce the reabsorption 
of uric acid, by reducing post-transciptional expression of the tested transporters. 
 When the consistency of the population characteristics was tested, the 
analyses suggested that the anthropometric variables and blood pressure were 
consistent over the three visits. This is also what was expected as the study 
population was an adult population, therefore with a stable height; the study 
participants were not following any prescribed diet or following a weight-loss diet, 
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therefore having a stable weight, BMI, waist circumference, hip circumference and 
consequently a stable waist to hip ratio; and the study population was in general 
good health and later analyses confirmed this judgement, therefore large fluctuations 
in blood pressure in a relaxed state were not expected. For the biomarkers measured, 
cysteinylglycine and glutathione were systematically non-consistent between visits, 
as assessed by an ANOVA test with repeated measures. However, the averaged 
coefficients of variation in the population were suggestive of a low intra-individual 
variation. As for insulin, the difference between visits was statistically significant 
when an ANOVA test with repeated measures was conducted, but not significant 
when a non-parametric Friedman's test was run instead. 
 Particular attention needs to be paid when it comes to statistical analyses. 
Although both parametric and non-parametric tests can be conducted with a same 
data set in an attempt to answer a certain question, the choice for a particular 
statistical test requires careful thought as the outcomes can vary. In this current case, 
the choice of taking into account the results from the non-parametric Friedman's test 
instead of those from the ANOVA with repeated measures, for those data which 
have outliers and/or do not follow a normal distribution, is likely the most 
appropriate. In conclusion, the recruited population was, first self-reported and 
subsequently confirmed by measurements, in general good health and with a 
consistent metabolism for the selected biomarkers of health.  
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Chapter 6  
Impact of habitual consumption of (poly)phenol-rich products, 
general daily habits and anthropometrics on health biomarkers and 
associations amongst health biomarkers 
 
6.1 Abstract 
 The associations between the data collected by procedures discussed in 
earlier chapters are discussed in the present chapter. Firstly, associations between 
variables were assessed, followed by the correction for age, gender and waist-to-hip 
ratio. Adjusted statistical analyses revealed numerous significant associations, 
although fewer when compared to the unadjusted analyses. Variables of coffee 
consumption were positively associated with the four aminothiols studied, the 
homocysteine-to-cysteine ratio and uric acid, but had no association with glucose or 
insulin. No association with the time a subject had reported to be a consumer of tea 
was detected upon adjustment for the age, gender and the waist-to-hip ratio. The 
(poly)phenolic intake from cocoa beverages was negatively associated with uric 
acid. For other (poly)phenol-containing dietary products studied, only the 
consumption of herbs and spices was positively associated with glucose and the 
consumption of vegetables was positively associated with uric acid. Data suggested 
that a habitual consumption of coffee and associated components, specifically 
including (poly)phenols but not excluding other compounds, are more susceptible to 
have a higher impact on homocysteine than on cysteinylglycine, cysteine and 
glutathione, as assessed by the number of significant associations. Also a habitual 
consumption of tea did not have any effect on the selected biomarkers in the 
adjusted analyses. Finally, the observations of the present study cannot be 
extrapolated to a population that does not match the selection criteria of the present 
study. 
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6.2 Introduction 
 Biomarkers arise from normal metabolic processes and constitute a useful 
tool for the prediction, diagnosis and monitoring of health conditions, as well as for 
monitoring the impact of interventions (BDWG, 2001). In the present observational 
study, biomarkers of inflammation and cardiovascular health were monitored in the 
fasting plasma of a healthy adult population. Total aminothiols are frequently 
quantified as a measure of inflammation and cardiovascular health, and recently, a 
few substrate-to-product ratios within the transsulfuration pathway have been 
described (Mangoni et al., 2013). Higher concentrations of aminothiols may result 
from an increased synthesis and/or a decrease of degradation, while lower 
concentrations may result from a decreased synthesis and/or an increase of 
degradation. Substrate-to-product ratios between thiols have therefore been 
considered to be representative of the enzymatic activity in the transsulfuration 
pathway (Figure 3.1). As part of their research, Mangoni et al. measured the 
homocysteine-to-cysteine ratio as a marker of the cystathionine β-synthase and 
cystathionine γ-lyase activity, as well as the glutathione-to-cysteinylglycine ratio as 
a marker of the γ-glutamyltranspeptidase activity (Mangoni et al., 2013). 
Cystathionine β-synthase catalyses the synthesis of cystathionine from the 
condensation of homocysteine and serine, the initial reaction in the transsulfuration 
pathway (Figure 3.1). Cystathionine β-synthase-deficient humans and rats suffer 
from hyperhomocysteinemia and show earlier development of atherosclerosis, 
vascular disease and further non-cardiovascular conditions (Beard and Bearden, 
2011, Ishii et al., 2010). Cystathionine γ-lyase catalyses the hydrolysis of 
cystathionine into α-ketobutyrate and cysteine. As a result of a lack of activity or 
absence of the cystathionine γ-lyase, human patients exhibit increased levels of 
cystathionine in plasma and urine and lower levels of cysteine. The supplementation 
of the diet with cysteine has however, shown promising results with cystathionine γ-
lyase-deficient mice (Ishii et al., 2010, Paul et al., 2014), while a low cysteine diet 
led to lethal myopathy in the same mice (Ishii et al., 2010). The γ-
glutamyltranspeptidase catalyses the degradation of glutathione into cysteinylglycine 
and has been linked to a higher risk of developing adverse cardiovascular events, 
although the referenced research was conducted with T2DM patients (Sluik et al., 
2012). Mangoni et al. found lower serum cysteine, higher homocysteine and lower 
glutathione concentrations to be independently associated with cardiovascular risk 
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scores which were obtained from an equation taking into account the age, gender, 
systolic blood pressure, total and HDL cholesterol, smoking, diabetes, and 
electrocardiographic parameters of the left ventricular hypertrophy of subjects 
(Anderson et al., 1991, Mangoni et al., 2013).  
Circulating levels of glucose and one of its major regulating hormones, insulin, are 
finely balanced in order to maintain homeostasis and small variations of glucose lead 
to prompt pancreatic response for the secretion of insulin or glucagon (chapter 3). 
Imbalances in the glucose and insulin system may lead to diabetes and, 
subsequently, to cardiovascular events. As a result of genetic factors, lifestyle and 
environment, and despite the numerous prevention methods available, the incidence 
and prevalence of diabetes is increasing. Recently, 8.3 and 8.5 % of the global and 
European adult population, respectively, was estimated to suffer from diabetes. 
These numbers are predicted to reach 8.8 and 10.3 %, respectively, by 2035. Higher 
fasting glucose, as well as impaired glucose tolerance, which is characterized by 
abnormally elevated concentrations of glucose following a meal consumption, are 
considered to belong to a pre-diabetic state. Phenotypic features of diabetic patients, 
which include, but not exclusively, hyperglycaemia, hypertension and high levels of 
triglycerides and LDL cholesterol, put these subjects in a more vulnerable position 
in regards to developing cardiovascular and other health complications (IDF, 2013, 
Laakso and Kuusisto, 2014). For these reasons, the quantification of glucose, insulin 
and the insulin-to-glucose ratio are useful for identifying subjects at a higher risk of 
developing diabetes and subsequent complications that may lead to cardiovascular 
events. 
 The final biomarker investigated in the present study was uric acid. Although 
uric acid can eliminate singlet oxygen and free radicals, higher levels of circulating 
uric acid (hyperuricaemia) have been positively linked with a higher risk of 
developing gout (Choi et al., 2005, Roddy and Doherty, 2010, Wortmann, 2002). 
This condition, which is characterized by a long-term deposition of uric acid in the 
joints in the form of monosodium urate salt, has in turn been positively associated 
with insulin resistance, increased adiposity, hypertension, the metabolic syndrome 
and a higher risk for developing cardiovascular events (Choi et al., 2005, Richette 
and Bardin, 2010, Richette and Bardin, 2012, Roddy and Doherty, 2010, Terkeltaub, 
2010, Wortmann, 2002).  
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 Although the prevalence of hyperuricaemia and gout are known to be higher 
within the male population, women, most frequently menopausal and 
postmenopausal, are also affected (Choi and Curhan, 2010, Choi et al., 2005, 
Doherty, 2009, Richette and Bardin, 2010, Wortmann, 2002). The balance of both 
genetics and environmental factors influences the concentration of uric acid in the 
body, and hyperuricaemia often results from the combination of an insufficient 
urinary excretion, to a lesser extent from an excessive production, and from an 
excessive purine ingestion through diet (Choi et al., 2005, Richette and Bardin, 
2012, Roddy and Doherty, 2010, Terkeltaub, 2010, Wortmann, 2002). 
 How the uric acid level is affected by diet does not only depend on the 
administered dose, but also on the quality of the constituent purine precursors (Choi 
et al., 2005, Richette and Bardin, 2010, Roddy and Doherty, 2010). Thus, an RNA- 
and purine-rich diet from animal sources are higher contributors to the stocks of uric 
acid than DNA- and purine-rich vegetables, respectively. The latter have not been 
linked to any increase in uric acid and risk of developing gout. Furthermore, in a 
prospective study by Choi et al. with a healthy adult male population, alcohol 
consumption, more particularly beer followed by spirits, increased the risk of 
developing gout (Choi et al., 2004). Fructose was also shown to increase the 
circulating levels of uric acid (Choi et al., 2005). In the analysis of a large scale 
health and nutrition survey (NHANES-III), Choi and Curhan reported a negative 
association between the consumption of coffee, but not tea or caffeine, and the 
circulating levels of uric acid, after adjusting for age and gender (Choi and Curhan, 
2007). In a later cohort study, the same authors confirmed similar outcomes in a 
female adult population by reporting a negative association between long-term 
coffee consumption and the risk of developing gout. No association between the 
intake of caffeine in non-coffee consumers or the consumption of tea and the risk of 
developing gout was detected (Choi and Curhan, 2010). 
 Further factors associated with hyperuricaemia include an increased body 
mass index, waist-to-hip ratio, hypertension and insulin resistance. The mechanism 
by which hyperuricemia may be linked to insulin resistance may be an increased 
reabsorption of sodium through the proximal tubules of the nephron and a 
subsequent reduction of uric acid excretion in the urine (Wortmann, 2002). With the 
consumption of coffee having been positively associated with a lower concentration 
of insulin and increased insulin sensitivity, the negative correlation reported between 
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the consumption of coffee and the levels of circulating uric acid may be explained 
by the increased urinary excretion of uric acid resulting from the decreased levels of 
insulin (Choi and Curhan, 2010, Wortmann, 2002). 
 Hyperuricaemia is essential to develop into gout, but does not necessarily 
develop into the condition (Roddy and Doherty, 2010). The risk of hyperuricemia 
developing into gout is determined by the combination of multiple factors, which 
include the local physicochemical properties (Choi et al., 2005, Richette and Bardin, 
2010). Before developing into a chronic disease (gouty arthritis), gout is preceded by 
an asymptomatic hyperuricaemia stage and subsequent periods of acute gout attacks 
with asymptomatic intervals (Richette and Bardin, 2012). 
 Previous researches thus indicate that the quantification of biomarkers but 
also the correlation amongst themselves and with other variables, such as lifestyle 
and dietary habits, are key procedures to understand mutual effects and 
consequences on health. Significant correlations may be masked by confounders and 
the opposite, significant correlations may become non-significant when other 
confounders are taken into account. Therefore, it is important to conduct analyses 
adjusting for confounders. Numerous factors can be confounders but when 
performing a multiple regression analysis, it is not possible to take all of these into 
account at the risk of reducing the reliability of the results. The number of 
confounders introduced in the analysis is generally recommended to be 1 for every 
10 - 15 case number (Mangoni et al., 2013). 
 In the present chapter, the associations between selected biomarkers of 
inflammation and cardiovascular health themselves, and their association with non-
dietary and (poly)phenol-rich dietary lifestyle habits are investigated and discussed. 
Due to the vast amount of data, when adjusted analyses were conducted, only 
correlations that were significant upon adjustment for confounders are graphically 
presented.  
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6.3 Materials and methods 
6.3.1 Data collection and investigated relationships 
 The data analysed in the present chapter were obtained from the earlier 
described health assessment and food frequency questionnaires filled in by each 
participant and from the analysed plasma samples. The data collection and sample 
processing was discussed in earlier chapters (chapters 3 to 5). As a brief recall, 
besides the information on the age and gender, information on the anthropometrics, 
general daily habits, general (poly)phenol-rich dietary habits and concentration of 
selected inflammation and cardiovascular health biomarkers were collected for each 
participant. The weight, height, BMI, waist, hip and waist-to-hip ratio were recorded 
as the anthropometric measurements. Information on general daily habits included 
habits of physical activity, bowel movement frequency, smoking and alcohol 
consumption. Information on general (poly)phenol-rich dietary habits, included 
details on the consumption habits of coffee, tea, cocoa beverages, fruits, vegetables, 
herbs and spices, and supplements and vitamins together. Finally, the total 
aminothiols cysteine, homocysteine, cysteinylglycine and glutathione, as well as 
glucose, insulin and uric acid, were quantified in fasting plasma as the biomarkers of 
inflammation and cardiovascular health. 
 As the biomarkers of inflammation and cardiovascular health play a central 
role in the present study, the associations between the latter and relevant 
anthropometrics, general daily habits, general dietary habits and amongst themselves 
were investigated. In the present chapter a few new variables were introduced. As 
mentioned earlier, substrate-to-product ratios between aminothiols have been 
considered to be useful markers of enzymatic activity and for this purpose, the 
homocysteine-to-cysteine was measured to assess the activity of the cystathionine β-
synthase and cystathionine γ-lyase, while the glutathione-to-cysteinylglycine ratio 
was used to assess the activity of the γ-glutamyltranspeptidase. A further ratio, 
cysteinylglycine-to-cysteine, which was not found in literature, was introduced in 
order to assess the enzymatic activity of the dipeptidase responsible for the cleavage 
of cysteinylglycine into cysteine and glycine. 
 Due to the low percentage of reported smokers and former smokers, 
associations which included these variables were not part of the investigation. For 
the bowel movement, the data of one participant was excluded as it was assumed to 
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result from an error. Further investigation aimed at assessing the associations 
between the anthropometric variables and general daily and dietary habits. The 
associations between the general daily habits and with general dietary habits were 
assessed. The associations between (poly)phenol-rich dietary habits amongst 
themselves have already been discussed in chapter 4. Since the focus of the present 
study was not the anthropometrics or the general daily habits themselves, no 
relationship analysis amongst the variables within each of these categories was 
performed. Also, associations which included the height were not studied. 
 
6.3.2 Statistics 
 Statistical analyses of the present chapter were performed using the 
Microsoft Office Excel 2007 and IBM SPSS statistics 20 software packages. The 
first visit data set (baseline) of the complete population (n = 62) was taken into 
account. For the assessment of relationships, including the biomarkers of interest, 
the data sets of two subjects were excluded. These belonged to one subject that did 
not fast during the first visit and to another for which, due to fear of needles, no 
blood was withdrawn on the first visit. For this reason and due to the incomplete 
information provided by some subjects, the analyses rely on a maximal number of 
60 data sets and vary depending on the variables analysed. The data are expressed as 
mean ± standard deviation unless otherwise stated. When the analysis was limited to 
the relationship between two variables, this was performed by conducting simple 
correlation tests. When possible, a parametric Pearson's test was run. The presence 
of outliers was tested by visual inspection of scatter plots and boxplots. If outliers 
were detected and considered to be genuine unusual data points, these were included 
in the analyses unless otherwise stated. When outliers were detected and/or bivariate 
normality was not obtained, an alternative non-parametric Spearman's test was 
conducted. The differences between genders were assessed by running a parametric 
independent t-test or a non-parametric Mann-Whitney U-test. The associations 
between the anthropometrics, general daily habits and general (poly)phenol-rich 
dietary habits with age and gender have already been investigated and discussed in 
chapters 4 and 5, however the influence of both age and gender are assessed here on 
the newly introduced substrate-to-product ratios of the transsulfuration pathway and 
insulin-to-glucose ratio. 
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 All the relationships which included the biomarkers of health variables (i.e. 
biomarkers vs. biomarkers, biomarkers vs. anthropometrics, biomarkers vs. general 
daily habits and biomarkers vs. general (poly)phenol-rich dietary habits) were 
subsequently analysed in a model of multiple linear regression for the adjustment for 
age, gender and waist-to-hip ratio. When required, some of the continuous variables 
were subject to transformation in order to achieve homoscedasticity, a normal 
distribution of the residuals and to deal with influential outliers. These are specified 
in the relevant sections. For some variables, such as the consumption of cocoa 
beverages or the consumption of supplements, numerous subjects had a value of "0". 
Applying a transformation such as a log10 to these variables would result in a 
reduction of the data available. In order to overcome this issue, the value of "0.01" 
was added to each data point of the variables prior to transformation and is described 
in the relevant sections. 
 
6.4 Results 
6.4.1 Effect of gender, age on selected biomarkers of inflammation and 
cardiovascular health 
6.4.1.1 Influence of gender on selected biomarkers of health 
 No outlier was detected upon inspection of box plots and the distribution was 
normal in both groups for the cysteinylglycine-to-cysteine ratio (females: p = 0.066, 
males: p = 0.999). For this pair, the association with gender was tested by 
conducting a parametric independent samples t-test. The results of a Levene's test 
indicated that equality of variances between genders was met for the 
cysteinylglycine-to-cysteine ratio (p = 0.387). The difference of the means between 
the female (0.122 ± 0.029) and male (0.127± 0.026) populations was - 0.005 (95 % 
CI, - 0.021 to - 0.010) and was statistically not significant, t (58) = - 0.672, p = 
0.504. 
 A non-parametric Mann-Whitney U-test was conducted to assess the 
difference between gender for the glutathione-to-cysteinylglycine, the 
homocysteine-to-cysteine and the insulin-to-glucose ratios. For these variables, 
outliers were present and normality was not met. The distribution patterns of the 
- 164 - 
glutathione-to-cysteinylglycine ratio was similar for both genders, as assessed by 
visual inspection. The median glutathione-to-cysteinylglycine ratio was statistically 
significantly different between females (Mdn = 0.29) and males (Mdn = 0.24), U = 
249, z = - 2.368, p = 0.018 (Figure 6.1, A). The distribution of the homocysteine-to-
cysteine ratio was similar for both genders, as assessed by visual inspection. The 
median homocysteine-to-cysteine concentration was statistically significantly 
different between females (Mdn = 0.032) and males (Mdn = 0.034), U = 525, z = 
1.960, p = 0.050 (Figure 6.1, B). The distributions of insulin-to-glucose were similar 
for both genders, as assessed by visual inspection. The median insulin concentration 
was statistically not significantly different between females (Mdn = 1.85) and males 
(Mdn = 1.70), U = 297.5, z = - 1.613, p = 0.107.  
 
p = 0.018 p = 0.05A B
 
Figure 6.1: Significant differences between genders, in biomarkers of health 
measured in plasma at baseline. GSH-to-CysGly, glutathione-to-cysteinylglycine; 
HCys-to-Cys, homocysteine-to-cysteine. : non-extreme outlier (the data point is > 
1.5 box-length away from the corresponding plotted box edge), *: extreme outlier 
(the data point is > 3 box-lengths away from the corresponding plotted box edge). 
 
6.4.1.2 Influence of age on selected biomarkers of health 
 When the aminothiol substrate-to-product and insulin-to glucose ratios were 
analysed by the age, only cysteinylglycine-to-cysteine significantly correlated, rs 
(58) = - 0.398, p = 0.002 (Figure 6.2). This correlation is likely to be due to the 
cysteinylglycine, as cysteine had no significantly association with age, as seen in 
chapter 5. 
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rs = - 0.398
p = 0.002
 
Figure 6.2: Scatter plot representation of the only variable that revealed a significant 
association with the age at baseline. The significance of the association between 
cysteinylglycine and age observed in chapter 5 is a likely explanation for the 
significant correlation detected between the cysteinylglycine-to-cysteine ratio and 
age. CysGly-to-Cys, cysteinylglycine-to-cysteine. 
 
6.4.1.3 Influence of anthropometrics on selected biomarkers of health 
 When the associations between biomarkers of health and anthropometrics 
were tested, positive correlations were detected by running a Spearman's test, 
between the total concentration of cysteine and the weight, rs (58) = 0.420, p = 
0.001; BMI, rs (58) = 0.319, p = 0.013; waist circumference, rs (58) = 0.420, p = 
0.001; hip circumference, rs (58) = 0.273, p = 0.035; and waist-to-hip ratio, rs (58) = 
0.319, p = 0.013. Numerous positive correlations were also detected between the 
concentration of total homocysteine and anthropometrics. A Spearman's test 
revealed significant positive associations between total homocysteine and the 
weight, rs (58) = 0.398, p = 0.002; BMI, rs (58) = 0.334, p = 0.009; waist rs (58) = 
0.380, p = 0.003; waist-to-hip ratio, rs (58) = 0.321, p = 0.012; and systolic blood 
pressure, rs (57) = 0.363, p = 0.005. Cysteinylglycine was only significantly 
positively associated with the systolic blood pressure, as assessed by a Spearman's 
test, rs (57) = 0.396, p = 0.002. A Spearman's test detected negative associations 
between the concentration of total glutathione and the weight, rs (58) = - 0.260, p = 
0.044; BMI, rs (58) = - 0.278, p = 0.031; and waist circumference, rs (58) = - 0.257, 
p = 0.047. A negative association was also detected between the glutathione-to-
cysteinylglycine ratio and the weight, rs (58) = - 0.272, p = 0.035. The only 
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significant association with the cysteinylglycine-to-cysteine ratio was a positive 
correlation with the systolic blood pressure, as assessed by a Spearman's correlation 
test, rs (58) = 0.297, p = 0.023. When the associations between the homocysteine-to-
cysteine ratio and the anthropometrics were investigated, positive correlations were 
detected by conducting a Spearman's test, with the weight, rs (58) = 0.294, p = 
0.023; BMI, rs (58) = 0.279, p = 0.031; waist circumference, rs (58) = 0.282, p = 
0.029; and systolic blood pressure, rs (58) = 0.366, p = 0.004. Positive associations 
only were detected by a Spearman's test between the concentration of glucose and 
the weight, rs (58) = 0.399, p = 0.002; BMI, rs (58) = 0.395, p = 0.002; waist, rs (58) 
= 0.419, p = 0.001; and hip circumference, rs (58) = 0.393, p = 0.002. When the 
associations between the concentration of insulin at fast and the anthropometrics 
were tested by conducting a Spearman's test, a positive correlation was detected with 
the BMI, rs (58) = 0.266, p = 0.040. Finally, numerous significant associations were 
observed between the concentration of uric acid in plasma at fast and the 
anthropometrics. All of the latter were assessed by a Spearman's correlation test and 
were between uric acid and the weight, rs (58) = 0.457, p < 0.0005; BMI, rs (58) = 
0.274, p = 0.034; waist, rs (58) = 0.432, p = 0.001; and waist-to-hip ratio, rs (58) = 
0.497, p < 0.0005. 
 Upon adjustment for the age, gender and waist-to-hip ratio, fewer 
associations were detected. The concentration of total cysteine was positively 
associated with the weight, B = 0.79, t (58) = 2.36, p = 0.022; BMI, B = 0.21, t (58) 
= 2.01, p = 0.049; waist, B = 1.319, t (58) = 2.30, p = 0.025 and hip circumferences, 
B = 1.03, t (58) = 2.35, p = 0.022 (Figure 6.3, A-D). The cysteine and BMI variables 
were subject to a log10 transformation prior to the analysis between each other. The 
concentration of total homocysteine was only positively associated with the BMI, B 
= 0.73, t (58) = 2.38, p = 0.021 (Figure 6.3, E). Both variables were also log10-
transformed for the regression analysis. The association between the concentration 
of cysteinylglycine and the systolic blood pressure remained unchanged, B = 0.22, t 
(57) = 2.64, p = 0.011(Figure 6.3, F). All the associations between the concentration 
of glucose and the anthropometric variables were unchanged and glucose was 
positively associated with the weight, B = 0.02, t (58) = 3.02, p = 0.004; BMI, B = 
0.04, t (58) = 2.50, p = 0.016; waist circumference,  B = 0.03, t (58) = 3.17, p = 
0.002 and hip circumference, B = 0.02, t (58) = 3.11, p = 0.003 (Figure 6.3, G-J). 
Insulin remained positively associated with the BMI, B = 0.62, t (58) = 2.34, p = 
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0.023 (Figure 6.3, K). Both variables were subject to a log10-transformed for the 
regression analysis. The insulin-to-glucose ratio was newly positively associated, 
with the BMI, B = 0.52, t (58) = 2.05, p = 0.045 (Figure 6.3, L). The insulin-to-
glucose ratio and the BMI were log10-transformed prior to the regression analysis. 
Finally, the only significant association detected with uric acid was with the weight, 
B = 0.11, t (58) = 2.10, p = 0.041 (Figure 6.3, M). For this final regression, the uric 
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Figure 6.3: Scatter plot representation of the significant relationships at baseline 
observed between biomarkers of health in fasting plasma and anthropometric 
variables upon adjustment for age, gender and waist-to-hip ratio. The red data points 
indicate distinct and ambiguous outliers. pLMR, p-value obtained upon multiple 
regression, tCys, total cysteine; tHCys, total homocysteine; tCysGly, total 
cysteinylglycine; Glc, glucose; Ins, insulin; Ins-to-Glc, insulin-to-glucose; UA, uric 
acid; BMI, body mass index; Systolic BP, systolic blood pressure. 
 
6.4.2 Impact of general daily habits on selected biomarkers of health 
 All the associations between the biomarkers of health and variables of 
general daily lifestyle habits were tested by conducting a Spearman's correlation test 
due to the presence of outliers and/or the absence of bivariate normality, and when 
the bowel movement was part of the analysed pair, due to the ordinal nature of the 
variable. 
 Few statistically significant associations were detected within this category. 
The bowel movement was not associated with any of the biomarkers of health (p > 
0.05). Glucose was negatively associated with the physical activity score, as 
assessed by a Spearman's correlation test, rs (55) = - 0.284, p = 0.032. Positive 
associations were detected between the consumption of alcohol and 
cysteinylglycine, rs (58) = 0.524, p < 0.0005; the cysteinylglycine-to-cysteine ratio, 
rs (58) = 0.371, p = 0.004; and uric acid, rs (58) = 0.336, p = 0.009. Finally, a 
negative association was detected between the consumption of alcohol and the 
glutathione-to-cysteinylglycine ratio, rs (58) = - 0.402, p = 0.001. 
 Upon adjustment for the age, gender and waist-to-hip ratio, no new 
association was identified and the only unchanged statistically significant 
associations were between the consumption of alcohol and the fasting concentration 
of cysteinylglycine, B = 0.453, t (58) = 2.176, p = 0.034; the cysteinylglycine-to-
cysteine ratio, B = 0.002, t (58) = 2.110, p = 0.039 and the glutathione-to-
cysteinylglycine ratio, B = - 0.007, t (58) = -2.531, p = 0.014 (Figure 6.4 A-C). 








rs = - 0.402
pLMR = 0.014
 
Figure 6.4: Scatter plot representation of the significant relationships observed at 
baseline between biomarkers in fasting plasma and general daily lifestyle habits after 
adjustment for age, gender and waist-to-hip ratio. The red data points indicate 
distinct and ambiguous outliers. pLMR, p-value obtained upon multiple regression, 
tCysGly, total cysteinylglycine; CysGly-to-Cys, cysteinylglycine-to-cysteine ratio; 
GSH-to-CysGly ratio, glutathione-to-cysteinylglycine ratio. 
 
6.4.3 Impact of habitual consumption of coffee and other (poly)phenol-
rich products on selected biomarkers of health 
 The relationships between all the pairs were assessed by running a non-
parametric Spearman's correlation test due to the presence of outliers and/or the 
absence of bivariate normality. The analyses revealed a statistically significant 
association between the following pairs: the concentration of total cysteine and the 
time a subject had reported to be a consumer of coffee, rs (48) = 0.282, p = 0.047; 
the concentration of total cysteine and the coffee level, rs (50) = 0.326, p = 0.018; 
the concentration of total homocysteine and the weekly coffee consumption, rs (52) 
= 0.301, p = 0.030; the concentration of total homocysteine and the coffee level, rs 
(50) = 0.300, p = 0.030; the concentration of total homocysteine and the 
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consumption of supplements, rs (55) = - 0.275, p = 0.034; the concentration of total 
cysteinylglycine and the coffee level, rs (50) = 0.312, p = 0.025; the concentration of 
total cysteinylglycine and the time a subject had reported to be a consumer of tea, rs 
(50) = - 0.364, p = 0.009; the concentration of total glutathione and the coffee level, 
rs (50) = 0.307, p = 0.027; the concentration of total cysteinylglycine and the 
consumption of filtered coffee (rs (51) = 0.304, p = 0.027). This association suggests 
a beneficial effect from consuming coffee lacking the majority of diterpenes. 
Although coffee diterpenes are known to possess cholesterol-rising effects, in these 
have also shown anti-inflammatory effects in several in vitro experiments and, 
therefore, such an association was not expexted. Also associated were the 
cysteinylglycine-to-cysteine ratio and the time a subject had reported to be a 
consumer of tea, rs (50) = - 0.299, p = 0.035; the homocysteine-to-cysteine ratio and 
the weekly coffee consumption, rs (52) = 0.290, p = 0.037; the homocysteine-to-
cysteine ratio and the coffee level, rs (50) = 0.283, p = 0.042; the homocysteine-to-
cysteine ratio and the time a subject had reported to be a consumer of tea, rs (50) = - 
0.292, p = 0.040; the homocysteine-to-cysteine ratio and the consumption of 
supplements, rs (55) = - 0.307, p = 0.017; the concentration of glucose and the 
consumption of herbs and spices, rs (55) = 0.345, p = 0.007; the concentration of 
glucose and the consumption of arabic coffee, rs (52) = 0.277, p = 0.042. Arabic 
coffee is prepared with a mixture of spices (e.g. cardamom, saffron, cloves, 
cinnanon) which could contribute to this association, however only two subjects 
were regular consumers of this brew and this relation should not be considered. The 
concentration of insulin was negatively associated with the consumption of espresso 
(rs (51) = - 0.309, p = 0.025) and dark cocoa beverages (rs (53) = - 0.308, p = 0.022), 
however, as for the relation between glucose and arabic coffee, few subjects (n = 11 
for each beverages) were regular consumers and considering these relationships as 
definite would be borderline.The concentration of uric acid was negatively 
associated with the consumption of cappuccino (rs (51) = - 0.341, p = 0.012) and the 
intake of (poly)phenols from cocoa beverages (rs (53) = - 0.319, p = 0.018).  
 As for the previous relationships analysed, a fewer number of statistically 
significant associations were detected after adjustment for the age, gender and waist-
to-hip ratio. The concentration of total cysteine remained positively associated with 
only the time a subject had reported to be a consumer of coffee, B = 1.270, t (48) = 
2.632, p = 0.012 (Figure 6.5, A). Total homocysteine was positively associated with 
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both the weekly consumption of coffee, B = 0.117, t (52) = 3.010, p = 0.004, and the 
coffee level variable, B = 0.102, t (50) = 2.789, p = 0.008 (Figure 6.5, B and C). The 
concentration of total cysteinylglycine was positively associated with the coffee 
level variable, B = 0.054, t (50) = 2.243, p = 0.030 (Figure 6.5, D). The 
homocysteine-to-cysteine ratio maintained its positive association with both the 
weekly consumption of coffee and the coffee level, with B = 0.097, t (52) = 2.752, p 
= 0.009 and B = 0.083, t (50) = 2.483, p = 0.017, respectively (Figure 6.5, E and F). 
For the latter analyses, a log10 transformation was applied to the homocysteine-to-
cysteine ratio, the coffee level and the weekly consumption of coffee variables. The 
homocysteine-to-cysteine ratio was also negatively associated with the consumption 
of supplements, B = - 0.036, t (55) = - 2.079, p = 0.042 with a log10 transformation 
having been applied to the homocysteine-to-cysteine ratio and to the consumption of 
supplement variable + 0.01 (Figure 6.5, G). The concentration of glucose was 
positively associated with the consumption of herbs and spices, B = 0.010, t (55) = 
2.371, p = 0.021 and that of uric acid was negatively associated with the intake of 
(poly)phenols from cocoa beverages, B = - 0.28, t (53) = - 2.049, p = 0.046 (Figure 
6.5, H and I). 
 Numerous new significant associations were detected upon multiple 
regression. The concentration of total homocysteine was associated with the time a 
subject had reported to be a consumer of coffee and the intake of (poly)phenols 
through coffee preparations, with B = 0.100, t (49) = 2.142, p = 0.038 (Figure 6.5, J) 
and B = 0.117, t (55) = 2.876, p = 0.006 (Figure 6.5 K), respectively. For these two 
analyses, the three variables underwent a log10 transformation. The concentrations 
of total cysteinylglycine and glutathione were positively associated with the weekly 
consumption of coffee, with B = 0.133, t (52) = 2.158, p = 0.036 (Figure 6.5, L) and 
B = 0.049, t (52) = 2.008, p = 0.050 (Figure 6.5, M), respectively. The 
homocysteine-to-cysteine ratio was positively associated with the intake of 
(poly)phenols from coffee preparations, B = 0.096, t (53) = 2.578, p = 0.013 (Figure 
6.5 N). Finally, the concentration of uric acid was positively associated with the 
weekly consumption of coffee, B = 0.081, t (52) = 3.678, p = 0.0001 (Figure 6.5, O); 
the coffee level variable, B = 0.076, t (50) = 3.708, p = 0.0001 (Figure 6.5, P); the 
intake of (poly)phenols from coffee preparations, B = 0.074, t (53) = 2.974, p = 
0.005 (Figure 6.5, Q) and the consumption of vegetables, B = 0.046, t (52) = 2.364, 
p = 0.022 (Figure 6.5, R). 
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Figure 6.5: Scatter plot representation of the statistically significant correlations 
observed at baseline between biomarkers in fasting plasma and general 
(poly)phenol-rich dietary habits upon adjustment for age, gender and waist-to-hip 
ratio. The red data points indicate distinct and ambiguous outliers. pLMR, p-value 
obtained upon multiple regression, tCys, total cysteine; tHCys, total homocysteine; 
tCysGly, total cysteinylglycine; L-GSH, total glutathione; HCys-to-Cys ratio, 
homocysteine-to-cysteine ratio; Glc, glucose; UA, uric acid. 
 
6.4.4 Associations amongst biomarkers of health 
 The association between cysteine vs. cysteinylglycine, cysteinylglycine vs. 
cysteinylglycine-to-cysteine, cysteinylglycine vs. glucose, cysteinylglycine vs. uric 
acid and glucose vs. uric acid were analysed by running a Pearson's correlation test. 
Due to the presence of outliers and/or both variables in the analysed pairs not being 
normally distributed, all the other associations between biomarkers amongst 
themselves were tested by conducting a non-parametric Spearman's correlation test. 
The significant associations revealed by carrying out of a Pearson's or Spearman's 
test were between the following pairs: cysteine vs. homocysteine, rs (58) = 0.473, p 
< 0.0005; cysteine vs. uric acid, rs (58) = 0.451, p < 0.0005; homocysteine vs. 
cysteinylglycine, rs (58) = 0.374, p = 0.003; homocysteine vs. homocysteine-to-
cysteine ratio, rs (58) = 0.936, p < 0.0005; homocysteine vs. glucose, rs (58) = 0.273, 
p = 0.035; homocysteine vs. uric acid, rs (58) = 0.330, p = 0.010; cysteinylglycine 
vs. glutathione, rs (58) = 0.351, p = 0.006; cysteinylglycine vs. glutathione-to-
cysteinylglycine ratio, rs (58) = - 0.438, p < 0.0005; cysteinylglycine vs. 
cysteinylglycine-to-cysteine ratio, rp (58) = 0.887, p < 0.0005; cysteinylglycine vs. 
homocysteine-to-cysteine ratio, rs (58) = 0.369, p = 0.004; cysteinylglycine vs. uric 
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acid, rs (58) = 0.281, p = 0.029; glutathione vs. glutathione-to-cysteinylglycine ratio, 
rs (58) = 0.624, p < 0.0005; glutathione vs. cysteinylglycine-to-cysteine ratio, rs (58) 
= 0.271, p = 0.036; glutathione-to-cysteinylglycine ratio vs. cysteinylglycine-to-
cysteine ratio, rs (58) = - 0.419, p = 0.001; cysteinylglycine-to-cysteine ratio vs. 
homocysteine-to-cysteine ratio, rs (58) = 0.271, p = 0.036; glucose vs. insulin, rs (58) 
= 0.339, p = 0.008; and insulin vs. insulin-to-glucose ratio, rs (58) = 0.815, p < 
0.0005. 
 Upon analysis by multiple regression with adjustment for the age, gender and 
waist-to-hip ratio, the concentration of total cysteine remained significantly 
associated with total homocysteine (B = 2.842, t (58) = 3.181, p = 0.002) and uric 
acid (B = 161.964, t (58) = 2.353, p = 0.022) (Figure 6.6, A and B). Total 
homocysteine was significantly associated with total cysteinylglycine (B = 0.387, t 
(58) = 2.002, p = 0.050) and the homocysteine-to-cysteine ratio (B = 1.046, t (58) = 
21.451, p < 0.0005) (Figure 6.6, C and D). The three variables were subject to a 
log10 transformation. Total cysteinylglycine remained significantly associated with 
total glutathione (B = 0.931, t (58) = 2.841, p = 0.006), the glutathione-to-
cysteinylglycine ratio (B = - 30.118, t (58) = -3.137, p = 0.003) and with the 
cysteinylglycine-to-cysteine ratio (B = 209.040, t (58) = 14.479, p < 0.0005) (Figure 
6.6, E to G); total glutathione was significantly associated with the glutathione-to-
cysteinylglycine ratio (B = 20.360, t (58) = 6.962, p < 0.0005) (Figure 6.6, H); and 
the glutathione-to-cysteinylglycine ratio was significantly associated with the 
cysteinylglycine-to-cysteine ratio (B = - 0.578, t (58) = - 3.660, p = 0.001) (Figure 
6.6, I). Both variables were subject to a log10 transformation. Glucose was 
significantly associated with insulin (B = 0.009, t (58) = 3.150, p = 0.003) and 
insulin with the insulin-to-glucose ratio (B = 0.880, t (58) = 10.544, p < 0.0005) 
(Figure 6.6, J and K). Four new associations were revealed. Total cysteine was 
negatively associated with the cysteinylglycine-to-cysteine ratio (B = - 329.439, t 
(58) = - 2.776, p = 0.008) (Figure 6.6, L) and the glutathione-to-cysteinylglycine 
ratio with the insulin-to-glucose ratio (B = - 0.300, t (58) = - 2.071, p = 0.043) 
(Figure 6.6, M), while the homocysteine-to-cysteine ratio was positively associated 
with insulin (B = 0.271, t (58) = 2.010, p = 0.049) (Figure 6.6, N) and the insulin-to-
glucose ratio (B = 0.341, t (58) = 2.447, p = 0.018) (Figure 6.6, O). 
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Figure 6.6: Scatter plot representation of the statistically significant correlations 
observed at baseline between biomarkers in fasting plasma themselves upon 
adjustment for age, gender and waist-to-hip ratio. The red data points indicate 
distinct and ambiguous outliers. pLMR, p-value obtained upon multiple regression, 
tCys, total cysteine; tHCys, total homocysteine; tCysGly, total cysteinylglycine; 
tGSH, total glutathione; GSH-to-CysGly ratio, glutathione-to-cysteinylglycine ratio; 
CysGly-to-Cys, cysteinylglycine-to-cysteine ratio; HCys-to-Cys ratio, 
homocysteine-to-cysteine ratio; Glc, glucose; Ins, insulin; Ins-to-Glc, insulin-to-
glucose; UA, uric acid. 
 
6.4.5 Impact of habitual consumption of (poly)phenol-rich foods on the 
anthropometrics 
 No bivariate normality was observed in all pairs analysed between the 
anthropometric variables and the dietary lifestyle habits. The majority of the pairs 
also had outliers present, as detected by visual inspection of scatter plots. For these 
reasons, a Spearman's correlation test was conducted to assess the relationship 
between (poly)-phenol-rich dietary habits and the anthropometrics. Only one 
significant correlation was detected. This was a negative correlation between the 
years of tea consumption and the systolic blood pressure, rs (50) = - 0.328, p = 0.019 
Figure 6.7. 
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rs = - 0.328
p = 0.019
 
Figure 6.7: Scatter plot illustrating the only statistically significant correlation 
observed at baseline between the anthropometric and the general dietary habit 
variables, between the time a subject had declared to be a consumer of tea and the 
systolic blood pressure (BP). The red data points indicate distinct and ambiguous 
outliers. 
 
6.4.6 Association between the habitual consumption of (poly)phenol-rich 
products and general daily habits 
 No bivariate normality was observed between the possible pairs of general 
daily habits and the general dietary habits variables. Numerous outliers were also 
detected by visual inspection of scatter plots. A Spearman's correlation test was 
conducted to analyse the relationships between the variables in this category. There 
were five statistically significant associations detected. The bowel movement was 
positively correlated with the consumption of herbs and spices, rs (55) = 0.324, p = 
0.012 (Figure 6.8A). Alcohol was positively correlated with the consumption of 
fruits, rs (55) = 0.308, p = 0.015 (Figure 6.8B); fruits and vegetables, rs (55) = 0.289, 
p = 0.023 (Figure 6.8C); and herbs and spices, rs (55) = 0.333, p = 0.008 (Figure 
6.8D); and negatively correlated with the time a subject had been a tea consumer, rs 
(50) = - 0.283, p = 0.042 (Figure 6.8E). The positive association identified between 
the consumption of alcohol and that of fruits and vegetables could be explained by 
the positive statistically significant correlation between the consumption of alcohol 
and that of fruits, since no association was detected between the consumption of 
alcohol and the consumption of vegetables. 
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Figure 6.8: Statistically significant associations between the (poly)phenol-rich 
dietary habits and daily habits variables. Only few significant associations were 
revealed and most of them included the variable of alcohol consumption. The red 
data points indicate distinct and ambiguous outliers. 
 
6.5 Discussion and Conclusion 
 In the present chapter, the impact of a habitual consumption of coffee and 
other (poly)phenol-rich products on the anthropometrics and the biomarkers of 
health of interest, the influence of anthropometrics on the same biomarkers, as well 
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as the associations between biomarkers themselves were investigated in the study 
population. In a first stage, the relationship between two variables was assessed by 
conducting simple parametric and non-parametric tests of correlation. As a 
correlation between two variables may be masked or significant when analysed by 
simple correlation tests, multiple regression was used in a second stage in order to 
adjust for the simultaneous effect of selected risk factors for cardiovascular disease, 
namely the age, gender and waist-to-hip ratio. The waist-to-hip ratio was favoured 
over the BMI as it is a better indicator for abdominal adiposity. Unfortunately, due 
to the relatively small sample size when compared to epidemiological studies, the 
correction was limited to three confounders. Adjustment for further variables, such 
as the physical activity, the alcohol consumption and physiological measures may 
have been included; however, this would have resulted in a decreased statistical 
power. Multiple regression analysis was performed when in the pair analysed, one of 
the variables was a biomarker of health, this is, for the biomarkers vs. biomarkers, 
biomarkers vs. anthropometrics, biomarkers vs. general daily habits and biomarkers 
vs. (poly)phenol-rich dietary habits pairs. Some variables were subject to 
transformation in order to meet the conditions for running the analysis. Overall, 
fewer significant associations were identified upon multiple regression analysis, 
when compared to the bivariate analysis.  
 The lower homocysteine-to-cysteine and higher glutathione-to-
cysteinylglycine ratios observed in the female population  could suggest that females 
have a higher activity of cystathionine β-synthase and/or cystathionine γ-lyase as 
well as a higher activity of γ-glutamyltranspeptidase, when compared to men. A 
possible regulator of these enzymes would be estrogen, which would be in line with 
a report by Dimitrova et al. (2002). When Mangoni et al. (2013) reported the 
substrate-to-product ratios between homocysteine and cysteine and between 
glutathione and cysteinylglycine, data were not separated between gender, and no 
comparision can be made with the results obtained in the present research. From the 
substrate-to-product ratios tested,  only the cysteinylglycine-to-cysteine ratio 
decreased with the age, suggesting a lower enzymatic activity. Although a decreased 
hepatic activity with the age could be the cause of this observation, this was the only 
substrate-to-product ratio decreasing with age and few subjects were in the higher 
age range. To test this hypothesis, further subjects in the older age range would need 
to be tested. 
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 Numerous significant associations with the fasting concentration of total 
circulating aminothiols were detected. Some of the associations identified with total 
cysteine (i.e. weight, BMI, waist and hip circumferences, time a subject had reported 
to be a consumer of coffee) could suggest the following. Subjects likely to have a 
higher body fat content have a higher concentration of total cysteine and a link 
between the metabolism of lipids and cysteine may explain the association, which is 
consistent with previous reports by Elshorbagy et al. (Elshorbagy et al., 2008, 
Elshorbagy et al., 2009). The link between the metabolism of amino acids and that 
of lipids is the acetyl coenzyme A. The synthesis of the acetyl coenzyme A requires 
cysteine and once synthesized, it can be converted to fatty acids. Therefore, higher 
amino acids level would lead to more elevated fatty acids production. The time a 
subject had reported to be a consumer of coffee, but not any other variable of coffee 
or other (poly)phenol-rich product consumption was associated with the 
concentration of cysteine, suggesting little to no influence of (poly)phenols on this 
association. The positive association between cysteine and homocysteine observed 
in the present study is consistent with previous researches. Moat et al. detected a 
positive relationship between cysteine and homocysteine for subjects with 
concentrations of total homocysteine < 20 μM (Moat et al., 2001). Of note, the 
healthy subjects had an average age of 42 years old, which is 1.5 times that obtained 
in the present study (28 ± 8 years old). In a later study by Özkan et al., a similar 
outcome was reported for healthy subjects, however, the comparison with these 
reported data needs to be regarded carefully, as the contribution of other variables 
was not considered (Özkan et al., 2002). Finally, cysteine was positively a uric acid, 
and was negatively associated with the cysteinylglycine-to-cysteine ratio. Cysteine is 
a precursor of glutathione, taurine and by extension, of uric acid. Due to the lack of 
association between cysteine and glutathione, the data obtained suggest that in case 
of higher levels of cysteine, rather than the production of glutathione being 
stimulated, there is a shift towards the production of uric acid, putting subjects at a 
higher risk of developing hyperuricaemia.  
 The concentration of total homocysteine was positively associated with the 
BMI, which was also observed by Jacques et al. (2001) and Panagiotakos et al. 
(2005). In the present study, the time a subject had reported to be a consumer of 
coffee, the weekly coffee consumption, the coffee level and the intake of 
(poly)phenols through coffee preparations were associated with higher 
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concentrations of homocysteine. These associations suggest a homocysteine-rising 
effect from coffee components. Since the adjusted regression analyses did not reveal 
any significant asociations between individual coffee brews (e.g. espresso, latte, 
turkish) it was not possible to identify a particular influent beverage or specific 
component on the aminothiols. The concentration of circulating homocysteine has 
been reported to be influenced by the intake of food (Grubben et al., 2000, Jacques 
et al., 2001, Özkan et al., 2002). However, this observation cannot be generalized for 
all foods. Grubben et al. reported that the ingestion of higher amounts of dietary 
protein methionine, a precursor to homocysteine, did not influence the fasting 
concentration of homocysteine (Grubben et al., 2000). Upon analysis of samples 
from the Hordaland study, Nygard et al. identified a positive association between 
homocysteine and the consumption of caffeinated coffee brews (Nygard et al., 
1997). Of note, the The Hordaland study population consisted of healthy adults aged 
40 - 67 years old, which is higher than the average in the present study. The same 
was observed by other groups (Grubben et al., 2000, Urgert et al., 2000). Both 
referenced studies had a crossover design and in both studies, the amount of coffee 
administrated was high, 1 L, a volume which is likely to be consumed by only a 
minority of the coffee-consuming population. In the study by Grubben et al. (2000), 
unfiltered coffee was given to the study participants for two week and in the study 
by Urgert et al. (2000), filtered coffe was given for a period of four weeks. In the 
present study, the time a subject had reported to be a consumer of coffee, the amount 
of coffee consumed weekly, the coffee level and the (poly)phenolic intake from 
coffee preparations, but not any other reported (poly)phenol-rich product, were 
found to be associated with the concentration of total homocysteine after multiple 
regression, suggesting that caffeine and coffee (poly)phenols could possibly 
contribute to the observed associations. As (poly)phenols possess antioxidant 
properties, it would be coherent to detect no association or a negative association, 
however, a higher level of (poly)phenolic content, as assessed by a method described 
in chapter 4, does not take into account the content of other compounds with the 
potential to influence the concentration of homocysteine (Daly et al., 2009, Obeid 
and Herrmann, 2009). The data obtained in the present study also suggest that the 
habitual consumption of coffee and associated compounds, specifically including 
(poly)phenols but not excluding other compounds, are more susceptible to have a 
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higher impact on homocysteine than on cysteine. Homocysteine was associated with 
total cysteinylglycine and the homocysteine-to-cysteine ratio, which was expected. 
 The concentration of total cysteinylglycine was positively associated with the 
systolic blood pressure, the consumption of alcohol, the weekly consumption of 
coffee, the coffee level, the concentration of total glutathione and the 
cysteinylglycine-to-cysteine ratio, and was negatively associated with the 
glutathione-to-cysteinylglycine ratio. Özkan et al. reported no difference in the 
concentration of cysteinylglycine in healthy subjects which had never consumed 
alcohol and which consumed alcohol (Özkan et al., 2002). The results obtained in 
the present study cannot be compared to this outcome, as only two categories (i.e. 
coffee consumers vs non-consumers) were compared, contrarily to the present study 
where the consumption of alcohol was assessed on a continuous scale.  
 The concentration of total glutathione was positively associated with the 
weekly consumption of coffee and the glutathione-to-cysteinylglycine ratio only. 
Since a higher intake of coffee and associated components was associated with 
increased concentrations of homocysteine, cysteinylglycine and glutathione, 
potential mechanisms by which coffee components could contribute to an elevation 
of these aminothiols could be an inhibition of the conversion of homocysteine to 
methionine by the betaine homocysteine methyltransferase, and/or to cystathionine 
by the vitamin B6-dependant cystathionine β-synthase, an inhibition of the 
dipeptidase responsible for the hydrolyses cysteinylglycine into cysteine and 
glycine, and an increased activity of the glutathione synthetase, which catalyses the 
sysnthesis of glutathione from γ-glutamylcysteine. 
 The glutathione-to-cysteinylglycine ratio was negatively associated with the 
consumption of alcohol, the cysteinylglycine-to-cysteine ratio and the insulin-to-
glucose ratio. The cysteinylglycine-to-cysteine ratio was positively associated with 
the consumption of alcohol. The homocysteine-to-cysteine ratio was positively 
associated with the weekly coffee consumption, the coffee level, the intake of 
(poly)phenols from coffee preparations, insulin and the insulin-to-glucose ratio, and 
was negatively associated with the consumption of supplements. Although substrate-
to-product ratios in the transsulfuration pathway were used previously as an 
indicator of enzymatic activity and some were subject of analyses in the present 
study, the earlier described homocysteine-to-cysteine ratio (Mangoni et al., 2013) 
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and the newly introduced cysteinylglycine-to-cysteine ratio do not seem to be 
appropriate indicators of the enzymatic activity responsible for the corresponding 
reactions. In the transsulfuration pathway, cysteine can be obtained from the 
hydrolysis of cystathionine and the breakdown of cysteinylglycine in reactions 
catalyzed by the cystathionine γ-lyase and a peptidase, respectively (Himmelfarb et 
al., 2002). Measuring the above-mentioned ratios would therefore not distinguish 
between the cysteine obtained by either reaction. 
 Glucose was positively associated with the weight, the BMI, both the waist 
and the hip circumferences, the consumption of herbs and spices and insulin. The 
latter was positively associated with the BMI and the insulin-to-glucose ratio. The 
insulin-to-glucose ratio was positively associated with the BMI. The weight, BMI, 
waist and hip circumferences are all direct or indirect measures of body fat and 
therefore the associations observed with the ciculating concentrations of glucose and 
insulin are consistent with the link between three metabolic pathways. In a normal 
situation, upon elevation of glycemia, the secretion of insulin by the pancreatic β-
cells increases. Consequently, the endogenous glucose production by 
gluconeogenesis and glycogenolysis is inhibited and its uptake, utilization and 
storage in muscle and fat is stimulated (Saltiel and Kahn, 2001). During adipocyte 
lipolysis, triglycerides are hydrolysed into glycerol and fatty acids. While glycerol is 
converted to glyceraldehyde phosphate, an intermediate in both gluconeogenesis and 
glycolysis, fatty acids are subject to β-oxidation and enter the Krebs cycle in form of 
acetyl coenzyme A to contribute to the production of ATP (Campbell and reece, 
2002). In addition, circulating free fatty acids inhibit the insulin secretion and the 
glucose uptake in the muscle and stimulate the endogenous glucose production. 
Since the glycaemia is a result of the balance between the glucose anabolic and 
catabolic pathways, a hypothesis to explain the observed associations would be that 
in healthy subjects with higher levels of body fat also have higher levels of free fatty 
acids, which action overpowers that of insulin and thus resulting in a higher 
glycaemia. The positive association between uric acid and the weight, the weekly 
consumption of coffee, the coffee level, the intake of (poly)phenols from coffee 
preparations and the consumption of vegetables and the negative association with 
the intake of (poly)phenols from cocoa beverages, suggest a negative effect of coffee 
polyphenols on the circulating concentrations of uric acid. In two earlier studies, a 
negative association between uric acid and the consumption of coffee, but not tea, 
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were reported (Choi and Curhan, 2007, Kiyohara et al., 1999). In the referenced 
studies, the population size was larger, included a broader population age with an 
older age average and more subjects were representing the higher intake of coffee. 
These factors may contribute to a different outcome. 
 Further significant associations, which did not involve the biomarkers of 
health and whose analysis did not include adjustment for age, gender and waist-to-
hip ratio, were also identified. The time a subject had reported to be a consumer of 
tea consumption was negatively associated with the systolic blood pressure and the 
consumption of alcohol. The latter was positively associated with the consumption 
of fruits, fruits and vegetables and herbs and spices. There is no logical explanation 
to the remaining significant associations with the consumption of alcohol. These 
could, nonetheless, be due to a positive association with a different variable not 
taken into account in the statistical analyses.  
 No association was detected between the frequency of the bowel movement 
and the biomarkers of health and this could perhaps be explained by the fact that 
with a shorter transit time, toxic as well as health-promoting compounds remain for 
less time in the gastrointestinal tract, and therefore fewer amounts of either would be 
absorbed. This question may be attempted to be answered in an animal model, by 
comparing the effect on biomarkers of health of an exposure to "toxic" compounds 
and to compounds with protective properties. The gastrointestinal tract playing a 
central role in the absorption and metabolism of (poly)phenolic compounds, the 
analysis of the microbiota present in healthy subjects and subsequent association 
testing with biomarkers of health would therefore be of major interest to investigate 
the influence of populations and their density on the absorption and metabolism of 
(poly)phenols, as well as on biomarkers of health. 
 Overall, the variables of coffee consumption (i.e. time of consumption, 
weekly consumption, coffee level and (poly)phenolic intake) whether combined or 
individually, were linked to higher levels of total aminothiols, the homocysteine-to-
cysteine ratio and uric acid. The variables of tea consumption (i.e. time a subject had 
reported to be a consumer of tea and weekly consumption) were only associated 
with lower levels of cysteinylglycine. These could possibly be explained by a higher 
cleavage rate of cysteinylglycine into cysteine and glycine, as judged by the negative 
correlation between the consumption of tea and the cysteinylglycine-to-cysteine 
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ratio, prior to adjustment for age, gender and waist-to-hip ratio. Despite these results, 
it would be erroneous to conclude with certainty that the consumption of those 
beverages is responsible for the increase or decrease of the affected variables. 
Further predictor variables would have to be adjusted for. The lack of associations 
with individual brews could be due to the fact that not all subjects were regular 
consumers of all the suggested preparations, thus resulting in a narrower range of 
consumption for particular brews, when compared to the estimated polyphenolic 
intake. The advantage of the latter, is that for each reported brew, an index 
representative of the polyphenolic content was attributed (see section 4.4.3), which 
allowed a non-null value for each participant on a broader scale and consequently no 
statistical loss of power. 
 In general, the lack of significance of some relationships may be explained 
by the fact that the population for the present study was relatively young and in 
general good health, resulting in less marked variations in the selected biomarkers. 
In the present study, the compounds of coffee for which the attention was brought to 
were (poly)phenols. Other compounds, which include the cholesterol-raising 
diterpenes kahweol and cafestol, were not considered for the characterization of the 
beverages reported in the food frequency questionnaires completed by each 
participant. Furthermore, a positive association has also been reported between 
caffeine and homocysteine (Jacques et al., 2001). These compounds may thus 
explain some associations, such as the positive relationship between the level of 
(poly)phenols ingested with coffee preparations. Finally, for certain pairs tested, 
different outcomes have been reported in the literature. The main contributors to this 
difference are a diverging size and characteristics of the study population, a different 
study design and different analytical procedures. These discrepancies make the 
comparison with published work challenging. Therefore, the observations of the 
present study cannot be extrapolated to a population that does not match the 
selection criteria of the present study. 
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Chapter 7  
Bioavailability of coffee chlorogenic acids and circulating levels of 
selected biomarkers of health, and the influence of habitual 
consumption of coffee and other daily habits 
 
7.1 Abstract 
 In the present chapter, the high inter-individual variation observed in the 
metabolism of coffee phenolics (Renouf et al., 2010b) was aimed to be exploited for 
the identification of subjects with good and poor absorption and metabolism of 
coffee chlorogenic acids. The absorption of coffee chlorogenic acids within and 
between individuals, assessed by a colleague (Mr. Nicolai U. Kraut), was not 
consistent between the completed visits, as shown by high coefficients of variation 
between visits in the urinary excretion of chlorogenic acid-derived metabolites for 
some of the participants. (Poly)phenols have been reported to have beneficial effects 
on health, with a reduction of risk of developing some inflammation-derived 
degenerative diseases, however, the metabolic effect of any compound depends on 
how well these are absorbed. The impact of the absorption of coffee chlorogenic 
acids and its intra-individual variation on selected biomarkers of health was thus 
assessed, to evaluate whether subjects with a higher absorption of coffee chlorogenic 
acids have a better profile of selected inflammation and cardiovascular health 
biomarkers. Also, in order to assess whether the habitual consumption of coffee and 
some lifestyle habits have any impact on the absorption of coffee chlorogenic acids 
and its intra-individual variation, the relationships between the descriptive variables 
were assessed. As a measure of coffee chlorogenic acids absorption, six major 
derived metabolites were quantified in urine up to 36 hours post-consumption of a 
provided coffee beverage. Age- and/or gender-adjusted analyses only revealed few 
significant associations when the chlorogenic acid-derived metabolites were 
analysed together as a combined average, as opposed to when the metabolites were 
regarded individually. The habitual consumption of coffee, whether analysed by the 
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volumes or the (poly)phenols ingested, was related to a lower combined appearance 
of chlorogenic acid-derived metabolites, and when individually analysed, mainly 
with a lower urinary excretion of dihydrocaffeic acid 3-O-sulfate. Little influence of 
daily habits was detected on the absorption and metabolism of coffee chlorogenic 
acids. Also, gender, more than the age, was a more important determinant of the 
relationships of interest. Overall, the data suggested that a habitual consumption of 
coffee reduces the bioavailability of selected chlorogenic acids, that general daily 
habit have the potential, however little, to influence the bioavailability of 
chlorogenic acids and further researches targeting the colonic microbiota population 
may help understanding the link between the presence of certain chlorogenic acid-
derived metabolites and the inflammation and cardiovascular status in subjects. 
 
7.2 Introduction 
 Evidence for the beneficial role of (poly)phenols in the prevention of 
degenerative diseases has been reported (Manach et al., 2004, Scalbert et al., 2005, 
Vauzour et al., 2010, Chong et al., 2010, Higdon and Frei, 2006, Andersen et al., 
2006) and the consumption of (poly)phenol-rich products has been encouraged. The 
bioactivity of a compound, however, does not only depend on the amount ingested, 
but also on its bioavailability (Williamson and Manach, 2005), which in turn is 
influenced by numerous determinants, including the structure of the compound, its 
physicochemical properties, the food matrix and host factors such as the age, gender, 
medication, health status or microbial populations in the gastrointestinal tract 
(Manach et al., 2004, D'Archivio et al., 2010, Stalmach et al., 2014, Bohn, 2014, 
Shivashankara and Acharya, 2010). 
 (Poly)phenols and hence chlorogenic acids are processed as xenobiotics and 
therefore not stored in the organism. Upon release from the ingested food matrix, 
(poly)phenols undergo digestion in the stomach, under the combined action of 
pepsin, peristaltic movements and a low pH, and in the small intestine, where the 
increase of pH activates the enzymes secreted by the pancreas and bile (Bohn, 2014, 
van Duynhoven et al., 2011). While aglycones are readily absorbed by the 
enterocytes, the majority of the (poly)phenol esters first need to be hydrolysed, and 
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approximately 70 % of these structurally more complex (poly)phenols that are not 
absorbed in the small intestine pass through to the colon (Stalmach et al., 2010, 
Renouf et al., 2010b, Crozier et al., 2009). The absorbed compounds undergo phase 
I and II metabolism. Phase I metabolism, mainly consisting of a reduction, 
oxidation, hydrolysis or hydration, increases the hydrophilicity of the compounds 
and prepares them for phase II reactions by either the addition or the exposure of 
functional groups (Bohn, 2014, Scheepens et al., 2010). Phase II metabolism 
primarily includes sulfation, methylation and glucuronidation, and occurs in the 
intestine in the first place, where glucuronosyltransferases and sulfurotransferases 
have been identified. Once in the enterocyte, the compounds may be transported 
back into the intestinal lumen or into the blood. In the circulation, the (poly)phenol-
derived metabolites are distributed to the target tissues and organs, where they are 
available for further metabolism and/or biological activity. In the liver, phase I and 
II metabolism also takes place. The compounds which are not absorbed or which 
have been re-excreted into the intestinal lumen via the enterohepatic circulation (i.e. 
bile) or pancreatic secretions are subject to the enzymatic activity of the intestinal 
microbiota, which has the ability to deglycosylate, dehydroxylate, demethylate, 
deconjugate and hydrolyse the compounds amongst other properties. Finally, the 
excretion of the (poly)phenol-derived metabolites occurs via the urine, mainly, and 
the faeces (Bohn, 2014). The pharmacokinetics and pharmacodynamics of a 
compound will depend on the conditions of each stage of this complex chain of 
events, often abridged ADME for the absorption, distribution, metabolism and 
elimination processes. 
 Coffee is highly consumed worldwide and is rich in chlorogenic acids, which 
are esters formed between one molecule of quinic acid and one or more 
hydroxycinnamic acid(s). The contents of chlorogenic acids can reach 422 mg for a 
single espresso serving (Crozier et al., 2012). The three predominant chlorogenic 
acids in processed coffee are 5-caffeoyquinic acid and its two isomers, namely 3- 
and 4-caffeoylquinic acid. These three isomers can represent approximately up to 74 
% of the total chlorogenic acids present in coffee, as recently reported by Stalmach 
et al. (2014). 
 From previous in vivo human studies, the analysis of plasma and urine of 
subjects with an intact colon and the ileal effluent and urine of ileostomy patients 
has allowed the identification of the absorption sites of a number of chlorogenic 
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acids and their derivatives (Stalmach et al., 2009, Stalmach et al., 2010). In vitro 
studies have helped understanding some mechanisms involved in the metabolism of 
ingested chlorogenic acids and their derivatives (da Encarnação et al., 2014, Farrell 
et al., 2011, Plumb et al., 1999, Scherbl et al., 2014) and in their protective effects on 
health (Del Rio et al., 2013). Epidemiological studies have suggested beneficial 
effects of coffee consumption in regards to type 2 diabetes mellitus (van Dam and 
Hu, 2005, Oba et al., 2010), cardiovascular (Andersen et al., 2006, Mineharu et al., 
2011) and inflammation health (Andersen et al., 2006) with the intake of coffee, but 
to date, no research has investigated the link between the absorption and metabolism 
of coffee chlorogenic acids and the health status in humans. The aim of the present 
chapter was thus to assess the impact of the absorption and metabolism of major 
coffee chlorogenic acids in health human adult subjects on selected biomarkers of 
health measured in fasting plasma. The influence of habits of consumption of coffee 
and other daily habits on the bioavailability of coffee chlorogenic acids was also 
investigated. The novel perspective for studying the health effects of chlorogenic 
acids was to exploit the previously reported inter-individual variation in the 
metabolism of coffee phenolics (Renouf et al., 2010b) to rank the subjects from 
highest to lowest absorption and compare their profile of selected health biomarkers. 
 
7.3 Materials and methods 
7.3.1 Data sets and biological samples analysed 
 For the analyses of the present chapter, only the data sets of subjects which 
completed the three possible visits (n = 40) were included. However, from the 40 
participants, four sample sets were excluded. One of the excluded participants did 
not have any blood taken on the first visit, due to the fear of needles. The second 
excluded participant had blood taken on each visit, however, the participant had 
eaten one banana shortly before the first visit. The third and fourth excluded 
participants did not collect the urine sample in full, as self-reported. 
- 193 - 
 
7.3.2 Biomarkers and metabolites of interest 
 The biomarkers of health used for the analyses of the present chapter were 
the total aminothiols cysteine, homocysteine, cysteinylglycine and glutathione, 
glucose, insulin, the insulin-to-glucose ratio and uric acid. All were quantified in 
fasting plasma, as described in chapters 3 and 5. The thiol substrate-to-product ratios 
described in chapter 6, namely the glutathione-to-cysteinylglycine, the 
cysteinylglycine-to-cysteine and the homocysteine-to-cysteine ratios, were not part 
of the analyses, as these were judged to be insufficiently good indicators of the 
enzymatic activity within the transsulfuration pathway. In the transsulfuration 
pathway, cysteine can be obtained from the hydrolysis of cystathionine and the 
breakdown of cysteinylglycine in reactions catalyzed by the cystathionine γ-lyase 
and a peptidase, respectively (Himmelfarb et al., 2002), so that measuring the 
homocysteine-to-cysteine and cysteinylglycine-to-cysteine ratios does not 
distinguish between the cysteine obtained by either reaction. 
 As a reflection of the absorption and metabolism of coffee chlorogenic acids, 
a selection of chlorogenic acid-derived metabolites were quantified in urine. These 
were analysed by liquid chromatography linked to mass spectrometry (1200 series 
Agilent Technologies, Berkshire, UK) in the urine of each participant following the 
consumption of coffee. The latter consisted of 4 g "Green Blend" Nescafé instant 
Coffee (Nestlé) dissolved in approximately 300 mL boiling water. The subjects then 
collected the totality of the urine produced from 0 - 4, 4 - 8, 8 - 12, 12 - 24 and 24 - 
36 hours after the consumption of the beverage in separate containers. As notified in 
chapter 4, all the urine samples were processed and analysed by a colleague PhD 
student, Mr. Nicolai U. Kraut, and details other than the relevant data for the present 
chapter are not discussed in this manuscript. Six major urinary metabolites were 
identified in preliminary analyses by Mr. Nicolai U. Kraut. These were 
dihydrocaffeic acid-3-O-sulfate, feruloylglycine, vanilloylglycine, ferulic acid-4-O-
sulfate, dihydroferulic acid-4-O-sulfate and dihydroferulic acid and were therefore 
the metabolites of interest in the present study and chapter. For each subject, the 
chlorogenic acid-derived urinary metabolites were analysed combined and 
individually. For the analyses with the combined metabolites, the average of each 
chlorogenic acid-derived urinary metabolite was first summed for each visit. The 
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values obtained for the three completed visits were then averaged to obtain the 
variable referred thereafter as the "averaged sum of metabolites". For the analyses of 
the individual metabolites, the average of each chlorogenic acid-derived urinary 
metabolite was calculated from the three completed visits. All amounts of excreted 
urinary metabolites are the average ± standard deviation and expressed in µmol, 
unless otherwise stated. 
 
7.3.3 Impact of the absorption and metabolism of coffee chlorogenic acids 
and its intra-individual variation on selected biomarkers of health at 
fast 
To assess the impact of the absorption and metabolism of coffee chlorogenic acids 
and the intra-individual variation on the general inflammation and cardiovascular 
health status, simple correlation tests were carried out, followed by age and/or 
gender adjustment. The simple relationship between the averaged sum of 
metabolites or the individual metabolites and each biomarker of health was first 
investigated. As an indicator of the magnitude of intra-individual variation for each 
subject who completed three visits, the averaged coefficient of variation was 
obtained from the division by the averaged sum of metabolites of the corresponding 
standard deviation. The result was then multiplied by 100 to obtain a percentage. 
Simple correlation tests were then carried out between the coefficients of variation 
of the combined metabolites or the individual metabolites and each biomarker of 
health. 
 
7.3.4 Influence of habitual coffee consumption and general daily habits 
on the absorption and metabolism of coffee chlorogenic acids and 
its intra-individual variation 
 The influence of habitual coffee consumption and the influence of general 
daily habits on the absorption and metabolism of coffee phenolics was first 
investigated by carrying out simple correlation tests. In a further stage, the analyses 
were adjusted for the age and gender of the subjects. The information regarding the 
habits of coffee consumption included details on the time in years a subject had 
declared to be a coffee consumer, the weekly consumption of coffee, the coffee level 
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of coffee consumption variable ("coffee level") and the intake of (poly)phenols from 
coffee preparations ("coffee polyphenolic level"). The information regarding the 
general daily habits included details on the consumption of alcohol, the physical 
activity habits ("physical activity score") and the weekly frequency of bowel 
movements. The information was obtained by analysis of the food frequency 
questionnaire completed by each participant, as described in chapters 4 and 5. 
 
7.3.5 Statistical analyses 
 The simple correlation tests carried out consisted of either a parametric 
Pearson's or its non-parametric equivalent Spearman's correlation test. Bivariate 
normality was assessed by a Shapiro-Wilk test and the presence of outliers by visual 
inspection of scatter plots. Outliers were included in the statistical analyses unless 
these were assessed to be non-genuine unusual points. If bivariate normality was 
achieved, a Pearson's correlation test was run to assess the relationships of interest. 
If, on the other hand, bivariate normality was not achieved and/or that one of the 
analysed variables was ordinal or had any outlier, a Spearman's correlation test was 
carried out. 
 The same relationships, adjusted for age and gender, were examined in a 
model of linear multiple regression. Since the age and the gender are two 
determinants of the bioavailability of dietary (poly)phenols in humans (D'Archivio et 
al., 2010), an initial simultaneous adjustment for the age and gender was performed 
for all the studied pairs. As the number of data sets available was reduced to n = 36, 
a risk of statistical power loss was present. The pairs for which the p-value was < 
0.200 were therefore subjected to further analyses with separate adjustment for the 
age and gender. The distribution of the residuals was assessed by visual inspection 
of histograms and Q-Q plots. Data points were assessed as influential, when the 
corresponding distance of Cook D was D > 1. When influential data points were 
detected, the multiple regression analysis was first repeated upon exclusion of these. 
If the outcome differed from that obtained with inclusion of the influential data 
points, then, in order to reduce the effect of these on the trend of the relationship, a 
transformation was applied to the variable with the influential data points included. 
For clarity, the results only present the statistically significant detected associations. 
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7.4.1 Bioavailability of coffee chlorogenic acids and variability 
 An average of 882 μmol caffeoylquinic acids (i.e. 3-, 4- and 5-caffeoylquinic 
acid) were ingested with the consumption of the provided coffee prepared with 4 g 
"Green Blend" Nescafé. Amongst the six urinary metabolites analysed, 
dihydrocaffeic acid-3-O-sulfate, a metabolite absorbed in the colon, was excreted in 
highest amounts, with an average of 64.5 ± 53.3 μmol, followed by feruloylglycine 
with 49.6 ± 22.7 μmol, the newly identified vanilloylglycine with 40.4 ± 30.8 μmol, 
ferulic acid-4-O-sulfate with 38.0 ± 23.0 μmol, dihydroferulic acid-4-O-sulfate with 
28.0 ± 30.5 μmol and dihydroferulic acid with 17.7 ± 13.7 μmol (Figure 7.1). The 
averaged sum of metabolites ranged from 68.4 to 613.8 μmol with an average of 
238.2 ± 120.4 μmol. On average, a high intra-individual variation was observed and 
was translated into high coefficients of variation which ranged from an average of 
37 % for feruloylglycine, to as high as 54 % for dihydrocaffeic acid-3-O-sulfate. 
Due to the high intra-individual variability of the bioavailability of coffee 
chorogenic acids, it was not possible to categorise the study participants into either 
good or poor absorbers of chlorogenic acids, instead, the total population with three 
completed visits was ranked from lowest to highest absorbers of coffee chlorogenic 
acids and studied. 
 All outliers were assessed to be genuine unusual data points and therefore 
included in the subsequent statistical analyses. Two subjects showed a particularly 
high excretion of chlorogenic acid-derived urinary metabolites corresponding to 67.3 
and 69.9 %, respectively, of the ingested chlorogenic acids and indicative of a high 
absorption. Although these values could be a result of a deviation from the imposed 
dietary restrictions, the values do not exceed 100 % and therefore it would be 
borderline to exclude the corresponding data sets under the assumption that these 
participants have not complied with the diet restriction. 






































Figure 7.1: Absolute 36-hour excretion of the six major chlorogenic acid-derived 
urinary metabolites detected upon consumption of 4 g "Green Blend" Nescafé 
instant coffee (average from 36 participants). The large coefficients of variation 
(data not shown) and standard deviation error bars reflect a high intra- and inter-
individual variation. DHCA-3-O-S, dihydrocaffeic acid 3-O-sulfate; FA-GLY, 
feruloylglycine; VA-GLY, vanilloylglycine; FA-4-O-S, ferulic acid 4-O-sulfate; 
DHFA-4-O-S, dihydroferulic acid 4-O-sulfate; DHFA, dihydroferulic acid. 
 
7.4.2 Impact of the absorption and metabolism of coffee chlorogenic acids 
on the circulating levels of selected biomarkers of health at fast 
 Bivariate normality was not obtained by any of the biomarker vs. averaged 
sum of metabolites pairs tested. A Spearman's rank-order correlation test was thus 
run to assess the relationships between the averaged sum of excreted chlorogenic 
acid-derived metabolites in urine and the circulating concentration of cysteine, 
homocysteine, cysteinylglycine, glutathione, glucose, insulin and uric acid as well as 
the insulin-to-glucose ratio at fast. When the metabolites were analysed individually 
against each biomarker of health, bivariate normality was only observed for the 
cysteine vs. feruloylglycine, glutathione vs. feruloylglycine, and uric acid vs. 
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feruloylglycine pairs. For these same pairs, no outlier was detected and therefore a 
Pearson's correlation test was carried out the assess the relationship between these 
variables. A Spearman's rank-order correlation test was run to analyse the 
relationship between the remaining biomarkers and individual metabolites pairs. 
 Only one statistically significant association was identified when the 
metabolites were analysed as a combined average. This was a moderate positive 
association between the circulating concentration of insulin and the averaged sum of 
metabolites, rs (34) = 0.343, p = 0.041. When the metabolites were regarded 
individually, homocysteine was weakly positively associated with the excretion of 
vanilloylglycine, rs (34) = 0.334, p = 0.047; insulin was moderately positively 
associated with dihydrocaffeic acid-3-O-sulfate, rs (34) = 0.410, p = 0.013, and 
ferulic acid-4-O-sulfate, rs (34) = 0.464, p = 0.004; and the insulin-to-glucose ratio 
was weakly positively associated with dihydrocaffeic acid-3-O-sulfate, rs (34) = 
0.377, p = 0.023, and moderately positively associated with ferulic acid-4-O-sulfate, 
rs (34) = 0.416, p = 0.012. 
 Upon adjustment for age and gender, analysis of histograms and Q-Q plots 
indicated that all the residuals followed a normal distribution. Some outliers and 
leverage points were present, but none of them was influential, as assessed by 
inspection of Cook's distances (D < 1). The previously detected association between 
the averaged sum of metabolites and insulin was not significant upon adjustment, 
whether it was simultaneously adjusted for the age and gender, B = 0.036, t (34) = 
1.659, p = 0.107; or individually adjusted for the age, B = 2.139, t (34) = 1.594, p = 
0.120; or the gender, B = 2.446, t (34) = 1.745, p = 0.090. The circulating 
concentration of cysteinylglycine was negatively associated with the amount of 
excreted ferulic acid 4-O-sulfate, when the age and gender were simultaneously 
adjusted for, B = - 0.079, t (34) = - 2.264, p = 0.031; but not when individually 
adjusted for either the age, B = - 0.058, t (34) = - 1.456, p = 0.155; or the gender, B = 
- 0.069, t (34) = - 1.957, p = 0.059. Since the analysed population (n = 36) was 
rather small and a simultaneous adjustment of the age and gender may result in a 
slight deviation of the statistical power, it is safer to consider the results obtained 
from separate adjustment for the age or the gender. The circulating concentration of 
glutathione was negatively associated with the excreted feruloylglycine upon 
adjustment of both age and gender, B = - 0.025, t (34) = - 2.224, p = 0.033; and 
when the age was adjusted for, B = - 0.024, t (34) = - 2.245, p = 0.032; but not when 
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only the gender was taken into account, B = - 0.015, t (34) = - 1.351, p = 0.186 
(Figure 7.2, A). Furthermore, when individual adjustment for either the age or the 
gender was carried out on the relationships for which p < 0.200 was obtained upon 
simultaneous adjustment for the age and gender, glutathione was also related to an 
increase in urinary vanilloylglycine upon adjustment for the gender, B = 0.018, t (34) 
= 2.232, p = 0.033; but not upon adjustment for the age, B = 0.015, t (34) = 1.839, p 
= 0.075 (Figure 7.2, B); cysteine was related to the measured urinary vanilloylglyine 
when the influence of age was adjusted for, B = 0.262, t (34) = 2.095, p = 0.044; but 
not when gender was adjusted for, B = 0.209, t (34) = 1.731, p = 0.093 (Figure 7.2, 
C); and the insulin-to-glucose ratio was related to an increase in urinary 
dihydrocaffeic acid 3-O-sulfate upon adjustment for the gender, B = 1.78*10
-8
, t (34) 
= 2.090, p = 0.044; but not for the age, B = 1.52*10
-8
, t (34) = 1.707, p = 0.097 
(Figure 7.2, D). The number of significant associations was relatively small, when 
compared to the relationships analysed. These results, however, indicate that 
absorption and metabolism of coffee chlorogenic acids may influence the circulating 
levels of specific biomarkers of health. These results also suggest that the age and 
gender differentially determine some of these relationships. 




















































Figure 7.2: Scatter plot representation of the significant relationships between 
observed biomarkers of health and excreted chlorogenic acid-derived urinary 
metabolites, upon adjustment for the age and/or gender. The red-marked data points 
indicate outliers, which were, however, genuine and included in the analysis. pLMR, 
p-value obtained upon multiple regression, tCys, total cysteine; DHCA-3-O-S, 
dihydrocaffeic acid 3-O-sulfate; FA-GLY, feruloylglycine; tGSH, total glutathione; 
Ins-to-Glc, insulin-to-glucose ratio; VA-GLY, vanilloylglycine. 
 
7.4.3 Relationship between biomarkers and the magnitude of intra-
individual variability of absorption and metabolism 
 Bivariate normality was obtained with all the biomarker vs. coefficient of 
variation of the excreted metabolite pairs analysed, except for the homocysteine vs. 
coefficient of variation of the excreted metabolite pair. A Pearson's correlation test 
was therefore run to assess the relationship between the coefficient of variation of 
the excreted metabolites and the fasting concentration of cysteine, cysteinylglycine, 
glutathione, glucose, insulin, the insulin-to-glucose ratio and uric acid. A Spearman's 
test was run to assess the relationship between the coefficient of variation of the 
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excreted metabolites and the fasting concentration of homocysteine. Analysis of the 
correlation factors and corresponding p-values indicated no significant association 
within the pairs analysed. There was no significant association detected either 
between the biomarkers of health and the individual urinary metabolites (p > 0.05). 
 Similar to the influence of the absorption and metabolism of coffee 
chlorogenic acids on the circulating concentrations of selected biomarkers of health, 
upon adjustment for age and gender, inspection of histograms and Q-Q plots 
indicated a normal distribution of all the residuals. Some outliers and leverage points 
were also present, but none of them was influential, as assessed by inspection of 
Cook's distances (D < 1). None of the biomarkers of health was significantly related 
to the intensity of the intra-individual variability of the averaged sum of metabolites, 
whether the adjustment for the age and gender (p ≥ 0.154) was simultaneous or 
performed in separate analyses (p ≥ 0.151) and when the intra-individual variation 
for each individual metabolite was regarded, only the circulating concentrations of 
cysteine was associated with an increased intra-individual variation of urinary 
vanilloylglycine, when the gender, B = 0.292, t (34) = 2.054, p = 0.048; but not the 
age, B = 0.260, t (34) = 1.720, p = 0.095 was adjusted for (Figure 7.3). These results 
suggest that the intra-individual variation in the absorption and metabolism of coffee 
chlorogenic acids has very little to no influence on the circulating concentrations of 















Figure 7.3: Scatter plot representation of the only significant association detected 
between the coefficient of variation in the excretion of metabolites and the 
biomarkers of health. CV, coefficient of variation; pLMR, p-value obtained upon 
multiple regression, tCys, total cysteine; VA-GLY, vanilloylglycine. 
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7.4.4 Influence of habitual consumption of coffee on the absorption and 
metabolism of coffee chlorogenic acids 
 Bivariate normality was not obtained by any of the analysed pairs and 
therefore a Spearman's rank-order correlation test was run to assess the relationships 
of interest in this category. Although some relationships were close to achieve 
statistical significance, no association was detected between the averaged sum of 
metabolites in urine and the time one subject had been a coffee consumer, rs (31) = - 
0.053, p = 0.768; the weekly consumption of coffee, rs (34) = - 0.283, p = 0.094; the 
coffee level, rs (34) = - 0.321, p = 0.056; or the (poly)phenolic intake with coffee 
preparations, rs (34) = - 0.326, p = 0.052. When the metabolites were analysed 
individually against each variable of coffee consumption, the weekly consumption 
of coffee was negatively associated with the urinary excretion of dihydrocaffeic 
acid-3-O-sulfate, rs (34) = - 0.438, p = 0.008; and dihydroferulic acid-4-O-sulfate, rs 
(34) = - 0.377, p = 0.023. The "coffee level" variable was also negatively associated 
with dihydrocaffeic acid-3-O-sulfate, rs (34) = - 0.462, p = 0.005; and dihydroferulic 
acid-4-O-sulfate, rs (34) = - 0.388, p = 0.019. The additional variable characterizing 
the (poly)phenolic intake from coffee preparations, namely the "coffee polyphenolic 
level" variable, was negatively associated with dihydrocaffeic acid-3-O-sulfate, rs 
(34) = - 0.499, p = 0.002; and dihydroferulic acid-4-O-sulfate, rs (34) = - 0.402, p = 
0.015; as well as with dihydroferulic acid, rs (34) = - 0.331, p = 0.049. 
 Upon simultaneous adjustment for the age and gender, inspection of 
histograms and Q-Q plots indicated a normal distribution of all the residuals. Some 
outliers and leverage points were present, and some, as assessed by inspection of 
Cook's distances (D > 1), were also influential data points. The data treatment in the 
case of influential data points is discussed in the relevant section. When adjusted for 
both the age and gender, the intake of (poly)phenols from coffee preparations 
described by the "coffee (poly)phenolic level" variable was identified to be 
significantly associated with the averaged sum of metabolites, B = - 1.189, t (34) = - 
2.447, p = 0.020. Upon separate adjustment for the age or gender, the relationship 
remained significant, independently of whether the analysis was adjusted for the age, 
B = - 1.135, t (34) = - 2.330, p = 0.026; or for the gender, B = - 1.208, t (34) = - 
2.348, p = 0.025 (Figure 7.4, A). When the analysis was adjusted for the gender, an 
influential data point was detected and removed from the data set for a subsequent 
analysis. Upon exclusion of the influential data point the outcome was not 
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influenced, B = - 2.145, t (33) = - 2.436, p = 0.021. A few new significant 
associations were also identified. The weekly consumption of coffee was negatively 
associated with the averaged sum of metabolites, when the influence of gender, B = - 
2.677, t (34) = - 2.065, p = 0.047; but not when the age B = - 2.075, t (34) = - 1.611, 
p = 0.117 was taken into account (Figure 7.4, B). The "coffee level" variable was 
significantly negatively related to the averaged sum of metabolites, when adjusted 
for the gender, B = - 1.053, t (34) = - 2.115, p = 0.042; but not when adjusted for the 
age, B = - 0.769, t (34) = - 1.542, p = 0.133 (Figure 7.4, C). 
 When the impact of habitual consumption of coffee was assessed on the 
excreted individual chlorogenic acid-derived metabolites, the weekly consumption 
of coffee was associated with a decrease in urinary dihydrocaffeic acid 3-O-sulfate, 
when the age and gender were adjusted for simultaneously, B = - 1.162, t (34) = - 
2.033, p = 0.05. The relationship remained significant when the gender, B = - 1.322, 
t (34) = - 2.349, p = 0.025; but not the age, B = - 1.110, t (34) = - 1.932, p = 0.062, 
was taken into account, suggesting that the age, more than the gender is a 
determinant of this relationship (Figure 7.4, D). The intake of (poly)phenols from 
coffee preparations, described by the "coffee polyphenolic" variable, was associated 
with a decrease in urinary dihydrocaffeic acid 3-O-sulfate, B = - 0.491, t (34) = - 
2.203, p = 0.035 (Figure 7.4, E); and feruloylglycine, B = - 0.227, t (34) = - 2.474, p 
= 0.019, upon simultaneous adjustment for the age and the gender. When the age 
and gender were adjusted for separately, the "coffee polyphenolic" variable 
remained negatively associated with the urinary dihydrocaffeic acid 3-O-sulfate 
(age-adjusted: B = - 0.464, t (34) = - 2.072, p = 0.046; gender-adjusted: B = - 0.498, t 
(34) = - 2.169, p = 0.037), and the exclusion of an influential data point, identified 
when the analysis was adjusted for the gender, did not influence the outcome, B = - 
1.065, t (33) = - 2.778, p = 0.009. The relationship between the "coffee 
polyphenolic" variable and the urinary levels of feruloylglycine was not significant 
upon separate adjustment for either the age or gender (p > 0.05). As notified in 
section 7.4.2, the analysed population (n = 36) was rather small and a simultaneous 
adjustment for the age and gender may result in a slight deviation of the statistical 
power. For this reason, it is wiser to consider the results obtained from separate 
adjustment for the age or the gender. When individual adjustment for either the age 
or the gender was carried out on the relationships for which p < 0.200 was obtained 
upon simultaneous adjustment for the age and gender, the weekly consumption of 
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coffee was associated with lower amounts of urinary feruloylglycine upon 
adjustment for the gender, B = - 0.555, t (34) = - 2.318, p = 0.027; but not the age, B 
= - 0.447, t (34) = - 1.838, p = 0.075 (Figure 7.4.F). 
 The time that a subject has been a consumer of coffee, as self-reported, did 
not have any impact on the absorption and metabolism of coffee chlorogenic acids, 
however, the identified relationships suggest a potential effect of a habitual 
consumption of coffee preparations, on the absorption and metabolism of coffee 
chlorogenic acids, with a lower urinary excretion being associated with higher 
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Figure 7.4: Influence of a habitual consumption of coffee on the absorption and 
metabolism of chlorogenic acid upon adjustment for the age and/or gender. The red-
marked data points indicate the presence of outliers, which were included in the 
analyses, as these were considered to be genuine unusual data points. pLMR, p-value 
obtained upon multiple regression, DHCA-3-O-S, dihydrocaffeic acid 3-O-sulfate; 
FA-GLY, feruloylglycine. 
 
7.4.5 Influence of a habitual consumption of coffee and other 
(poly)phenol-rich products on the variation of the absorption and 
metabolism of coffee chlorogenic acids 
 Bivariate normality was not obtained by any of the analysed pairs. A 
Spearman's rank-order correlation test was therefore run to assess the relationships 
of interest. The correlation factors and corresponding p-values revealed no 
significant association in the pairs analysed and consequently, no indication of an 
influence of the habits of coffee consumption on the variation of the absorption and 
metabolism of tested coffee chlorogenic acids. The same was observed when the 
variation of each metabolite was analysed individually. 
 Upon adjustment for the age and gender, visual inspection of histograms and 
Q-Q plots indicated that all the residuals followed a normal distribution. Some 
outliers and leverage points were present, but none of them was identified to be 
influential, as assessed by inspection of Cook's distances (D < 1). No significant 
associations were detected within this category, indicating no influence of the 
habitual consumption of coffee on the variability of absorption and metabolism. 
 
7.4.6 Influence of general daily habits on the absorption and metabolism 
of coffee chlorogenic acids 
 Bivariate normality was not obtained by any of the analysed pairs. Also, due 
to the ordinal nature of the "frequency of bowel movement" variable, the three 
associations were tested by carrying out a Spearman's rank-order correlation test. 
The results indicated no association between the absorption and metabolism of 
selected coffee chlorogenic acids and the consumption of alcohol, rs (34) = - 0.193, 
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p = 0.258; the physical activity, rs (33) = - 0.228, p = 0.187; or the frequency of 
bowel movement, rs (34) = 0.068, p = 0.694. When regarded individually, no urinary 
metabolite was associated to either the consumption of alcohol, the habits of 
physical activity or the frequency of bowel movement (p > 0.05). 
 Upon adjustment for the age and gender, visual inspection of histograms and 
Q-Q plots indicated that all the residuals followed a normal distribution. Some 
outliers and leverage points were present, but none of them were influential, as 
assessed by inspection of Cook's distances (D < 1). The consumption of alcohol, the 
level of physical activity and the frequency of bowel movement remained unrelated 
to the amounts of excreted urinary metabolites, with B = - 9.454, t (34) = - 1.636, p = 
0.112; B = - 5.186, t (33) = - 1.767, p = 0.087; and B = 2.204, t (34) = 0.346, p = 
0.732, respectively. Since a p-value < 0.200 was obtained for the pairs that included 
the consumption of alcohol and the physical activity, a multiple regression with 
separate adjustment for the age or the gender was carried out. The outcome was not 
influenced for the impact of the alcohol consumption habits (age-adjusted B = - 
6.222, t (34) = - 1.140, p = 0.262, gender-adjusted B = - 5.303, t (34) = - 0.884, p = 
0.383) or the level of physical activity (age-adjusted B = - 4.244, t (33) = - 1.462, p = 
0.116, gender-adjusted B = - 5.904, t (33) = - 1.950, p = 0.060) on the absorption and 
metabolism of coffee chlorogenic acids. When the impact of daily habits was 
assessed on the individual excreted chlorogenic acid-derived metabolites, however, 
the consumption of alcohol was associated with lower amounts of urinary ferulic 
acid 4-O-sulfate upon simultaneous adjustment for the age and gender, B = - 2.705, t 
(34) = - 2.458, p = 0.020; but not upon separate adjustment (p > 0.05) and the 
relationship was therefore not considered. When individual adjustment for either the 
age or the gender was carried out on the relationships for which p < 0.200 was 
obtained upon simultaneous adjustment for the age and gender, a higher level of 
physical activity was associated with a lower excretion of urinary dihydroferulic 
acid 4-O-sulfate, when the gender, B = - 1.163, t (33) = - 2.097, p = 0.044; but not 
when the age was adjusted for, B = - 0.894, t (33) = - 1.583, p = 0.123 (Figure 7.5). 
These results indicate little influence from the tested daily habits on the absorption 
and metabolism of coffee chlorogenic acids. 
















rs = - 0.144
pLMR = 0.044
 
Figure 7.5: Impact of daily habits on the absorption and metabolism of chlorogenic 
acids upon adjustment for the age and/or gender. The red-marked data point 
indicates the presence of a genuine outlier and was therefore included in the 
analysis. pLMR, p-value obtained upon multiple regression, DHFA-4-O-S, 
dihydroferulic acid 4-O-sulfate. 
 
7.4.7 Influence of general daily habits on the variation of the absorption 
and metabolism of coffee phenolics 
 Bivariate normality was not obtained by any of the pairs analysed and all the 
associations were therefore tested by carrying out a Spearman's rank-order 
correlation test. The results indicated no association between the variation of the 
urinary excretion of selected coffee chlorogenic acids and the consumption of 
alcohol, the level of physical activity, or the frequency of bowel movement (p > 
0.05). One outlier present in the variable of frequency of bowel movement was 
excluded due to the unlikelihood of the value (i.e. one bowel movement per week). 
When the influence of the alcohol consumption habits, physical activity and bowel 
was assessed on the intra-individual variation of individual urinary metabolites, the 
consumption of alcohol was negatively associated with the variation of excretion of 
dihydrocaffeic acid 3-O-sulfate, rs (34) = - 0.410, p = 0.013; and that of 
dihydroferulic acid 4-O-sulfate, rs (34) = - 0.455, p = 0.005. Also, the frequency of 
bowel movement was negatively associated with the variation of excretion of 
dihydrocaffeic acid 3-O-sulfate, rs (34) = - 0.342, p = 0.041; feruloylglycine, rs (34) 
= - 0.394, p = 0.017; and ferulic acid 4-O-sulfate, rs (34) = - 0.345, p = 0.039. 
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 Upon adjustment for the age and gender, visual inspection of histograms and 
Q-Q plots indicated that all the residuals followed a normal distribution. The 
relationship between the variability of the combined metabolites and the 
consumption of alcohol, the level of physical activity or the frequency of the bowel 
movement remained non-significant. During the analysis with the "physical activity" 
variable, an influential data point was identified (Cook's D > 1). The exclusion of the 
latter did not influence the outcome, however, as an important decrease of the p-
value was observed, a subsequent analysis with inclusion of the influential data point 
and separate adjustment for the age and gender was performed. The results indicated 
the same outcome, with the relationships remaining non-significant, when the age or 
gender were adjusted for. When the variability of the urinary excretion was regarded 
individually for each metabolite, the frequency of bowel movement was negatively 
associated with dihydrocaffeic acid 3-O-sulfate, B = - 2.776, t (34) = 2.103, p = 
0.043. This relationship remained significant upon adjustment of either the age, B = - 
2.896, t (34) = - 2.175, p = 0.037; or the gender, - 2.797, t (34) = - 2.153, p = 0.039 
(Figure 7.6, A). The frequency of bowel movement was also negatively associated 
with ferulic acid 4-O-sulfate, B = - 2.090, t (34) = - 2.112, p = 0.043, with the 
relationship remaining unchanged upon adjustment of either the age, B = - 2.030, t 
(34) = - 2.063, p = 0.047; or the gender: - 2.087, t (34) = - 2.145, p = 0.039 (Figure 
7.6, B). When both the age and the gender where taken into account, no significant 
association between the frequency of bowel movement and feruloylglycine was 
identified, but due to the low p-value of 0.055, further investigations were carried 
out with individual adjustment for either the age or the gender. The results revealed 
a significantly negative relationship between both variables when either the age, B = 
- 1.890, t (34) = - 2.057, p = 0.048; or the gender, - 1.840, t (34) = - 2.011, p = 0.035 
were corrected for (Figure 7.6, C). 
 These results may be suggestive of an influence of the frequency of bowel 
movement on the intra-individual variation in the absorption and metabolism of 
coffee chlorogenic acids, however, the range observed in the frequency of bowel 
movement within the study population was very narrow. Also, 44 % of the 
participants shared the same frequency of bowel movement. Altogether, it may not 
be appropriate to conclude any relationship between the influence of the frequency 
of bowel movement on the variation of the absorption and metabolism of 
chlorogenic acid. 



































































rs = - 0.345
pLMR = 0.043
rs = - 0.342
pLMR = 0.043
rs = - 0.394
pLMR = 0.048
 
Figure 7.6: Scatter plot representation of significant relationships between selected 
daily habits and the variation of the absorption and metabolism of coffee chlorogenic 
acids. Purple-marked *, excluded outlier, due to the unlikelihood of the bowel 
frequency. CV, coefficient of variation; pLMR, p-value obtained upon multiple 
regression, DHCA-3-O-S, dihydrocaffeic acid 3-O-sulfate; DHFA-4-O-S, 
dihydroferulic acid 4-O-sulfate; FA-GLY, feruloylglycine; FA-4-O-S, ferulic acid 4-
O-sulfate. 
 
7.5 Discussion and conclusion 
 Whether a compound has biological effects will partly depend on its 
bioavailability, to what extent it is absorbed and metabolized. Studying the 
bioavailability of compounds is therefore important in order to understand their 
effect(s) on the organism. In the present chapter, the influence of the absorption and 
metabolism of coffee chlorogenic acids on the circulating concentrations at fast of 
selected biomarkers of inflammation and cardiovascular health was assessed. In a 
study by Renouf et al. (2010b), high inter-individual variations were reported in the 
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bioavailability of coffee phenolics. The inter-individual variation was aimed to be 
exploited in the present study in order to categorise the participants into good or 
poor absorbers of coffee chlorogenic acids. Due to the high intra-individual variation 
in the excretion of coffee chlorogenic acid-derived metabolites amongst the three 
completed visits, the categorisation of the study population was not possible and 
instead it was analysed as a single group. One possible explanation for this high 
intra-individual variation is the diet during the study. Although the diet of each 
participant was limited to low-(poly)phenol products, the same diet was not imposed 
upon the participants during the three visits. A plethora of factors, whether 
endogenous or exogenous, have been reported to influence the bioavailability of 
(poly)phenols (Bohn, 2014) and include, but not exclusively, the food matrix (e.g. 
fat contents, protein contents and other (poly)phenols), the structure of the 
compound, the amount of food simultaneously ingested and microbiota population. 
The latter is very likely one major cause behind the intra-individual variations 
observed. Recent research has indicated that diet is able to significantly affect the 
human microbiota (i.e. difference in diversity and metabolic activity), even in the 
short-term (David et al., 2014). Similar observations had previously been reported in 
a study by Jaquet et al. (2009), where, upon consumption of coffee at higher doses, 
over a period of three weeks, modifications of the microbiota population were 
observed, with an increase in number of Bifidobacterium spp. and, for some 
subjects, in metabolic activity. A standardization of the accompanying diet may 
therefore stabilize the microbiota populations, reduce the intra-individual variation 
and improve the identification of good and poor absorbers of coffee chlorogenic 
acids. To test this, the analysis of the populations, density and metabolic activity of 
the microbiota present in the faeces may give a better understanding of the 
differential metabolism observed for coffee chlorogenic acids and other 
(poly)phenols. 
 In further analyses, the relationships between habits of consumption of coffee 
and some general daily habits on the bioavailability of coffee chlorogenic acids and 
its intra-individual variability were investigated. Simple correlations tests were 
complemented by multiple regression analyses with adjustment for the age and/or 
gender, two known endogenous determinants of drugs and (poly)phenols 
bioavailability (D'Archivio et al., 2010). 
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 When the influence of the absorption and metabolism of coffee chlorogenic 
acids, on the circulating levels of selected biomarkers of health was assessed, no 
significant association was detected when the metabolites were analysed as an 
averaged sum, whether the analyses were adjusted for the age and/or the gender. 
When the relationships with individual chlorogenic acid-derived metabolites were 
assessed, glutathione was associated with higher urinary vanilloylglycine levels 
(gender-adjusted) and negatively associated with the feruloylglycine levels in urine 
(age- and gender-adjusted, and age-adjusted only). Cysteine was associated with 
higher levels of urinary vanilloylglycine (age-adjusted). Finally, the insulin-to-
glucose ratio was associated with higher levels of urinary dihydrocaffeic acid-3-O-
sulfate (gender-adjusted). Considering the number of associations tested, the 
significant associations were relatively few, however these are still suggestive of an 
influence of the bioavailability of coffee chlorogenic acids on specific biomarkers of 
health. All the associations detected between the selected biomarkers of health and 
coffee chlorogenic acid-derived metabolites involved colonic metabolites. The colon 
is home to about 10
12
 bacteria per gram of contents in the colon (Sekirov et al., 
2010). The gastrointestinal microbiota was shown to be a determining factor for the 
health status of the host metabolism (Tremaroli and Backhed, 2012) and may 
therefore also play an important in the profile of the selected biomarkers in the 
present study. Since about 70 % of the chlorogenic acids reach the colon, the 
bacteria responsible for the catabolism of these, could very well have an influence 
on the general health biomarkers. This would have to be tested by simultaneous 
analysis of selected biomarkers of health, microbiota in the faeces and their 
metabolic activity on (poly)phenols.  
 Given the reported benefits of (poly)phenols on health, it would be coherent 
that a high bioavailability of such compounds would result in a lower presence of 
biomarkers of degenerative diseases and/or higher presence of biomarkers of "good" 
health. In the present study, few associations were identified. As the study 
population was a group of healthy adults, it is possible that smaller variations in the 
biomarkers were observed than if a group of subjects suffering from an 
inflammatory or cardiovascular condition had also been included. 
 A negative association between the absorption and metabolism of coffee 
chlorogenic acids and the intake of (poly)phenols from coffee preparations was 
detected upon the simultaneous or separate adjustment for the age and gender and 
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with or without inclusion of a detected influential data point. The weekly 
consumption of coffee and the intake of (poly)phenols from coffee preparations (i.e. 
"coffee level" and "coffee polyphenolic level" variables) were all negatively 
associated with the total excretion of metabolites in adjusted analyses. The "coffee 
polyphenolic level" variable was also associated with a lower urinary excretion of 
dihydrocaffeic acid-3-O-sulfate (age- and/or gender-adjusted), the major urinary 
metabolite of coffee chlorogenic acids. A higher weekly consumption of coffee was 
associated with a lower urinary excretion of dihydrocaffeic acid-3-O-sulfate (age- 
and gender-adjusted, and gender-adjusted only) and feruloylglycine (gender-
adjusted). Although a relatively broad time of long-term coffee consumption (1 - 40 
years) was observed and was likely to be sufficient to observe any effect, if there 
were any, the time that a subject had declared to be a consumer of coffee did not 
have any impact on the absorption and metabolism of coffee chlorogenic acids. This 
outcome could be explained by the fact that a subject that has been consuming 
coffee for a longer time does not necessary have a higher intake of coffee. As an 
example, one subject may consume three coffees per week and be a coffee consumer 
for 10 years, while a different subject may consume twenty-one coffees per week, 
and be a coffee consumer for 4 years. The consumption of coffee may have a more 
important effect on the second subject. The identified relationships are suggestive of 
a potential effect of a habitual consumption of coffee preparations, in terms of 
volume ingested and (poly)phenolic intake, on the absorption and metabolism of 
coffee chlorogenic acids, with a lower urinary excretion being associated with higher 
intakes of coffee preparations. In a recent research investigating the impact, although 
acute, of the dose of ingested chlorogenic acids with a coffee beverage on the 
bioavailability of coffee chlorogenic acids, a higher dose was associated with a 
reduced urinary excretion of chlorogenic-derived metabolites. Taking into account 
the previously reported data from Erk et al. (2012), Stalmach et al. (2014) suggested 
a reduced bioavailability of coffee chlorogenic acids upon consumption of higher 
levels of chlorogenic acids. The results obtained in the present study would be in 
line with those of Stalmach et al. (2014) and it could additionally be suggested that 
habitual consumption of higher amounts of coffee and stronger coffee preparations 
in terms of (poly)phenolic contents are associated with a reduction of bioavailability 
of coffee chlorogenic acids in healthy adults. The obtained results could, however, 
also indicate that there is a shift toward the metabolism of other metabolites that 
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were not measured. The negative correlation observed between the variables of 
coffee consumption and dihydrocaffeic acid-3-O-sulfate could partly be explained 
by the ability of coffee compounds, to inhibit the SULT1A1 and SULT1A3 
(Okamura et al., 2005), the two main sulfotransferases responsible for the sulfation 
of dihydrocaffeic acid (Wong et al., 2010). 
 No association between the consumption of alcohol, the habits of physical 
activity or the frequency of bowel movement and the absorption and metabolism of 
the combined metabolites was identified. However, when regarded individually, a 
lower urinary excretion of dihydroferulic acid 4-O-sulfate was associated with a 
higher level of physical activity. These results indicate that although the impact may 
be limited, daily habits are susceptible to influence the absorption and metabolism of 
coffee chlorogenic acids. Since the absorption of chlorogenic acids and derived 
metabolites occurs in the gastrointestinal tract, a significant relationship was 
expected between the frequency of bowel movement and the metabolites, whether 
regarded as a summed average or individually. This was not the case. One possible 
explanation would be the relatively narrow range of frequencies observed in the 
study population. 
 Finally, the intra-individual variation in excretion of metabolites had little to 
no influence on the circulating biomarkers and was not influenced by the habitual 
consumption of coffee, alcohol, the level of physical activity or the frequency of 
bowel movement. 
 The simultaneous adjustment of the age and gender is important, however, 
only 40 subjects completed the three possible study visit and 4 data sets were 
excluded. The simultaneous adjustment for the age and gender can result in a loss of 
statistical power and missing significant associations. In order to overcome this 
issue, a separate adjustment for the age and gender was performed for the pairs for 
which p < 0.200 was obtained upon a simultaneous adjustment of the age and 
gender. The results revealed a number of new and interesting significant 
associations. The results from the present study emphasize the importance of 
studying the bioavailability of (poly)phenols to understand the health effects of these 
phytochemicals. Standardizing of the accompanying diet may reduce the intra-
individual variability observed through the excreted coffee chlorogenic acid-derived 
metabolites. Also, a study of the colonic microbiota will be relevant to assess 
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whether these can explain the relationships observed between selected biomarkers of 
health and some colonic coffee chlorogenic acid-derived metabolites. Finally, in 
vitro experiments testing the ability of different coffee compounds to inhibit 
SULT1A1 and SULT1A3 will help understanding whether a higher consumption of 
coffee can explain the decrease in chlorogenic acid-derived sulfated metabolites or 
whether other dietary factors are also significant contributors. The focus in the 
present study was on coffee chlorogenic acids, however it is likely that similar 
relationships would be observed if other (poly)phenols were targeted. 
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Chapter 8  
Summary, future perspectives and conclusion 
8.1 Purpose of the investigations and outcome  
 (Poly)phenols are plant secondary metabolites playing an important role in 
the protection from external stresses such as UV radiation, infection by pathogenic 
microorganisms, or protection from herbivores and have often been associated with 
a reduction in the risk of developing certain chronic conditions (Crozier et al., 
2006b, Manach et al., 2004, Petti and Scully, 2009). The effect of their consumption 
on health has thus attracted increased attention. Coffee, one of the most consumed 
beverages worldwide, is rich in chlorogenic acids, a family of quinic acid esters 
formed with one or more molecules of hydroxycinnamic acids (Clifford, 1985, 
Fraga, 2010). A regular consumer of coffee can easily reach a daily intake of 1 g of 
chlorogenic acids (Clifford, 2000), but these, like any other compound, need to be 
absorbed in order to have an influence on the metabolism. The importance of 
conducting bioavailability studies in humans is undeniable. Since the intact 
(poly)phenols are hardly absorbed in their unmodified chlorogenic acid form, their 
metabolites are most likely the compounds responsible for the biological activity. As 
a brief reminder, once ingested, chlorogenic acids are released from the food matrix. 
The first site of absorption has been reported to be the stomach, where esterase 
activity has been detected (Farrell et al., 2011). The compounds which are not 
absorbed reach the small intestine where a higher pH of 6 - 7 favours the activation 
of enzymes secreted by the pancreas and from the bile and thus allowing the 
absorption of further compounds. Finally, the chlorogenic acids which are not 
absorbed in the small intestine (approximately 70 %) or which have been absorbed 
and re-excreted into the gastrointestinal lumen reach the colon, where an abundant 
population of microbiota efficiently cleaves the majority of chlorogenic acids. The 
absorbed compounds undergo phase I and II metabolism which render the 
compounds more water-soluble and therefore facilitate their excretion, usually in the 
urine, but also in the faeces. The compounds that have not been absorbed in any of 
the segments of the gastrointestinal tract will be excreted via the faeces (Bohn, 2014, 
van Duynhoven et al., 2011). Measuring the metabolites excreted in urine, mainly, 
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and in faeces is thus a useful tool to evaluate the bioavailability of chlorogenic acids 
as these are a good reflection of the absorption and metabolism of the parent 
compounds. In the present thesis, the effect on health of a habitual consumption of 
popular (poly)phenol-rich products, with emphasis on coffee, was investigated. 
 
 The questions raised and aimed at to be answered with the present PhD thesis 
were described in section 1.3 (Chapter 1). No investigations on the effect of roasting 
or decaffeination of the free phenolic profile in coffee was previously reported, 
neither was the contribution of free phenolics present in a regular cup of coffee to 
the early appearance (i.e. up to 3 hours upon consumption of the beverage) of 
derived metabolites in plasma. In an attempt to answer questions 1 and 2, chapter 2 
reports the analysis of six major hydroxycinnamic acids in five different soluble 
coffees. These were, although present in much lower amounts than chlorogenic acids 
(Hoelzl et al., 2010), present in higher amounts than their respective limit of 
detection and for some, the limit of quantification. As observed with chlorogenic 
acids and other (poly)phenols, processing affects the (poly)phenolic profile of edible 
plant-derived products (Clifford, 1999, Manach et al., 2004), and decaffeination and 
roasting of coffee seems to result in a lower content of free phenolic acids. Using 
pharmacokinetic modelling, the contribution of these same free phenolic acids 
present in coffee to the early presence of respective metabolites in plasma following 
the consumption of a regular cup of coffee was assessed to be non-significant. 
Additional in vitro work performed by Mr. Nicolai U. Kraut and former colleague 
Dr. Tracy Farrell with Ms. Alexandra Ryder investigating the esterase activity of 
pancreatic secretions and preparations of Caco-2 cells monolayers on coffee and 
major chlorogenic acids suggested that the hydrolysis of more complex compounds, 
such as chlorogenic acids, are major contributing mechanisms to the pool of plasma 
metabolites observed up to three hours following the consumption of the beverage. 
The hydrolysis of 5-caffeoylquinic acid by pancreatic esterases and 3-caffeoylquinic 
acid by the small intestinal brush border esterases was the most abundant. Although 
a minimal contribution of free hydroxycinnamic acids to the pool of corresponding 
free metabolites in plasma was expected, no research had previously been done on 
whether these were present in sufficient quantities in order to significantly contribute 
to the presence of derived metabolites in plasma resulting from a pre-colonic 
absorption. 
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 To answer questions 3 to 7 the most appropriate methods with high 
repeatability and recovery were sought. Chapters 3 and 5 described the optimisation 
and validation of the different methods used for the recruitment of the study 
population using a health assessment questionnaire, the assessment of their dietary 
habits using food frequency questionnaire, the record of their anthropometrics, and 
the withdrawing, processing and analysis of the blood samples. When compared to 
the method of Pfeiffer et al. (1999), used as a reference for the optimisation of the 
aminothiol detection method, the chromatographic separation was improved. 
Overall, the methods specific for the biomarkers of interest had a good 
reproducibility and recovery, and particularly for the measurement of glucose and 
uric acid, were time efficient. 
 Question 3 was answered in chapter 4, where the recruited population was 
characterized in terms of the habitual consumption of coffee, tea and cocoa 
beverages, three popular non-alcoholic (poly)phenol-rich products. The recruited 
population had a weekly consumption of coffee higher than the estimated UK 
average, a higher total tea consumption when compared to coffee, corresponding to 
the estimated average consumption in the UK and a minimal cocoa consumption. 
Overall, in the studied population, subjects with a higher (poly)phenolic intake from 
a particular product were more likely to consume more of other (poly)phenol-rich 
products. 
 Question 4 was answered in chapter 5, with the characterization of the study 
population in terms of non-dietary daily habits, anthropometric and biomarkers of 
health. The study population was in general good health, as assessed by their 
circulating fasting levels of inflammation and cardiovascular health biomarkers. All 
the anthropometric features were stable over a period of at least 8 weeks and only 
two of the biomarkers, namely cysteinylglycine and glutathione, were not consistent 
over the study period. However, the obtained coefficients of variation were 
suggestive of a little intra-individual variation. It can thus be concluded that the 
tested biomarkers of health were in general stable over a period of at least 8 weeks. 
  Question 5 was addressed in chapter 6, where the habitual consumption of 
popular (poly)phenol-rich products such as coffee, tea and cocoa beverages, as well 
as fruits, vegetables and supplements was analysed for associations with the 
different inflammation and cardiovascular health biomarkers levels in plasma. From 
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the obtained results, it cannot be concluded that a higher consumption of 
(poly)phenol-rich products is associated with a better profile for the selected 
biomarkers of health. Overall, a higher consumption of (poly)phenol-rich products 
was not associated with a healthier profile of glucose metabolism, which is in line 
with observations from van Dieren (2009) et al., Kempf et al. (2010) and Carter et 
al. (2010) for the consumption of coffee, tea (mainly black) and fruit and vegetables. 
Yamaji et al. (2004), however, reported a lower fasting glucose for consumers 
consuming ≥ 5 cups coffee per day inflammation or cardiovascular health. Of note, 
in the present study, only 4 subjects had a regular daily coffee consumption ≥ 5 
cups. Grubben et al. (2000) and later Kempf et al. (2010), reported higher levels of 
homocysteine and some biomarkers of inflammation, respectively, for relatively 
high consumption of coffee. These were observed after a daily consumption of 1 L 
unfiltered coffee for 2 weeks, in a healthy adult population (Grubben et al., 2000) 
and 8 cups filtered coffee for 1 month, in a healthy but at higher risk of developing 
T2DM adult population. Although the study designs differ, the results of the present 
study are in line with these observations and suggests that a regular lower 
consumption is also able to increase the levels of biomarkers of inflammation and 
cardiovascular health. From two combined cohort studies, De Koning Gans et al. 
(2010) reported a lowest hazard ratio for coronary heart disease for a daily 
consumption of 2.1 to 3 cups coffee, but found no association with the incidence of 
stroke. On the contrary, in a meta-analysis of 11 prospective cohort studies, Larsson 
and Orsini (2011) reported a U-shape relationship between the consumption of 
coffee and the incidence of stroke, with the lowest reduction of relative risk for a 
daily consumption of 3 - 4 cups. In regards to the habitual combined consumption of 
fruit and vegetables and its impact on selected biomarkers of health, no association 
was detected with any of the biomarkers tested in the present study. This is in 
agreement with a meta-analysis carrier out by Carter et al. in regards to the 
combined consumption of fruit and vegetables, however, a higher consumption of 
green leafy vegetables was associated with a lower incidence of type 2 diabetes 
mellitus (Carter et al., 2010). In the present study, the specific effect of habitual 
consumption of green leafy vegetable was not investigated and therefore, a different 
outcome cannot be excluded if this had been analysed.  
 Questions 6 and 7 were addressed in chapter 7, where the associations 
between variables describing the habitual consumption of coffee and the excretion of 
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major chlorogenic acid-derived metabolites were investigated. Although few 
significant associations were identified, the detected associations may suggest a 
possible influence of the bioavailability of coffee chlorogenic acids on specific 
biomarkers of health, in healthy adults. As the human gastrointestinal microbiota has 
shown variations shortly after dietary changes and due to the fact that these are 
important determinants of the host metabolism and immune system, it is suggested 
here that the microbiota is an important link between the bioavailability of coffee 
chlorogenic acids or other (poly)phenols and specific biomarkers of health. Further 
analyses described in chapter 7 suggested that habitual consumption of coffee at a 
higher level, but not the time a subject had declared to be a consumer of coffee, may 
reduce the bioavailability of coffee chlorogenic acids, a hypothesis that is in line 
with recent observations reported by Erk et al. and Stalmach et al. (Erk et al., 2012, 
Stalmach et al., 2014). Also, the inhibition of sulfotransferases by coffee 
compounds, or other habitual dietary foods correlated with the consumption of 
coffee but not tested in this study, may contribute to the negative association 
observed between the variables of coffee consumption and dihydrocaffeic acid-3-O-
sulfate, a major colonic chlorogenic acid-derived metabolite. Finally, from the daily 
lifestyle habits tested, only the physical activity seemed to have an impact on the 
bioavailability of the coffee chlorogenic acids. The obtained data are illustrative of 
the complexity of the field and indicate that the bioavailability of (poly)phenols and 
their impact on health result from the combined action of multiple factors and 
compounds, which as observed in this study, do not equally affect the biomarkers of 
health. 
 The chart presented in Figure 8.1 summarizes the major significant 
associations between the studied variables in the present study. Not presented in the 
chart are the associations with gender or age and the substrate-to-product ratios of 
aminothiols that were assessed (chapter 6) not to be suitable indicators of the 
enzymatic activity of specific reactions in the transsulfuration pathway. 


















































































































































































































































































































































































































































Figure 8.1: Significant associations detected in the present research study between 
the studied variables, upon adjustment for potential confounders. Bold lines 
represent positive associations and dashed lines represent negative associations. a, 
age; g, gender; WHR, waist-to-hip ratio. 
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8.2 Strengths of the present study 
-  A major strength of the present study is the novelty of the approach for 
understanding the health effects of particular (poly)phenols in the long-term, by 
studying the link between their habitual consumption from diet, their absorption and 
general health biomarkers. 
-  Another strength, when compared to some published works (de Bree et al., 
2001, Nygard et al., 1997, Nygard et al., 1998, Rasmussen et al., 2000) is the 
analysis of fasting plasma for the measurement of the health biomarkers, which 
excludes any post-prandial effect on the target biomarkers.  
-  An improvement compared to previous studies, was the increase of the 
washout period length from 24 hours to 36 hours to ensure the elimination of 
metabolites resulting from the consumption of (poly)phenol-rich foods consumed 
prior the commencement of the study. As seen in previous pharmacokinetic studies, 
some participants only reach baseline values for particular phenolic acids after 24 
hours following coffee consumption (raw data from Renouf et al. (2013)). 
-  The study population size of 62 subjects was appropriate, as determined by 
the sample size calculation, although a higher sample size would have allowed 
simultaneous adjustment of further confounders. 
-  The adjustment of the associations which were between the measured 
biomarkers of health or chlorogenic acid-derived metabolites and other variables for 
known confounders reduced the influence of these on the trend and strength of the 
relationships. However, the possibility of confounding by unmeasured factors cannot 
be ruled out. 
-  The urine samples have not been treated to hydrolyse the chlorogenic acids 
by any esterase, glucuronidase or sulfatase, so that the integrity of the compounds 
was maintained, representing the effective relative amount of metabolites. Also, the 
quantification was improved by the use of standards. 
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8.3 Limitations and adjustments that may be implemented for 
future studies 
-  Although, this may give rise to disagreements regarding ethical issues, a 
100% standardized and controlled diet for the study participants with overnight stays 
during the study period, including the washout and urine collection period following 
the consumption of coffee, may help reduce the inter- and most importantly the 
intra-individual variation in the bioavailability of coffee chlorogenic acids and allow 
a better identification of subjects with good or poor absorption (of chlorogenic 
acids). Due to lack of facilities for an overnight stay and financial means, this was 
unfortunately not feasible for the present study. 
-  The influence of genetics on the bioavailability of could be excluded if 
monozygotic twins with different or not habitual consumption of coffee, dietary and 
lifestyle habits would be the subjects of analysis. 
-  The analysis of faeces for microbiota and metabolites will certainly be useful. 
Microbiota are a major factor in the metabolism of consumed products and studying 
the microbiota populations in the faeces of participants will allow the construction of 
a microbiota profile and assess if these represent an important link between the 
circulating metabolites and the general health status. The analysis of metabolites 
excreted in the faeces would allow an estimation of the elimination by the biliary 
route. Although the urinary route elimination is the predominant, adding both the 
urinary and biliary route elimination fractions would provide a more complete 
estimation of the bioavailability of coffee chlorogenic acids in the subjects. 
-  In vitro investigations of the ability of coffee compounds to inhibit 
sulfotransferases responsible for the sulfation of chlorogenic acid derivatives will 
contribute to the understanding of why lower levels of dihydrocaffeic acid-3-O-
sulfate are associated with variables of higher habitual consumption of coffee is 
linked. 
-  A coffee beverage prepared with 4 g coffee was given to each subject. In 
order to take into account the difference in available body tissue surface, it may be a 
good idea to administrate a coffee beverage prepared from an amount of coffee per 
kg bodyweight. 
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-  The food frequency questionnaire was asked to be completed once for each 
participant. A repeated dietary assessment for each completed visit may help 
assessing the consistency of dietary habits for each study participant and minimizing 
the misestimation of the habitual food consumption by each participants. 
 
8.4 Concluding remarks 
 As much as it is important to understand the impact of widespread 
(poly)phenol-rich products on human health and the mechanisms behind it, studying 
the health effects of popular products such as coffee is an great challenge that 
requires a clever approach in order to be overcome. The study of new or sparse 
products, as well as selected (poly)phenols present in only certain foods, are more 
easily tested, since a totally naïve population may still be isolated and the exclusion 
of products containing the compounds of interest can easily be done with fewer 
dietary restrictions. Coffee is one of the most consumed beverages worldwide and 
therefore, finding non-consumers is very difficult and finding non-consumers that 
are willing to consume coffee for a research study is even more. The innovative 
approach used for running this project was based on the fact that an important inter-
individual variation in the bioavailability of (poly)phenols was observed, as reported 
by Renouf et al. (2010b) that obtained broad ranges of Cmax and Tmax, for intestinal 
phenolic acid equivalents. Each participant underwent a 36-hour wash out period 
prior to each visit to allow the clearance of (poly)phenolic-derived metabolites from 
any (poly)phenol-rich product consumed up to this point. Besides the challenges 
with the study design, all researchers conducting human studies are faced with the 
honesty and reliability of the participants. Although a food diary was kept by each 
participant, the only method of control used in this study was the profile of urinary 
metabolites at a fasting state and during the 36 hours following coffee consumption. 
Particularly urinary dihydrocaffeic acid-3-O-sulfate and feruloylglycine, which have 
been proposed to be sensitive biomarkers for the consumption of even small 
amounts of coffee (Stalmach et al., 2009). 
 Overall, the results obtained in the present investigations support previous 
reports and if not, this could be due to the characteristics of the present study 
population. The present research suggests that both roast and decaffeination reduce 
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the amount of free phenolics in coffee, as has previously been reported for the 
chlorogenic acid content (Clifford, 1999, Manach et al., 2004). Also, previous 
studies on the absorption and metabolism of chlorogenic acids have assumed that 
following consumption of coffee hydrolysis of chlorogenic acids was the major 
pathway for release of free phenolic acids metabolites. The data obtained in the 
current investigation further support this idea. 
 A higher consumption of (poly)phenol-rich products was not associated with 
a healthier profile of glucose metabolism, and the lack of association could be due to 
the fact that only 4 subjects had a regular daily coffee consumption ≥ 5 cups. The 
results of the present study suggest that a regular consumption coffee at the level 
reported by the study population (≤ 5 cups per day) is able to increase the levels of 
biomarkers of inflammation and cardiovascular health. 
 Finally, the data from the bioavailability part of this study are suggestive of a 
lower absorption of chlorogenic acids with a higher consumption of coffee, which is 
consistent with recent results from Erk et al. (2012) and Stalmach et al. (2014). A 
higher absorption of chlorogenic acids was associated with a varied outcome in 
regards to the profile of health biomarkers. 
 Interesting and promising results contributing to the knowledge of the impact 
of coffee and other (poly)phenol-rich products to the human health were revealed 
from this study. Studying the bioavailability of (poly)phenols and their influence on 
health is, however, a complex research field with still a lot remaining to be explored. 
A combination of a few adjustments to the design of future studies will complement 
the obtained results and provide more information about the complex and variable 
metabolism of (poly)phenols and further improve the understanding of the effects of 
coffee on human health. 
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